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Surface electrocardiography (ECG) is the most common non-invasive tool to diagnose 
cardiac diseases. It is solidly in the clinical practice from more than 80 years. The history of 
ECG is associated with evolution of many theories to find the best configuration for number 
of electrodes and their placement. The widest accepted theory originated the so called 12-lead 
electrocardiography, which was finalized in 1942 and it requires ten electrodes of which six 
are placed on the chest (precordium) and the remaining four at the extremities. The 12 lead 
ECG has been widely used all around the world since then. However, many hypothesis and 
assumptions which shape the 12-lead electrocardiography were found incorrect either during 
its development or after finalizing this framework. One important hypothesis is to subtract all 
the six chest electrodes’ potential from the “zero” assumed potential reference point, named 
after its inventor Wilson Central Terminal (WCT). Although this hypothesis was built upon 
an oversimplification of human body and many suggested to use different reference points, 
this hypothesis eventually was accepted and widely used. The WCT was known to have a 
high potential, which consequently could impair diagnosis by removing important features 
from the precordial leads. This associated error has been neglected as there was no routine 
approach available to measure the influence of WCT on the precordial leads. 
This thesis provides comprehensive literature review of the electrocardiography evolution to 
highlight the important theories behind the development of the electrocardiography device. 
More importantly, it discusses different electrode placement on the chest, and their clinical 
advantages. This work presents a technical detail of a new ECG device which was developed 
at MARCS institute and can record the WCT components in addition to the standard 12-lead 
ECG. This ECG device was used to record from 147 patients at Campbelltown hospital over 
three years. The first two years of recording contain 92 patients which was published in the 
Physionet platform under the name of Wilson Central Terminal ECG database 
 
 v 
(WCTECGdb). This novel dataset was used to demonstrate the WCT signal characterisation 
and investigate how WCT impacts the precordial leads. Furthermore, the clinical influence of 
the WCT on precordial leads in patients diagnosed with non-ST segment elevation 
myocardial infarction (NSTEMI) is discussed. The work presented in this research is 
intended to revisit some of the ECG theories and investigate the validity of them using the 
recorded data. Furthermore, the influence of the left leg potential on recording the precordial 
leads is presented, which lead to investigate whether the WCT and augmented vector foot 
(aVF) are proportional. Finally, a machine learning approach is proposed to minimise the 
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Chapter 1 Introduction 
This chapter introduces the research presented in this thesis. First, it provides detailed 
background information about the electrodes’ placement on the body for surface 
electrocardiography (ECG) recording. It then discusses the validity of Wilson Central 
Terminal (WCT) hypothesis, and a history of attempts to measure the actual potential of the 
WCT to highlight the motivation behind this research. Then, it describes a new ECG device, 
which provides the foundation upon which the research in this thesis is built introduced along 
with an overview of the undertaken research, a summary of thesis contributions, and a list of 
publications resulting from this research presented in this thesis. Finally, the overall layout of 
the thesis is presented. 
Some of the work presented in this chapter has been published in: 
1. H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O’Loughlin, M. I. 
Shugman, J. C. Tapson, A. Thiagalingam and G. D. Gargiulo. “Unipolar Cardiac Leads 




1.1 Electrocardiography in history 
This section reviews the milestones in the electrocardiography history, which have led to the 
current understanding of the ECG, its physiological model and clinical practice. Since this 
thesis also proposes a new setup for recording the potential of the chest electrodes, this 
review is focused on the changes in electrode placement on the body. The review presented 
here also covers the evolution of the Einthoven limb leads, precordial leads, and augmented 
leads. 
1.1.1 Einthoven limb leads  
The first electrical signal variation fluctuation associated with the human heart was recorded 
in 1887 by Waller [1], who applied four electrodes on limbs and one electrode on the mouth. 
He found the detected changes in an electrometer reading synced to the heartbeat [1], [2], and 
named the changes Cardiograph [1], [3]. Einthoven then improved the electrometer, such 
that the electrical heart activity could present five deflections. He called these deflections ‘P’, 
’Q’, ’R’, ’S’, and ‘T’, and introduced the term electrocardiography to present these 
recordings in 1893 [4], [5]. Later, he made a major breakthrough in electrocardiography by 
using the string galvanometer in 1901 to record the heart activity [2]. Many believed Ader 
initially developed the string galvanometer in 1881 for a different application [3], [6], and 
Einthoven only improved its sensitivity to use it in recording the heart activity. Namely, the 
string galvanometer was more sensitive and convenient than the electrometer [3]. It contained 
a silver-coated quartz filament (or string) in a strong magnetic field to measure the strength 
and direction of the current impressed by the heart to the body surface [7]. The string was 
moved in the magnetic field when the current of the heart moved through it [7]. Einthoven 
only used three electrodes on two arms and left leg, as he believed the electrodes on the right 
leg and mouth were redundant [8].  
Einthoven’s device was very bulky and far from the hospital. Hence, he used the telephone 
wire to receive the patients’ heart impulses from the hospital [9], [10]. He published the first 
clinical usage of a string galvanometer in 1906 and identified different arrhythmia patterns, 
including heart block, bigeminy, P mitrale, and left/right ventricular hypertrophy [3], [9]. He 
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then published different arrhythmia patterns from patients and showed the diagnostic 
possibilities for them in 1908 [11], [12]. Later, Thomas Lewis made a significant influence 
on electrocardiography clinical advancement. He characterised the atrial fabrication using the 
electrocardiogram in 1909 [11]. Lewis continued developing the clinical electrocardiogram 
until the late 1920s, which made him a great icon in cardiology [12].  
In 1912, Einthoven introduced three leads (I, II, and III) and their mathematical relations, 
which is known as the Einthoven Triangle hypothesis [8], [13], [14]. The vertices of the 
Einthoven Triangle are electrodes placed on the right arm (RA), left arm (LA), and left leg 
(LL) [2], [14]. In this theory, the human body is characterised as a two dimensional, 
homogeneous conductor, and a part of infinity with the heart considered as a single dipole 
and located in the centroid of the triangle [2], [8], [15], [16].  
I = LA − RA 
II= LL − RA 
III= LL − LA 
(1-1) 
As the three limb leads construct a closed-loop (Figure 1-1), Kirchhoff’s voltage law can 
show the relationship between the limb leads (Eq. 1-2) [15]. 
I + III = II (1-2) 
Although some researchers suggested a different system to record the heart activity [1], [15], 
[17], only the Einthoven limbs’ leads theory was clinically used for three decades [7], [15], 
[18]. While the three limb leads system was found satisfactory to determine arrhythmias, it 




Figure 1. 1 Illustration of the three Einthoven limb leads constructing a closed loop. 
 
1.1.2 Precordial leads  
The origin of precordial leads goes back to 1887 when the first recording from the human 
heart occurred [1]. Waller applied one electrode on precordium and another on a variety of 
positions, including four limbs and the back [1]. In 1900, Einthoven and Lint tried different 
electrodes configurations to reach maximum possible deflection, and he found the right arm 
and the apex the best locations to fulfill this requirement [19], [20]. However, precordial 
leads were neglected for several years after the introduction of the Einthoven limb leads [20] 
and were used only for a few clinical studies.  
In 1909, Lewis proposed modifying lead I and putting the right arm and left arm electrodes 
on the second and fourth right intercostal space [11]. He claimed this modification could 
improve recognition of P-wave in patients with auricular fibrillation [11], [21]. In 1914, 
Lewis et al. applied two electrodes directly to the ventricular surface, and showed that the 
recorded signal was impossible to be interpreted as it had variable shapes [22], [23]. 
In 1920, Wilson and Herrmann put five electrodes naming them with the letters A, B, C, D, 
and E, at different distances on an imaginary line drawn from fourth costal cartilage to below 
Poupart’s ligament on the left leg [24]. They paired these electrodes and recorded four leads 
(AB, BC, CD, and DE) and showed that the QRS deflection decreases with distance from the 
heart. Furthermore, they found out in the case that the referenced electrode was located in a 
considerable distance from the principal electrode, the shape and size of ventricular 
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deflection were almost the same and independent from the referenced electrode placement 
[16], [24]. This hypothesis was completed ten years later by Wilson, in which he described 
the influence of the distance of electrodes from the heart on recorded signals [25]. He showed 
that the potential of electrodes placed close to the heart is much larger than the potential of 
those electrodes placed on the precordium region. Similarly, both are five to ten times greater 
than the potential variation on the extremities [25]. Therefore, he concluded that although the 
second electrode placement has an impact on the precordial leads, its influence is negligible 
[25].  
In 1931, Wilson et al. further described this theory and introduced two new terms; “exploring 
electrode” and “indifferent electrode”. The anterior (exploring) electrode was designated as 
the principal electrode, while the posterior (indifferent) electrode had a minimum effect on 
recorded leads [26]. Therefore, the exploring electrode could be placed at every point of the 
human body, while the second electrode should be placed on only where it is considered far 
from the heart [26]. Wilson et al. also mathematically calculated the potential of the right arm 
(RA), left arm (LA), and left leg (LL) using three limb leads [26] (Eq.1-3). In 1932, Wilson et 
al. chose the left leg as an indifferent electrode and put four (or five in some cases) electrodes 













It is important to note that the importance of precordial leads in the diagnosis of cardiac 
diseases was first highlighted by Wolferth and Wood in 1932. They showed the limitation of 
three Einthoven leads to identify many cardiac diseases, and introduced two new precordial 
leads; named lead IV, and V. The lead IV was initially recorded by placing the exploring 
electrode near the cardiac apex and the indifferent electrode in the left paravertebral space 
[28]. They recorded lead IV from two patients with myocardial infarction and found "striking 
 
 6 
deviations in the S-T interval", while three Einthoven leads were quite normal [29], [30]. 
Since the Lead IV required putting an electrode on the patient’s back, it caused discomfort for 
patients. Therefore, Wolferth and Wood introduced lead V, which was recorded by placing 
the exploring electrode near the apex, and the indifferent electrode on the left leg [28]. They 
concluded that IV and V leads were identical, as both leads showed similar results. Therefore, 
it got customary to put the positive electrode on the left leg and refer it as lead IV [31]. These 
findings raised interest among researchers to employ precordial leads in the clinical practice 
[31] and assessed the lead IV clinical advantages [32]. It also initiated the wave of interest to 
apply principal and secondary electrodes on various places on the human body to find the 
chest lead, which yields the most information. 
Arthur Master recorded a chest lead from 104 healthy volunteers and reported the 
characteristics of the P-wave, T-wave, and QRS deflections in 1934 [33]. He attached the 
exploring electrode on near the lower level of the sternum about the level of the apex and 
placed the indifference electrode on the back over the vertebral column for most of the 
volunteers, and on the left leg for thirty patients [33]. Although he did not differentiate the 
results of the two groups and presented all the results together, he confirmed the Wilson 
hypothesis and reported no critical difference in changing the reference electrodes from back 
to the left leg [33]. Later in the same year, Wilson et al. published an important paper which 
shapes the fundamental of today’s precordial leads [34]. They suggested placing six 
electrodes on six points on the chest including the fifth rib at the right sternal edge, the fifth 
rib at the left sternal edge, the fifth intercostal space midway between the left sternal edge 
and the left midclavicular line, the fifth intercostal space in the left midclavicular line, the 
sixth rib in the left anterior axillary line, and the tip of the ensiform process. These six leads 




Figure 1. 2 The electrode placement of precordial leads suggested by Wilson’s group. Image taken from [35]. 
 
Wilson et al. also undermined the indifference reference theory and claimed that the reference 
electrode has a considerable influence on some of the details of the recorded signals [34]. 
Therefore, they presented a new theory, which is the fundamental of today’s precordial leads. 
They assumed the heart is a single dipole located in the centroid of the Einthoven equilateral 
triangle, and the average potential of three electrodes placed on right arm (RA), left arm 
(LA), and left leg (LL) would yield the potential of the heart, which is independent of the 




(RA + LA + LL) (1.4) 
Therefore, the potential of the dipole (heart) could be used as a reference point to record the 
potential of every point in the human body. Wilson et al. suggested to connect the 
indifference electrode to this reference point and place the exploring electrodes on any part of 
the body to record unipolar leads [34]. This reference point was called the Wilson Central 
Terminal (WCT) and was measured by connecting three large resistors to three limbs’ 
electrode [34]. The introduction of WCT was associated with two hypotheses; first, the WCT 
was assumed null as it represents the potential of the dipole (heart), second, the sum of the 
potential differences between three limbs’ electrode and the nodal point connected to these 
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electrodes through the equal resistances is zero (Kirchhoff’s first law) [16], [34]. These 
hypotheses had absorbed researchers’ attention to measure the real amplitude of the WCT 
and investigate the validity of the WCT zero potential. A complete survey of these attempts is 
listed in the next section. 
Kossmann et al., who were members of Wilson’s laboratory, published a complementary 
paper in 1935 to present more details of Wilson’s leads. They used six electrodes on the chest 
paired with Wilson Central Terminal and characterised all the deflections on each precordial 
lead [35]. A year later, Kossmann compared lead IV and V with Wilson’s lead by placing the 
reference electrode on the Wilson Central Terminal, the back, and the left leg to record a 
single electrode potential on the chest [36]. He only recorded from nine patients and 
concluded that although the influence of each reference points was small on precordial leads, 
each impacted differently on every patient. Since these differences were not medically 
important, he reported the reference point would not have a medical impact on the chest leads 
[36]. But they also reported the potential variation of leads coupled with the WCT is usually 
greater than the other two leads [36].  
In 1935, Roth suggested fixing the exploring electrode on the left and right pectoral and 
placing the indifferent electrode on the right arm and left leg, which resulted in four new 
leads including left pectoral-right arm (LPR), left pectoral-left leg (LPF), right pectoral-right 
arm (RPR) and right pectoral-left leg (RPF) [20]. He showed that despite the indifference 
reference point hypothesis, the placement of the secondary electrode influenced the recorded 
leads. Roth characterised a reference point as ideal if the chest leads present auricular and 
ventricular components of the cardiac cycle, maximum deflection in all principal 
components, and symmetry with the standard leads. Therefore, he concluded that the right 
arm was a better reference point than the left leg, as it fulfills these requirements [20]. 
Furthermore, he also placed the exploring electrode on the apex and reported it as the least 
reliable chest lead [20].  
Later in 1937, Larsen investigated the best placement of exploring and indifferent electrodes 
[37]. He recorded from one healthy subject and put two exploring electrodes on the lower left 
corner of the sternum and 4cm lateral to the apex [37]. He compared different reference 
points, including the right arm, left arm, left leg, Wilson Central Terminal, and the angle of 
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the right scapula to find the optimum place [37]. He claimed that the right arm is a most 
expedient reference point as the precordial leads’ deflections, in this case, are greater than 
those when using any other reference points [37]. Sorsky and Wood showed the similarities 
and differences in leads obtained by placing the exploring electrodes on the apex, left and 
right pectoral which are coupled with the right arm, and left leg [38]. They found out shifting 
the exploring electrode to the right of the apex resulted in relatively small positive deflection 
and less inverted T-wave [38]. They only characterised the chest leads’ deflections by 
recording from 150 healthy individuals, without suggesting a preferred reference electrode 
setup [38].  
There was no common opinion among researchers regarding the number of electrodes and 
their locations on the chest. Thus, the American Heart Association and the Cardiac Society of 
Great Britain & Ireland each appointed a committee to reach an agreement over the number 
and position of the electrodes in 1938 [39]. Wilson was a member of the standardisation 
committee; therefore, the committee was aware of his research group’s findings, including 
Wilson Central Terminal, unipolar lead concept, and the use of six electrodes on the chest. 
However, all the members except Wilson did not recognize the importance of these findings 
[18], [40]. Therefore, the standardisation committee only had a mutual agreement on using 
lead IV with reference to an arbitrary choice among the right arm, left arm, left leg, Wilson 
Central terminal, and left interscapular region [39]. A month later, the American Heart 
Association conducted a supplementary statement, which was more aligned with Wilson’s 
group achievements. In this report, six electrodes were suggested to be used on the chest 
naming (V1: V6), but still, there was no unanimous agreement on the second electrode 
placement [41]. Therefore, the right arm, left arm, and Wilson Central Terminal were 
reported as three feasible choices for the second electrode placement [41]. Additionally, this 
report claimed no significant difference in recording precordial leads using either the left leg 
or Wilson Central Terminal as the reference point [41].  
In 1938, Edwards and Vander Veer used standard six electrodes on the chest associating with 
the right arm, left arm, and left leg [42]. They recorded from ten healthy and fifty patient 
volunteers with an abnormal cardiac condition. They reported that the recordings coupled 
with the left leg did not present any superiority, while the leads which were referenced with 
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the right arm showed maximum deflections in almost all cases [42]. There were only three 
cases in the recordings with the left arm as the reference that presented greater deflections in 
the QRS and T waves [42]. 
Groedel conducted two comprehensive studies to find the least variant reference points in 
1939 [43]. In the first paper, he applied the reference electrode on the left leg, left arm, right 
arm, forehead, and back. He placed two exploring electrodes on the left border of the lower 
end of the sternum and the left axilla line at the height of the apex [43]. Groedel recorded 
from thirty-two subjects, including individuals with heart arrhythmia and healthy heart [43]. 
As in leads coupled with the right arm, the Q and S deflections were usually shown better and 
the T-wave was almost the highest, Groedel nominated the right arm as a better reference 
point [43]. In the second paper, Groedel added the WCT in the same experimental setting and 
recorded it from ten patients. He concluded that the LL and LA could cause having 
abnormality in the chest leads, while the recorded signals coupled with the RA were quite 
normal [44]. Furthermore, he showed that the maximum potential in each extremity presented 
at a very different time [44]. Consequently, the WCT amplitudes vary in different volunteers 
as the limbs’ potential can be completely or partially summed up, or they could neutralize 
each other more or less [44].  
In 1939, Geiger compared the IV leads referenced to the right arm, and left leg and found out 
that the IV R usually had more visible P, QRS, and T waves than the IV F. He recorded 400 
electrocardiograms from 349 patients and reported in more than eighty percent of recordings, 
the IV R and IV L were mainly the same. However, in fifty-five of the instances, the 
arrhythmia was either better shown or it was only presented in the IV F lead. Therefore, he 
suggested that the left leg was a superior reference point than the right arm [45]. In the same 
year, Wood and Selzer applied the exploring electrodes on the apex, right and left pectoral 
referenced respectively to the right arm, and left leg. They recorded six precordial leads from 
314 patients to clinically investigate the influence of the reference electrode’s position on the 
recorded signals. They came to the conclusion that choosing the right arm as the reference 
point leads to having more convenient and informative recordings compared to when the left 
leg is used as the reference point [46].  
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In 1942, Hecht investigated the influence of using four different reference points, including 
right arm, left arm, left leg, and Wilson Central Terminal on precordial leads’ shape and 
amplitudes [47]. He only used V1, V3, and V6 chest electrodes and recorded from twenty 
healthy volunteers. He concluded that the position of reference electrode has a notable 
influence on the size and shape of recorded precordial leads [47]. Furthermore, all the 
reference points were found to distort the recorded leads, but their influence varied in 
different volunteers. Therefore, he could not find the most desirable reference point for all 
patients. Nevertheless, he reported that while the distortion caused by the right arm was not 
smaller than the left arm or left leg, it is more uniform in the amplitude and duration. 
Moreover, he found that the WCT caused minimum distortion in the precordial leads [47].  
This uncertainty on choosing the WCT as the reference point continued, and it was clearly 
stated by Wolferth and Livezey in 1944 [48]. They suggested putting the reference electrode 
on the spine of the right scapula and compared the results with three precordial signals 
recorded with WCT as their reference point [48]. Wolferth and Livezey claimed that the 
Wilson Central Terminal has more interference with the potential variation of the chest 
electrodes; therefore, the spine of the right scapula is better for recording the unipolar leads 
[48]. In addition to the serious doubt in choosing the WCT as the reference point, using six 
electrodes on the chest was not widely accepted as most cardiologists used a single precordial 
lead even six years after chest electrodes standardisation [49]. Therefore, Wilson published 
two papers to establish the theoretical concept of using six chest electrodes and Wilson 
Central Terminal in 1944 and 1946 [16], [50]. In his papers, he confirmed the validity of 
previous experiments by measuring the actual potential of the WCT, which showed the WCT 
does not have a null amplitude, and it varies during the cardiac cycle. However, he still 
considered the WCT potential variations negligible compared to the potential of the exploring 
electrodes [50].  
However, there was still doubt in the validity of Wilson’s hypothesis, and its claimed 
theoretical advantages [51]. Therefore, practically every hypothesis was believed to be the 
only feasible approach to understand the advantages of each reference point [52]. In 1946, 
Wallace and Grossman compared the WCT and the left leg by recording three leads (V2, V4, 
and V5) from 91 volunteers. Their results showed that the WCT did not have any advantage 
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over the left leg, and both are equally acceptable [51]. Hoyos and Tomayo in 1947 [53] and 
Dolgin et al. in 1949 [54] compared four of the most commonly known reference points, 
including the right arm, left arm, left leg, and the WCT. Their experiment was similar to 
Hecht’s work in 1942 [47], except that they recorded from patients having different cardiac 
diseases [53], [54]. Hoyos and Tomayo recorded from ten healthy volunteers and a hundred 
cases diagnosed with different cardiac problems. They reported the left leg was the only 
reference that caused having more distortion on the precordial leads, and they did not find 
any particular differences in recordings obtained from healthy subjects using different 
reference points [53]. Furthermore, they found the chest leads coupled with right arm and 
WCT without having significant differences; therefore, as the right arm was easier to use, it 
was nominated as a better reference point [53]. Dolgin et al. used seven electrodes on 
precordium and confirmed the influence of different reference points on the shape and 
amplitude of the recorded leads [54]. They only found different interpretations in the 
recordings obtained using the left leg for five percent of the patients, while the recordings 
using other reference points showed the same interpretation [54]. Therefore, they could not 
find the ideal location for the reference point [54]. In 1948, Hull et al. recorded V1: V6 using 
both the left leg and WCT for four healthy volunteers. They found false T-wave inversions in 
the recordings using the left leg as the reference point [55].  
In 1949, the British Cardiac Society recommended to couple the reference electrode by the 
WCT and to discontinue using the right arm, and left leg [56]. However, this 
recommendation was not widely accepted, and the idea of finding the best reference point for 
the chest leads was still trending. Leatham compared the right arm, left leg, and Wilson 
Central Terminal by connecting them to seven electrodes on the chest in 1950 [57]. He put 
six electrodes on the standard positions and one on the posterior axillary line [57]. He did not 
clinically analyse the recorded signals and only reported the statistical factors such as mean 
and standard deviation of R, S, and T waves of the recorded signals. He concluded that the 
chest leads coupled with the left leg were too variable compared to the other references, while 
the WCT and right arm did not have any advantage over each other [57]. In the same year, 
Herrmann et al. compared the WCT, right arm, left arm, and left leg as reference points for 
the six standard precordial electrodes (V1: V6) [52]. They recorded from 200 healthy subjects 
and cardiac patients. They concluded that the left leg and left arm caused the most variations 
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on the recorded chest signals, which demonstrated false abnormalities depending on the 
electrical position of the heart [52]. They concluded that the Wilson Central Terminal was the 
superior reference, as the false abnormalities were neither obtained nor were significant [52]. 
Finally, the American heart association published the second report of standardisation in 
1954 and chose the Wilson Central Terminal as the reference point of precordial leads [58]. 
They suggested obtaining eight leads from the chest, designated as V1: V8 [58]. The chest 
electrodes’ location was standardised for each lead as described below [58]:  
• V1: the right sternal margin at the fourth intercostal space. 
• V2: the left sternal margin at the fourth intercostal space.  
• V4: the fifth intercostal space where it is crossed by the midclavicular line.  
• V3: a point midway between points 2 and 4.  
• V5: the junction of the left anterior axillary line with the horizontal level of electrode 
on position 4.  
• V6: the left midaxillary line.  
• V7: the left posterior axillary line.  
• V8: the left midscapular line.  
Table 1-1 shows a summary of the existing studies on the development of the precordial 
leads. Standardisation of the precordial leads did not stop the investigation of the validity of 
the Wilson Central Terminal, and the effort for measuring the actual potential of WCT 
continued in the following years.  
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electrode to the right of apex 
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The WCT amplitude varies in 
different patient. The LL and 
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1939 Geiger [45] one electrode on 
the apex 
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lead 
Left leg 
1939 Wood and 
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significant deflection in P and T 
waves in recordings coupled 
with right arm 
Right arm 
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left leg causes more distortion. 
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Right arm 
1949 Dolgin et. al. 
[54] 
V1:V7 right arm, left 
arm, left leg, 
and the WCT 
all recorded leads have the same 
interpretation, except for five 
percent of the leads, which 
coupled with the left leg 
No findings 
1948 Hull et. 
al.[55] 
V1:V6 left leg and 
WCT 
false T-wave inversion in 
recordings using the left leg as 
reference point 
WCT 
1950 Leatham [57] V1:V7 right arm, left 
leg, WCT 
left leg causes more distortion, 
while the right arm and WCT 
are equally acceptable 
Right arm or 
WCT 
1950 Herrmann et. 
al. [52] 
V1:V6 WCT, right 
arm, left arm, 
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WCT shows neither false 





1.1.3 Augmented leads 
In 1934, Wilson proposed to use three unipolar limb leads including vector right (VR), vector 
left (VL), and vector foot(VF), which were measured by the difference potential of limbs’ 
electrode and the WCT reference point [34].  
𝑉𝐿 = 𝐿𝐴 − Φ𝑊𝐶𝑇 
𝑉𝑅 = 𝑅𝐴 − Φ𝑊𝐶𝑇 
𝑉𝐹 = 𝐿𝐿 − Φ𝑊𝐶𝑇 
(1-5) 
Since the three unipolar limb leads had a small amplitude, Goldberger modified the WCT to 
increase the amplitude of these leads by 50% [59]. The new leads are measured as the 
potential difference between each limb potential and the average potential of the other two 
limbs. These leads are known as augmented leads and named as augmented vector right 
(aVR), augmented vector left (aVL), and augmented vector foot (aVF) [59].  
𝑎𝑉𝐿 = 𝐿𝐴 −
1
2
(𝑅𝐴 + 𝐿𝐿) 
𝑎𝑉𝑅 = 𝑅𝐴 −
1
2
(𝐿𝐴 + LL) 
𝑎𝑉𝐹 = 𝐿𝐿 −
1
2
(𝑅𝐴 + 𝐿𝐴) 
(1-6) 
The augmented leads were suggested in 1942 and finalized the development of the ECG lead 
system. In 1949, the committee of the British cardiac society suggested using three unipolar 
limb leads (VL, VR, and VF) [56], but seven years later, the American heart association 
recommended using three augmented leads [58].  
1.2 Wilson’s Central Terminal 
Wilson hypothesized that a neutral reference point of the human body could be measured by 
averaging the limb potentials. This reference point was introduced as having a null amplitude, 
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being steady, and locating in the centre of the Einthoven triangle [34]. The potential in the 
infinite medium has a null amplitude, which could be considered as the ideal reference point. 
In physics, we can only measure the potential difference between two points. However, we 
can have the potential of one point in case the second point is located in the far distance 
(infinity) from the first [60]. Thus, Wilson used three large resistors through which a 
negligible current would pass (based on Ohm’s law), and consequently, he was able to 
measure the limbs’ potential (Figure 1-3) [34]. 
 
Figure 1. 3 The average potential of limbs yields Wilson Central Terminal. Image taken from [2]. 
 
1.2.1 The WCT Location 
In theory, the WCT is located in the centroid of the Einthoven triangle. However, a research 
conducted in 2005 shows that many cardiologists do not have a clear understanding of 
unipolar leads and the WCT concept [61]. As mentioned earlier, although there was an initial 
wave of interest working on the fault in the WCT assumption after Wilson hypothesized this 
concept, the associated error has been widely accepted, and the topic received scant research 
attention. Furthermore, there is no consensus understanding of the Einthoven triangle, as its 
edges have been considered differently in the literature. Hence, a clear view of the Einthoven 




Einthoven assumed the human body is a two-dimensional conducting homogeneous medium 
with the shape of a triangle. The heart is regarded as a single dipole in the centre of the 
triangle. The dipole changes its magnitude and direction in every moment, which causes it to 
change its electrical field. Considering these assumptions, the potential of every point in the 
body is measured by Eq. 1-7 [15], in which Φ is the potential of a single current dipole ?⃗? 






+ 𝑐 (1-7) 
R is the length of the vector ?⃗? directed from dipole source location to the target point and 𝜃 is 
the angle between vectors ?⃗? and ?⃗?.  
As it is shown in Figure 1-4, the distance between each limb electrode and the dipole is 
equivalent. Therefore, the difference between the limb potential amplitudes is only dependent 
on the angles 𝜃1, 𝜃2(𝜃1 + 120) and 𝜃3(𝜃1 + 240). It could be easily shown that for every 
direction of the heart vector, the sum of the limb potential is equal to zero [62]. 
   
 
Figure 1. 4 Einthoven assumed the potential of each limb only depends on the angle between 𝑝 and ?⃗? vectors. 
The geometrical position of the limb electrodes shaped the Einthoven triangle [62]–[64]. 
Wilson assumed the symmetrical orientation of the heart vector with respect to the electrodes 
on the limbs [65]. He hypothesized that the potential of the heart dipole is equal to zero and 
calculated by the average of the Einthoven limb potentials. Although the Einthoven 





known to be tainted by oversimplification of the human body, and the electrical heart activity. 
The same argument can be made for the Wilson hypothesis.  
The WCT located in the centroid of the Einthoven triangle, represents the potential of the 
single dipole, and its potential is equal to zero in the case, in which the three limb electrodes 
are placed in the same distance from the heart, and all Einthoven assumptions are correct. 
However, as it can be referred from Eq. 1-7, in case that the imaginary line between limb 
electrodes do not build up the equilateral triangle, the limb potentials depend on the  𝑅 
amplitude and the angle 𝜃. Consequently, the centroid of the triangle cannot represent the 
dipole anymore. Furthermore, other assumptions (the electrical activity of the heart is a single 
dipole located in the centre of the body, and the human body is a homogeneous conductor) 
are ill-posed models of the human body [62]. 
In some literature, there is also a misunderstanding between geometrical space and electrical 
space. As an example, in the standard surface ECG representation, it is possible to see that 
limb leads are the edges of the Einthoven triangle; this can be easily shown to be incorrect. 
The Einthoven law (Eq. 1-2) contradicts with the fact that equilateral triangle edges are in the 
same length, and more importantly, three limb leads could only construct a triangle (not 
equilateral) for less than 50% of the cardiac cycle [66]. 
1.2.2 The WCT Measurement 
Wilson assumed the WCT has a zero potential, which was found incorrect and attracted 
immediate interests among researchers to measure this systematic error in 
electrocardiography. The WCT measurement methods can be categorized into two different 
perspectives. 
In the first approach, the human body is immersed in a large homogeneous conductor to 
measure the potential difference between the WCT and the assumed zero potential (the water 
itself). In 1938, Eckey and Frohlich immersed a human body into a full bathtub and 
determined the WCT amplitude to be in a range of 0.2-0.3 mV [67]. A year later, Burger and 
Wuhmann conducted the same experiment and immersed five men into a bathtub filled by 
water and reported an amplitude of 0.26 mV for WCT [68]. In 1946, Wilson submerged a 
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human in the Lake Michigan and found that the average absolute amplitude of the WCT 
could be as large as 0.15 mV [16]. Dolgin et al. repeated the same experiment with different 
adjustments in 1949. They confirmed that the WCT is not zero, and its amplitude varies in 
different subjects [69]. In 1954, Bayley et al. and Bayley and Kinard encased the body of 
volunteers inside a metal structure and immersed it in water for the duration of the recording 
[65], [70]. They found out that the WCT is not steady, and its amplitude could be as large as 
0.4 of Einthoven’s leads during the cardiac cycle [65], [70], [71]. Thus, they used three 
rheostats, adjusting the weights of the three WCT components, which led to minimising the 
WCT amplitude [65]. The legitimacy of the first approach was undermined by a variety of 
factors, including the effect of water pressure on ECG recording and the degree of the 
conductivity of surrounding water [72]. Additionally, the zero potential of surrounding water 
[16], [48] and the widespread use of this method [73] have been questioned.  
In the second approach, the zero potential of the human body was measured using either 
numerical methods [15], [74]–[76] or surface potential mapping [77]–[79]. In these methods, 
the zero potential is not exactly aligned with the WCT definition. However, they referred to it 
as Wilson Central Terminal. The numerical methods are developed based on the theory that 
the summation of the electrical potential at the body surface should be zero [15]. Miyamoto et 
al. used 128 electrodes placed on the thorax and averaged their potentials to estimate the 
amplitude of the human reference point. They reported the average value of the WCT as -
0.169 mV in 10 normal volunteers and -0.051 mV in all 60 subjects, including the controls 
and patients [72], [77], [78].  
In a third approach, the potential of the right arm, left arm and left leg were directly measured 
using the right leg as a reference point [80]. A new electrocardiography device was recently 
developed, which uses the right leg as a new reference point to measure the actual potential 
of three limbs’ electrodes and six chest electrodes. The new ECG device can simultaneously 
measure new nine unipolar leads in addition to the three limb leads and six precordial leads 
[80]–[84].  
The full development of the new ECG device is not a part of this project. Therefore, the 
hardware description is shortly discussed in the following section. 
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1.3 Research Motivation 
The presented literature review discussed the evolution of electrodes’ placement in 
electrocardiography. There were different opinions on choosing the optimal location for both 
the exploring and the reference electrodes to record the chest leads. Wilson had a great 
influence to the development of precordial leads. He published different hypotheses, which 
proved to be partially incorrect over time. However, these hypotheses were (and still are) at 
the foundation of precordial leads standardisation.  
Wilson’s first hypothesis pertaining the best placement of the reference electrodes was known 
as the ‘indifferent electrode’ theory. He believed that the reference electrode could be placed 
anywhere on the body, as long as it was far from the exploring electrode. Later, he found that 
although the reference electrode was placed far from the heart, it caused distortion on the 
recorded chest leads. Therefore, he published his second theory in the reference electrode’s 
placement. He introduced the Wilson Central Terminal as a new reference point, which he 
believed its potential amplitude to be zero. This theory was also proved to be wrong during 
the time in two different ways: 
• Comparison of different reference electrodes: some researchers compared the WCT 
reference point with other possible reference points. Eleven studies in the period of 
[1936-1950] made this comparison. The WCT was found as an ideal reference point only 
in four of the studies. Three studies found the WCT and other compared reference points 
equally desirable; three studies found the right arm as the best reference, and one study 
chose the Spine of right scapula the most ideal reference point.  
• Measuring the WCT amplitude: there are only a few studies in measuring the WCT 
amplitude in the period of [1938-1954]. They found the WCT was not constant during the 
cardiac cycle, and the WCT has a minimum amplitude of 0.15 mV and a maximum 
amplitude of 0.4 percent of lead II.  
A summary table including the reviewed different configurations of electrodes placement 
with their clinical features is presented in Table 1-1.  
 
 22 
Furthermore, the heart was theorized to act as a current source, and the electrocardiography 
model measured bio-currents using a very sensitive galvanometer (string galvanometer). 
Einthoven did not include the right leg in the cardiac conduction model, as the right leg is the 
most distant limb from the heart. Furthermore, there is no evident current pathway that 
includes the heart when the instrument is connected between the two legs. In other words, 
ECG recordings were intended as a measure of the net current impressed by the heart 
circulating into an external circuit closed by the measurement instrument. Therefore, Wilson 
could complete the transformation from the equilateral triangle (Einthoven’s triangle) to the 
equivalent star circuit (originating the augmented leads) when he faced the problem of 
finding a reference for precordial leads. In theory, if each of the Einthoven leads measures the 
net current impressed by the heart between the two limbs, averaging all the electrodes 
together should give the best approximation of the point of origin, the neutral point of the 
cardiac electrical activity. 
Impractical use of current measurement devices and the link between current and voltage 
resulted in the replacement of all ECG current measurements with voltage. However, this 
replacement neglected that measuring voltage instead of current requires dealing with the 
different impedances of body sections. In fact, each lead is interpreted as the voltage drop 
across a composed resistance (impedance, as a matter of fact) due to the net current 
impressed by the heart to the points of measurement based on Ohm’s law  
(Voltage = Resistance * Current). For example, lead I in Figure 1-5 can be interpreted as the 
drop of voltage across the sum of the contact impedance at both electrodes that includes the 
impedance of the two arms and the impedance of the chest across the shoulders that changes 
with respiration.  
The current and voltage measurements are perfectly interchangeable if the body is simply 
considered as a homogeneous volume conductor (constant resistance) with the limb 
electrodes placed at equal distance with no or negligible contact impedance. However, in real 
life, recording the contact impedance imbalance between the ECG electrodes is often not 
verified. Additionally, the limb leads are measured across different sections of the chest, 
which are different in shape, and their resistance changes with respiration and body posture, 
resulting in adding a frequency-dependent delay and a phase difference between the voltage 
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and current. The modified phase relationship between the voltage and current may also affect 
the limbs’ potential, and consequently, the WCT. Moreover, as the voltage potential 
difference between the reference point (right leg) and the other limb electrodes are used to 
measure the RA, LA and LL potentials, different body and contact impedances may impose 
different delays upon the limb potentials, resulting an unpredictable alteration of WCT [81], 
[84]. 
 
Figure 1. 5 Ideal measurement of lead I vs real measurement of lead I. Left panel shows idealized measurement 
of lead I using voltage; right panel refers to real measurements of lead I in which includes contact impedances 
(Zc1 and Zc2) and variable impedance of torso (Zt). 
Based on the Einthoven theory, if the limb electrodes are placed on the same distance from 
the heart, the WCT presents the potential of the dipole. However, it is not the case in practice. 
The WCT amplitude is highly dependent on where the limb electrodes are placed (Eq. 1-7). 
Hence, it is evident that the amplitude of average limb potentials would not be negligible. On 
the other hand, the location of the limb electrodes influences the shape and amplitude of 
precordial leads [85]. As our device uses the right leg as the reference point to measure the 
potential of the electrodes on the chest, the WCT variation does not affect the true unipolar 












1.4 True Unipolar ECG recording device 
The new ECG device was designed to record traditional ECG signals in addition to the nine 
true unipolar leads, including three limb potentials and six unipolar chest leads. The true 
unipolar leads are the raw biopotential measured from the exploring electrodes directly 
referred to the right leg (RL) (Figure 1-6). Although the right leg was not included in the 
original ECG montage, it was added as a necessary return grounding for voltage amplifier as 
well as a way to reduce the interference from external electric fields [86]. Reduction of 
interference from external electrical fields is usually achieved with a technique known as a 
driven right leg or right leg driver, which typically implies an injection of a small current into 
the body (via the right leg electrode) and measuring amplifier circuits (via their reference 
terminal). In some specific biopotentials applications, the right leg driver is avoided using a 
technique known as voltage reference bootstrap, which might result in reducing the common 
noise capture. [2], [15], [86]. 
 
Figure 1. 6 In our approach, the limb potential and unipolar chest lead are measured in respect to the right leg. 
Driven right leg circuitries (DRLs) are widely used for the majority of the designs. Using the 
DRL increases patient safety because the human body is not directly grounded [2], [86], [87]. 
Figure 1-7 shows an example of the DRL application. As can be seen, the human body is 
driven by a measure of the common mode signal at the measuring electrodes while the 





Figure 1. 7 ECG amplifier using right leg driver (lead I) 
We designed our hardware around the instrumentation amplifier INA116 [89], manufactured 
by Texas Instruments, Dallas, Texas USA (Burr-Brown series). According to the part 
specifications, its bias current (i.e. the load to the physiological signal source) is typically 
only 5 fA. This extraordinarily small value is achieved by the combination of an extremely 
high input impedance with a relatively small parasitic capacitance and an embedded active 
guard ring buffer (see technical documentation [89] for precise details). In order to preserve 
the mentioned characteristics, the printed circuit board is designed to take advantage of the 
embedded active guard ring amplifier on a Teflon substrate. Although the guard ring 
amplifier’s primary job is to reduce the noise pick-up at cable and board connections, as this 
offers a replica of the input signal, we also use it to measure the raw voltage of the WCT 
components [81], [83], [84], [90]. 
To ensure high conductivity of connections between pins and exposed pads on the board, the 
latter are silver-plated by immersion during manufacturing. To avoid mearing of solder under 
the chip body and between pins during soldering, the chip body is sealed in position prior to 
soldering, using a suitable printed circuit board with a non-conductive epoxy resin. As an 
additional precaution, the conductivity between electrode connections and chip pins is 
verified before soldering, using a multimeter. Each pin of the INA116 is then manually 
soldered to the pad using lead-free silver-based paste with a 0.2 mm diameter hot iron tip. To 
further minimise  parasitic capacitance at the board level, the guard ring pattern is repeated on 
each layer of the board, and aside from the chips’ necessary connections, no other traces are 
routed in the area under each INA116. As a last precaution, as recommended in the existing 
literature, wire connections to the chip are directly soldered to the board on the top layer (no 
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thru-hole connections) [91]–[93]. Finally, the assembled board is coated with conformal 
coating to protect it from moisture that could contaminate the board due to its use in the 
hospital environment (frequent cleaning and wiping of the enclosure/cables with 
disinfectant).  
The simplified schematic of the hardware, limited to the four limbs and one of the precordial 
leads, is depicted in Figure 1-9. Protection from electrostatic discharges is achieved by 
interconnection of a single high-precision low-noise Panasonic surface mount ECG series 
100 kΩ resistor. Protection against defibrillation discharges and simultaneous high-
impedance biasing of the INA116 electrodes’ connections is achieved by parallel connection 
of low-voltage activation gas discharge tubes with an arc voltage as low as 15 V [94]. Such  
connections protect the sensitive chip inputs even for voltages that are lower than the 
embedded overvoltage protection [94]. Discharge tubes also offer the perfect biasing pathway 
for INA116 due to their nominal resistance >10 GΩ and a negligible parasitic capacitance. 
The gas discharge tubes are not represented in Figure 1-8 to avoid cluttering.  
As mentioned, and as it is possible to infer from the schematic, the guard buffer of the left-
leg, left-arm, and right-arm electrodes are also used to measure the WCT components’ 
voltages directly. The gain set for the INA116 chips is 1 V/V, achieved by leaving pins 1 and 
8 floating (not noted in Figure 1-8). Necessary gain and band bass filtering is achieved by 
two AC coupled active non-inverting low-pass filters gaining 10 V/V and 100 V/V 
respectively. Each gain cell is designed around the amplifier chip OPA140 [89]. Aside from 
its very low-noise figure, the OPA140 has been selected because of its high slew rate, 
immunity from phase inversion, and very low current-bias. Owing to these characteristics, we 
have designed a high-gain non-inverting band-pass filtering gain cell that does not require 
additional biasing and copes well with the frequent swings between saturation voltages due to 
ECG artefacts. Aside from the value of some passive components to achieve different gains, 




Figure 1. 8 Simplified schematic limited to limbs’ connections and one of the precordial leads. 
 
 
Figure 1. 9 Active band-pass filter gain cell, see Table 1-2 for components’ values. 
In order to achieve a diagnostic quality ECG, both the high-pass and low-pass corner 


























































This part of the circuit is replicated six times (one for each precordial lead)
1 [V/V]
Non-amplified WCT reference signal for precordials 10 [V/V]
BP filter
100 [V/V]































than the theoretical values. In this way, even in the worst-case scenario of a −10% value due 
to the capacitor tolerances, the required bandwidth is assured. Frequency content 
normalization to the diagnostic bandwidth is operated via software after the signal 
acquisition. Components’ values are reported in Table 1-2 for both gain cells. Differences 
between values of components are highlighted in bold. As an additional precaution, high-
precision Murata ceramic capacitors have been used. 
Table 1. 2 Summary of components’ values for the gain cells. 
Component  10 V/V Gain Version 100 V/V Gain Version 
C-HiP 47 µF 47 µF 
R-HiP 100 kΩ 100 kΩ 
C-LowP 15 nF 1.5 nF 
R-F 100 kΩ 1 MΩ 
R-gain 10 kΩ 10 kΩ 
As noted in Figure 1-9, the circuit includes a modified voltage bootstrap circuitry [81], [82], 
[87], [90], [95] that directly drives the reference voltage of the circuit with a damped version 
of the average of all the electrodes. This solution proved successful in all of our past circuit 
implementations [81], [90], [96], particularly when the right-leg connection is included in the 
average. However, for this implementation, we introduced a driven-right-leg circuitry 
designed and dimensioned to contain the current drive to 20 µA [86], [97], [98]. The input 
signal for the driven-right-leg circuitry is the non-amplified average of the measurement 
electrodes (see Figure 1-9). 
The entire circuit is powered by a dual 9 V power supply formed by two 9 V batteries in 
series that proved sufficient for a day of recordings in the hospital. Digital conversion and 
data logging is operated at a 16-bit depth over the range of ±5 V and with a sample rate of 
800 Hz by the BIOADC [98], powered directly by the USB connection to a host laptop 
computer (battery-powered). Necessary anti-aliasing low-pass filtering at the Nyquist 
frequency is embedded in the BIOADC. The entire system is hosted on a standard hospital 
instrumentation trolley that allows easy transportation of the device around rooms, wards and 
ambulatories for the recording.  
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1.5 List of Publications 
The work presented in this thesis has resulted in seven peer reviewed works as leading 
author, one published ECG dataset, and three peer reviewed journal papers as a co-author. 
The full text of publications is provided in the appendix B. 
The ECG recorded dataset was published on Physionet platform as: 
• H. Moeinzadeh, G. Gargiulo, “Wilson Central Terminal ECG Database”. PhysioNet 
2019. Available at: https://doi.org/10.13026/f73z-an96 
I was a co-author of three peer-reviewed journal papers, which are listed below: 
1. G. D. Gargiulo, P. Bifulco, M. Cesarelli, A. L. McEwan, H. Moeinzadeh, A. O'Loughlin, 
M. I. Shugman, J. C Tapson, and A. Thiagalingam, “On the ‘Zero of Potential of the 
Electric Field Produced by the Heart Beat’. A Machine Capable of Estimating this 
Underlying Persistent Error in Electrocardiography” Machines, vol. 4, p. 18, Oct. 2016 
2. G. D. Gargiulo, P. Bifulco, M. Cesarelli, A. L. McEwan, H. Moeinzadeh, A. O'Loughlin, 
M. I. Shugman, J. C Tapson, and A. Thiagalingam, “On the Einthoven Triangle: A 
Critical Analysis of the Single Rotating Dipole Hypothesis” Sensors, vol. 18, p. 2353, Jul. 
2018 
3. K. Rajesh N. V. P. S., R. Dhuli, P. Pławiak, G. R. Naik, H.Moeinzadeh, G. D. Gargiulo, 
and S. Gunnam. “Towards Real-Time Heartbeat Classification: Evaluation of Nonlinear 
Morphological Features and Voting Method,” Sensors, vol. 19, p. 5079, Nov. 2019 
I was a lead author of seven published papers including two journal papers, one peer 
reviewed book chapter and four conference papers. 
1. H. Moeinzadeh, G. D. Gargiulo, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O'Loughlin, 
M. I. Shugman, J. C Tapson, and A. Thiagalingam,“Computing a new central terminal 
for ECG recording using combined genetic algorithm and linear regression from real 
patient data”. In: Proceedings of the Genetic and Evolutionary Computation Conference 
Companion (GECCO17). 2017. p. 293–4. 
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2. H. Moeinzadeh, G. D. Gargiulo, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O'Loughlin, 
M. I. Shugman, J. C Tapson, and A. Thiagalingam,“Minimize Wilson Central Terminal 
Using Genetic Algorithm”. Hear Lung Circ. 2018 Jan 1;27:S330.  
3. H. Moeinzadeh, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O'Loughlin, M. I. Shugman, 
J. C Tapson, A. Thiagalingam, and G. D. Gargiulo, “Minimization of the Wilson’s 
Central Terminal voltage potential via a genetic algorithm”. BMC Res Notes. 2018 Dec 
20;11(1):915. 
4. H. Moeinzadeh, G. Gargiulo, P. Bifulco, M. Cesarelli, A. O’Loughlin, M. I. Shugman, 
and A. Thiagalingam, “A Modern Wilson’s Central Terminal Electrocardiography 
Database” Hear. Lung Circ., vol. 27, pp. S293–S294, 2018 
5. H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O’Loughlin, M. I. 
Shugman, J. C. Tapson, A. Thiagalingam and G. D. Gargiulo. “Einthoven Unipolar 
Leads: Towards a better understanding of Wilson Central Terminal”. In: 2019 
International Conference on Electrical Engineering Research & Practice (ICEERP). 
IEEE, 2019:1–4. (Awarded best paper) 
6. H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O’Loughlin, M. I. 
Shugman, J. C. Tapson, A. Thiagalingam and G. D. Gargiulo. “Unipolar Cardiac Leads 
Between History and Science” in Biomedical Signal Processing, (pp. 203–224), 2019.  
7. H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. O’Loughlin, M. I. Shugman, and 
A. Thiagalingam, G. Gargiulo, “WCTECGdb: A 12-Lead Electrocardiography Dataset 
Recorded Simultaneously with Raw Exploring Electrodes’ Potential Directly Referred to 
the Right Leg”. Sensors 2020; 20:3275.  
In addition, the following papers are currently under consideration for publication (at the time 
of submission): 
1.  H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O'Loughlin, M. I. 
Shugman, J. C Tapson, and A. Thiagalingam, and G. D. Gargiulo, “On the resemblance 
between Wilson Central Terminal (WCT) and -2/3 of augmented Foot lead (aVF)”, 
Submitted to Applied Science journal, 2020. 
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2. H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O'Loughlin, M. I. 
Shugman, J. C Tapson, A. Thiagalingam, and G. D. Gargiulo “ECG abnormalities 
detected in Non-ST-segment Elevation Myocardial Infarction patients with a novel ECG 
device”, Submitted to JACC case report, 2020 
1.6 Thesis Organization 
Chapter 1 of the presented thesis provides a comprehensive literature review of the evolution 
in electrocardiogram leads. This chapter is partially published as a book chapter in the 
Biomedical Signal Processing book. 
Chapter 2 introduces the Wilson Central Terminal ECG database, which is published on the 
physionet platform. This chapter present the WCT signal features. Chapter 2 is a combination 
of one peer-reviewed conference paper, and a journal paper. 
Chapter 3 presents characterization of the limb’s potential, and whether the WCT and -
2/3aVF are equivalent. A reformatted version of this chapter is also combination of submitted 
peer-reviewed journal paper and published an IEEE conference paper.  
Chapter 4 presents clinical cases to discuss the influence of the WCT on recording precordial 
leads. This chapter is partially submitted as a case report to the JACC-case report journal 
paper. 
Chapter 5 presents an expert approach to minimise  the WCT using the genetic algorithm. 
This chapter is combination of one peer-reviewed journal paper and two conference papers. 
Chapter 6 concludes the thesis by discussing future directions and the overall contribution of 
the research. 
Appendix A provides MATLAB scripts of the graphic user interfaces developed for ECG 
recordings visualization with its corresponding user guidelines. 




Chapter 2 Wilson Central Terminal ECG 
database (WCTECGdb) 
This chapter introduce the WCTECGdb dataset, which was published on the Physionet 
platform. First, a brief background, discusses the differences between precordial leads and 
unipolar chest leads. It then describes the WCTECGdb features. Finally, the WCT signal 
characteristics is fully described in this chapter.  
Some of the work presented in this chapter has been published in: 
• H. Moeinzadeh, G. Gargiulo, “Wilson Central Terminal ECG Database”. PhysioNet 
2019. Available at: https://doi.org/10.13026/f73z-an96 
• H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. O’Loughlin, M. I. Shugman, and A. 
Thiagalingam, G. Gargiulo, “WCTECGdb: A 12-Lead Electrocardiography Dataset 
Recorded Simultaneously with Raw Exploring Electrodes’ Potential Directly Referred to 
the Right Leg”. Sensors 2020;20:3275.  
• H. Moeinzadeh, G. Gargiulo, P. Bifulco, M. Cesarelli, A. O’Loughlin, M. I. Shugman, 
and A. Thiagalingam, “A Modern Wilson’s Central Terminal Electrocardiography 





In this chapter, a unique dataset of surface electrocardiography is presented, which aside the 
standard 12-lead signals include the raw electrode biopotential for each of the nine exploring 
electrodes composing the 12-lead ECG system directly refereed to the right leg as well as the 
Wilson’s Central Terminal voltage potential (average of left arm, left leg and right arm 
potentials). This dataset comprises recording from 147 patients at Campbelltown Hospital, 
NSW Australia. With the unique 15-lead ECG device, I have been able to overcome the 
difficulties of recording the Wilson’s Central Terminal in a clinical setting and measure the 
potential of the chest electrodes independent from the WCT. I present an approach to 
measure the influence of the WCT on recording the precordial leads, which is referred as “the 
WCT error measurement” in this chapter. The recorded data confirmed that the WCT does 
not have negligible impacts on recording the precordial leads for 72 percent of patients. the 
WCT has standard ECG characteristics such as a P-wave and a T-wave with a high variability 
during the cardiac cycle.  
2.2 Background 
The 15-lead ECG device can record three limb leads (I, II, and III), six precordial leads  
(V1: V6), and the nine unipolar leads including the potential of three Einthoven limbs’ 
electrodes (LA, RA, and LL) and six chest electrodes (UV1: UV6) [80], [84], [90]. The 
average potential of three Einthoven limbs’ potential yields Wilson Central Terminal (WCT). 
Furthermore, the precordial leads can be obtained using the difference potential of unipolar 




(𝐿𝐴 + 𝑅𝐴 + 𝐿𝐿) 
(2-1) 
𝑉1: 𝑉6 = 𝑈𝑉1: 𝑈𝑉6 −𝑊𝐶𝑇 (2-2) 
Three Einthoven limbs’ potential have all the ECG segments, including P-wave, QRS, and  
T-wave. The left leg has the lowest potential among three limbs as it has the most distance 
from the heart. Furthermore, the left arm has the highest potential among Einthoven limbs in 
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only 47 percent of the patients (67 out of 147). As it is the first time to record three Einthoven 
limbs’ potential, they are fully discussed in chapter three.  
The WCT has been known as the zero-reference point to record precordial leads, while it was 
found having high amplitude [16], [67]–[71]. Therefore, it is fair to consider the WCT as a 
systematic error, which could remove important information from the actual potential of the 
chest electrodes (Eq. 2-2). As the real potential of chest electrodes (UV1: UV6) and the 
precordial leads were recorded simultaneously, it would be possible to investigate the 
influence of the WCT signal on the precordial leads’ shape and amplitude. In other words, the 
WCT error measurement could be possible by calculating the difference between the 
precordial leads and unipolar chest leads. The WCT error is embedded in every precordial 
lead either recorded from patients with cardiac abnormalities or healthy individuals. In this 
chapter, the statistical analysis of the WCT error for 147 patients is presented, and the clinical 
influence of WCT for NSTEMI patients is discussed in chapter four. Database characteristics 
The 15-lead ECG device can record signals using two different systems simultaneously [80]–
[84]. The ECG signals were recorded from patients at the Campbelltown hospital (New South 
Wales, Australia) over three years (2016-2019). All the patients volunteered for this study 
and gave written consent. This study was approved by the Ethics Committee of the South 
West Sydney Health District on 23rd September 2015 with the protocol number 
HREC/15/LPOOL/302.  
I published our recordings during the first two years in the Physionet platform. The dataset 
was published under the name of Wilson Central Terminal ECG database (WCTECGdb) 
[99], [100]. Each recording was segmented to ten seconds sections. Consequently, as the 
duration of the recording is different, each patient has a different number of segments, 
ranging between one to thirty-one. The WCTECGdb contains 540 ten seconds segments 
recoded from 92 patients (27 were female) [99], [101], [102].  
During the past year (2018-2019), 55 additional patients were recorded. Therefore, both 
published and recent records were included for the analysis performed in this thesis. Hence, 
the dataset comprises 147 patients (48 were female) with average age of 65.20 (with a 
standard deviation of 13.56). The majority of the patients had a history of cardiac disease and 
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had been admitted to the hospital from the emergency department because of difficulties in 
breathing and/or persistent chest pain. 
This dataset comprises raw and noise removed signals for the three limb leads, six precordial 
leads, nine unipolar leads including three WCT components, and six chest electrodes’ 
potential. As the WCT is the average of the limb potential, only the cleaned WCT signal was 
added into the dataset. The bandpass filter (0.05 Hz-149 Hz) and a 50 Hz with harmonics 
notch IIR filter were used to clean the signals. Both filters are 50th order and applied with a 
zero-phase lag [102].  
Supplementary information was included for each recorded segment, such as the patient’s 
‘age’, ‘gender’, ‘patient diagnosis’, and the ‘reconstructed precordial’ (if there is any). Each 
file in the dataset contains the signals and supplementary information listed in Table 2.1. 
Cleaned and raw signals are included in the dataset. The raw signals are specified by ‘-raw’ 
in the dataset (e.g., V2-raw) and refer to originally recorded signals prior to the noise filtering 
process. The WCT signal is only presented in a clean format [102]. 







I-raw I limb lead I 
II-raw II limb lead II 
III-raw III limb lead III 
V1-raw: V6-raw V1:V6 precordial leads 
LA-raw, RA-raw, LL-raw LA, RA, LL three WCT components  
UV1-raw: UV6-raw UV1: UV6 unipolar chest leads 









* Only included for 8 segments that needed to be synthesized for some of precordial leads. 
 
Synthesized precordial leads were included instead of directly measured signals for a total of 
eight segments (from 5 patients), due to poor signal to noise ratio and/or the final stage 
amplifier saturation. The signal saturation usually is seen when large contact impedances and 
electrode polarization generate large DC drifts at the unipolar potential that once amplified by 
the gain stages result in saturation of the output amplifier. As the potential of chest electrodes 
(UV1: UV6) and the WCT signal were recorded, the missing precordial leads could be 
reconstructed using Eq. 2-2. It should be noted that both cleaned and raw data are 
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reconstructed for these signals. These signals were flagged in the header file as 
“reconstructed precordial”, and present the list of patients and signals in Table 2.2 [102]. 
Table 2. 2 List of patients with reconstructed precordial leads 
Patient ID Segment ID Reconstructed precordial leads 
Patient7 Seg1 V2, V2-raw 
Seg2 V2, V2-raw 
Seg3 V1, V1-raw 
Patient8 Seg1 V1, V2, V1-raw, V2-raw 
Seg2 V1, V2, V1-raw, V2-raw 
Patient10 Seg1 V2, V2-raw 
Patient14 Seg1 V2, V2-raw 
Patient31 Seg1 V2, V2-raw 
 
The diagnosis quantity in the dataset is presented in Table 2.3. Unfortunately, the hospital 
could not provide us the diagnosis for ten patients, so the patient diagnosis labelled as “not 
reported” in the header files for those patients. 
Table 2. 3 Patient diagnosis list 
Patient diagnosis Count Patient diagnosis Count 
Angina 1 Non-ST segment elevation myocardial 
infarction (NSTEMI) 
23 
Atrial fibrillation 9 Pulmonary embolism-Atrial fibrillation 1 
Atrial flutter 1 Pulmonary embolism 1 
Atypical chest pain 5 Rapid atrial fibrillation with new 
cardiomyopathy 
1 
Cardiomyopathy 1 Rapid atrial fibrillation-pericarditis 1 
Chest pain 1 Severe Mitral Stenosis 1 
Complete Heart block 1 Sinus bradycardia 2 
Congestive cardiac failure (CHF) 
exacerbation 
1 Slow atrial fibrillation 1 
Congestive cardiac failure (CCF) 1 ST segment elevation myocardial 
infarction (STEMI) 
4 
Coronary artery disease 3 Stable angina 7 
Epigastric pain 1 Supraventricular tachycardia (SVT) 2 
Fall secondary to alcohol intoxication 1 Syncope 3 
Gastritis (non-cardiac chest pain) 1 Unstable angina 1 
Hypertrophic obstructive 
cardiomyopathy 
1 Urosepsis 1 
Inferior ST segment elevation 
myocardial infarction (STEMI) 
1 Ventricular tachycardia (VT) 3 
Myocardial infarction-Type 2 1 Not reported 10 
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2.3 Evaluation metrics 
Three consecutive beats were selected from each patient to analysis the recorded signals. The 
average peak-to-peak amplitude from these three beats for the WCT is measured, which was 
referred to the amplitude of the WCT. Two quantitative measurements are used to show the 
similarities between two signals (naming p and m):  
• Cross-Correlation: It is used to calculate the resemblance between two signals, where 
N, 𝜇 and 𝜎 are number of samples, the mean and the standard deviation of a signal, 
respectively. 
𝐶𝑜𝑟𝑟 =





• Sprague and Geer’s error [103], [104]: the agreement between two signals (m and p), 
which both have a length of N, could be measured using magnitude error (MS&G), 
























⁄  (2-5) 
𝐶𝑆&𝐺 = √𝑀𝑆&𝐺
2 + 𝑃𝑆&𝐺
2  (2-6) 
2.4 WCT characteristics 
The WCT initially assumed to be a steady signal with a negligible amplitude. However, in 
early attempts to record the WCT signal, the WCT was characterised as a high variant signal 
with a large amplitude [16], [65], [67]–[71]. Although these attempts were a significant 
breakthrough to show the incorrect assumption associated with the electrocardiography, the 
legitimacy and widespread usage of these attempts were undermined [16], [48], [72], [73].  
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The recorded signals from patients using the 15-lead ECG device gives the opportunity to 
obtain and analysis the WCT characteristics. Given the WCT as a systematic noise that could 
remove information from the potential of the chest electrodes, analysis of the WCT shape and 
amplitude could present the amount of this error. In other words, the WCT influences on 
recording the precordial leads could be measured by finding the dissimilarity between the 
precordial leads (V1: V6) and unipolar chest leads (UV1: UV6). In this chapter, the statically 
analysis of the WCT error on recording precordial leads is discussed. The clinical analysis of 
the WCT impact on the precordial leads requires conducting a well-powered study [105]. 
Since the WCTECGdb does not have enough recordings for each cardiac disease yet, the 
clinical analysis of the WCT on recording the precordial leads is shorty discussed in the 
chapter four.  
2.4.1 The WCT shape 
The WCT is constructed by three limbs’ potential, which all shows the ECG characteristics 
such as the P-wave and the T-wave. Therefore, the WCT signal presents with all ECG 
features. The distribution of the WCT polarity mostly has positive deflection, with some 
negative deflections and a handful of neutral polarities. The ‘neutral polarities’ is shown in 
those signals whose QRS is a bipolar and has an approximately equal positive and negative 
deflection [96]. Figure 2.1 demonstrates an example of positive, negatives, and neutral 
deflection of the WCT. 
2.4.2 The WCT Amplitude 
The WCT peak-to-peak amplitude for three consecutive beats is averaged, which presents the 
WCT amplitude for each patient. Figure 2.2 shows the WCT amplitude across the whole 
dataset. The WCT amplitude is in the range of [0.03 1.51] mV with the average and standard 







Figure 2. 1 Top panel: the WCT with positive deflection (patient ID 44); middle panel: the WCT with 
negative deflection (patient ID 50); bottom panel: the WCT with neutral deflection (patient ID 67). 
 
Figure 2. 2 The WCT potential amplitude for 147 patients. 





































































As it can be seen in Figure 2.2, contradictory to the WCT initial assumptions, the WCT has a 
high amplitude for many patients. However, the WCT amplitude is not a proper metric to 
show its impact on the shape or amplitude of the precordial leads for two reasons: 
a) The WCT relative amplitude: the WCT amplitude in relation to the precordial leads 
should be measured to show its real impact on precordial leads. It is a possible scenario 
that the WCT has high peak-to-peak amplitude, while it has a relatively small amplitude 
in regard to the precordial leads. Figures 2.3 and 2.4 present two patients with almost the 
sample WCT amplitude, while the WCT has different impacts on each patient’s 
precordial leads. Figure 2.3 shows a patient with 0.21 mV peak-to-peak WCT amplitude, 
which causes considerable differences between the unipolar chest leads (UV1: UV6) and 
the precordial leads (V1: V6). Noted, these changes may/may not be clinically important, 
and I do not intend to compare these two set of signals clinically in this chapter. Figure 
2.4 is an example of a patient with 0.19 mV peak-to-peak WCT amplitude. The precordial 
leads and unipolar chest leads are almost identical, which shows that the WCT signal has 
a negligible effect on recording the precordial leads. The combined Sprague and Geers’ 
error (CS&G) is used to show the agreement between the precordial and unipolar chest 
leads. 
b) P and T waves’ amplitudes: The QRS section of the WCT signal is not the only important 
part of the WCT signal, which influences the precordial leads. The P and T waves in the 
WCT signal could also remove information from the chest electrodes’ potential. Figure 
2.5 shows the patient with high peak-to-peak amplitude (0.4 mV) and relatively large P 
and T waves. Therefore, the WCT has considerable impacts on the P, QRS, and T 










Figure 2. 3 The influence of the WCT error in recording precordial leads. The unipolar chest leads and 
precordial leads are different in terms of shape and amplitude. The precordial leads are shifted by 0.5 mv from 
the original place for better visualization. (a) The WCT has a 0.21 mV peak-to-peak amplitude; (b) CS&G 
between V1 and UV1 is 0.47; (c) CS&G between V2 and UV2 is 0.42; (d) CS&G between V3 and UV3 is 0.75; (e) 
CS&G between V4 and UV4 is 0.33; (f) CS&G between V5 and UV5 is 0.54; (g) CS&G between V6 and UV6 is 0.66. 































































































































Figure 2. 4 The influence of the WCT error in recording precordial leads. The unipolar chest leads and 
precordial leads are identical. The precordial leads are shifted by 0.5 mv from the original place for better 
visualization. (a) The WCT has a 0.19 mV peak-to-peak amplitude; (b) CS&G between V1 and UV1 is 0.15; (c) 
CS&G between V2 and UV2 is 0.07; (d) CS&G between V3 and UV3 is 0.08; (e) CS&G between V4 and UV4 is 0.10; 
(f) CS&G between V5 and UV5 is 0.12; (g) CS&G between V6 and UV6 is 0.16. Recorded from 67 years old male 































































































































Figure 2. 5 The influence of the WCT error in recording precordial leads. The T and P waves have significant 
impact on the precordial leads. The precordial leads are shifted by 0.5 mv from the original place for better 
visualization.  (a) The WCT has a 0.4 mV peak-to-peak amplitude; (b) CS&G between V1 and UV1 is 0.34; (c) 
CS&G between V2 and UV2 is 0.11; (d) CS&G between V3 and UV3 is 0.30; (e) CS&G between V4 and UV4 is 0.64; 
(f) CS&G between V5 and UV5 is 0.64; (g) CS&G between V6 and UV6 is 0.55. Recorded from 58 years old female 


























































































































2.4.3 The WCT Error measurement 
The WCT peak-to-peak amplitude should be considered high or low in relation to the 
precordial leads’ amplitude, and all the WCT sections (P, QRS, and T waves) can have a 
considerable impact on recording precordial leads. Consequently, the Sprague and Geer’s 
error is used to measure the agreement between the precordial and unipolar chest leads. Since 
the Sprague and Geer metric calculates the combined phase and magnitude difference 
between two signals, it would reflect the precise impact of the WCT on recording the 
precordial leads. We defined ten error classes and plotted the number of patients within each 
(see Figure 2.6) to illustrate the error distribution among patients. Since there are a few 
patients having the WCT error greater than 0.9, they are grouped in one class with maximum 
error threshold of ten. The combined Sprague and Geer error (CS&G) is measured for every 
pair of precordial and unipolar chest leads (such as V1 and UV1). If the CS&G error of the 
patients is less than the nominated threshold for all the six precordial leads, a patient is 
assigned to that error group. 
 
Figure 2. 6 The distribution of the patients having different WCT error.  
The Sprague and Geer error presents the similarity between the unipolar chest leads and 
precordial leads. While an error of 0.1 presents the similarity of the signals, the error value of 
10 shows a significant difference between two recorded signals. Therefore, the impact of 
WCT on precordial leads is expected to be negligible in patients having small CS&G error. 
However, only visual comparison of the precordial and unipolar chest leads within each 
group can determine if the impact of WCT on precordial leads is negligible. Therefore, this 
visual comparison is used and divides patients into three groups based on the WCT influences 
on precordial leads recordings: 
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a) The WCT with a zero impact: patients having CS&G error less than 0.2 show to have 
identical precordial and unipolar chest leads (see Figure 2.4). About 14 percent of patients 
(20 out of 147) are categorized in this group (see Table 2.4). 
b) The WCT with a negligible impact: patients with CS&G error less than 0.3, have the WCT 
with insignificant impact on recording precordial leads. Therefore, the precordial leads 
have some minor differences from unipolar chest leads, but still they could be considered 
the same signals. About 14 percent of patients (20 out of 147) have the WCT with this 
characteristic (see Table 2.5). 
c) The WCT with a significant impact: the WCT has a considerable influence on recording 
precordial leads. For these patients, the clinical difference between precordial leads and 
unipolar chest leads should be investigated (see Figures 2.3 and 2.7). About 72 percent of 
patients (107 out of 147) have the WCT with this characteristic (see Table 2.6). 
Table 2.4, 2.5 and 2.6 show the correlation and Sprague and Geer’s error for each pair leads 
of precordial and unipolar chest leads for patients having the WCT with zero, negligible and 
significant impacts on the precordial leads recording, respectively. Noted, since the Sprague 
and Geer phase error (PS&G) could be negative, the absolute average is measured for each pair 
of leads. 
Table 2. 4 The correlation and Sprague and Geer’s error in patients having the WCT with 
zero impacts on recording precordial leads  
 (V1, UV1) (V2, UV2) (V3, UV3) (V4, UV4) (V5, UV5) (V6, UV6) 
PS&G 0.06 0.05 0.06 0.07 0.07 0.09 
MS&G 0.08 0.05 0.05 0.05 0.06 0.07 
CS&G 0.11 0.07 0.09 0.09 0.10 0.12 
Corr 0.96 0.98 0.98 0.98 0.98 0.97 
 
Table 2. 5. The correlation and Sprague and Geer’s error in patients having the WCT with 
negligible impacts on recording precordial leads. 
 (V1, UV1) (V2, UV2) (V3, UV3) (V4, UV4) (V5, UV5) (V6, UV6) 
PS&G 0.14 0.11 0.13 0.12 0.13 0.14 
MS&G 0.09 0.07 0.09 0.09 0.09 0.09 
CS&G 0.18 0.14 0.17 0.16 0.16 0.18 
Corr 0.95 0.97 0.95 0.95 0.96 0.95 
 
Table 2. 6. The correlation and Sprague and Geer’s error in patients having the WCT with 
significant impacts on recording precordial leads. 
 (V1, UV1) (V2, UV2) (V3, UV3) (V4, UV4) (V5, UV5) (V6, UV6) 
PS&G 0.31 0.22 0.28 0.29 0.40 0.45 
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MS&G 0.18 0.13 0.15 0.17 0.18 0.20 
CS&G 0.37 0.27 0.34 0.36 0.48 0.52 
Corr 0.32 0.80 0.88 0.85 0.82 0.80 
 
Figure 2.7 depicts the correlation drop by increasing the CS&G error intervals. The patients 
with small CS&G error (less than 0.3) have a high correlation (greater than 0.95) between 
unipolar chest leads and precordial leads.  
 
Figure 2. 7 Average correlation between unipolar chest leads and precordial leads within each error class. 
 
As the WCTECGdb was recorded from cardiac patients at hospital, it has some limitations. 
These limitations include (1) lack of data recordings from healthy subjects; (2) unequal 
distribution of age and gender in the collected; (3) unequal distribution of data for different 
cardiac abnormalities. Although the later limitation could be considered as bias in the WCT 
error analysis, the WCT error is present in every measurement regardless of the disease. 
2.5 Conclusion 
In this chapter, the WCTECGdb dataset is presented, which contains the WCT signal, six 
unipolar chest leads associated with three Einthoven limb leads and six precordial leads. The 
data is recorded from 147 patients at Campbelltown Hospital (Campbelltown, Australia). 
These recordings were partially published on the Physionet platform (92 patients). This 
chapter also characterised the WCT signal as a systematic error, which has a different 
influence on recording the precordial leads in every individual. Therefore, the dataset was 
divided into three groups of patients having zero, negligible, and significant WCT error. The 
results show that only 14 percent of patients have the WCT with zero impacts on the 
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precordial leads; therefore, unipolar chest leads and precordial leads are identical in patients 
within this group. The patients with a negligible WCT error are shaped 14 percent of the 
dataset, which they have similar unipolar and precordial chest leads with minor differences. 
The rest of the patients are categorized as having significant WCT error. These records are 
required a clinical investigation to measure the real impact of this error on precordial leads 




Chapter 3 Einthoven Limb Potential 
This chapter investigates the veracity of the Einthoven limbs’ potential assumption. Then, 
discuss whether the WCT and aVF are proportional. 
Some of the work presented in this chapter has been published or submitted in: 
• H. Moeinzadeh, J. Assad, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O’Loughlin, M. 
I. Shugman, J. C. Tapson, A. Thiagalingam and G. D. Gargiulo. Einthoven Unipolar 
Leads: Towards a better understanding of Wilson Central Terminal. In: 2019 
International Conference on Electrical Engineering Research & Practice (ICEERP). 
IEEE, 2019:1–4.  
• Hossein Moeinzadeh, Gaetano D Gargiulo, Paolo Bifulco, Mario Cesarelli, Alistair 
L McEwan, Aiden O'Loughlin, Ibrahim M Shugman, Jonathan C Tapson, Aravinda 
Thiagalingam, “On the resemblance between Wilson Central Terminal (WCT) and -





The Wilson central terminal (WCT) is at the foundation of modern electrocardiography 
(ECG); it is constructed as an average of the right arm, left arm, and left leg electrodes and is 
taught as not measurable directly. In addition, it is commonly accepted that the average of the 
three electrodes is dominated by the left arm (the highest potential) and that the left leg has a 
negligible amplitude that can be assumed as near zero. The latter assumption yields that the 
WCT resembles the -2/3 of the augmented Vector Foot (aVF) (also known as augmented foot 
lead). Since the current ECG device cannot record the WCT components, the validation of 
these hypotheses was impossible. Using the data was recorded from 92 patients included in 
the published dataset WCTECGdb (available for download at Physionet) and further 55 
recent recordings, all taken with the 15-lead ECG device capable of recording the WCT 
components together with standard 12-Lead ECG, the validity of these hypotheses was 
investigated. The results show that the left arm dominates the WCT for only 47% of our 
patients, while the left leg potential has a considerable amplitude for 25% of our recordings. 
These findings contradict the broadly accepted Wilson/Einthoven hypotheses and affect the 
shape of the WCT resulting with a low correlation between the recorded WCT and the 
 -2/3aVF. 
3.2 Einthoven limb hypothesis 
Einthoven assumed the body is a homogenous conductor, and the heart is a single dipole 
located in the centroid of the equilateral triangle [14], [15]. The electrical field varies in every 
moment by changing the dipole magnitude and direction. Therefore, the potential of every 
point with a distance R from the heart is measured by Eq. 3.1 which Φ is the potential of a 
dipole (?⃗? ) in infinite homogenous medium with a conductivity of (𝜎), and 𝜃 is the angle 







Hence, the potential decreases as 1 𝑅2⁄  by moving away from the dipole (heart) [15]. 
Furthermore, the left arm is considered to have a higher potential than the right arm as the 
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heart is located on the left side of the chest. The left leg has a negligible amplitude due to 
have a longest distance from the heart. 
Although this assumption is one of the results of the Einthoven hypothesis and has not 
directly affected the recording of 12 lead ECG, it was used to justify other assumptions and 
development in the field of electrocardiography [106]. Provided the left leg potential is 
approximately zero: 
𝐼𝐼 = 𝐿𝐿 − 𝑅𝐴   
𝐿𝐿≅0
⇒     𝐼𝐼 = −𝑅𝐴 (3.2) 
𝐼𝐼𝐼 = 𝐿𝐿 − 𝐿𝐴   
𝐿𝐿≅0




(𝐿𝐴 + 𝑅𝐴 + 𝐿𝐿)   
𝐿𝐿≅0





Since the current electrocardiography device cannot record the WCT amplitude, the 
authentication of relationship between the WCT and aVF is an alternative way to estimate the 
WCT signal. Given that the WCT is a systematic error with clinically relevant amplitude in 
recording the precordial leads [65], [70], [71], [78], this approach could be regarded as a 
solution for removing the WCT from the precordial leads, and it would obtain the “true 
unipolar leads” from the chest electrodes. The recorded WCT and aVF signals are used to 
evaluate this hypothesis. 
3.3 Evaluation metrics 
Three consecutive beats are selected from each patient to evaluate this hypothesis. The 
average of peak-to-peak amplitude from these three beats are measured for the LA, RA, and 
WCT. Therefore, the averages represent the potential of each limb’s electrodes and the WCT 
for each patient. We used two quantitative measures to show the similarities between two 
signals (naming p and m):  
• Cross-Correlation: It is used to calculate the resemblance between two signals, where 
N, 𝜇 and 𝜎 are number of samples, the mean and the standard deviation of a signal, 
respectively. 
𝐶𝑜𝑟𝑟 =

















Statistics results are measured from the WCTECGdb and the additional 55 recently recorded 
data and reported as a mean (𝜇) and standard deviation (𝜎). 
3.4 Wilson limb potential amplitudes 
The statistical analysis of three limbs’ potential and Wilson central terminal among all 
patients is demonstrated in Table 3.1. The average and standard deviation of the WCT are not 
negligible, which contradicts with the Wilson hypothesis. Therefore, the WCT amplitude is 
clinically relevant, which may cause removing important clinical information from the 
precordial leads. The statistical comparison of the limbs’ potential amplitudes aligns with the 
initial assumption in limbs’ potential. The LL has the smallest average and standard 
deviation, while the LA has the greatest potential among three limbs. However, this summary 
does not present the different characteristics of limbs potential; therefore, different 
approaches are used to have a comprehensive view.  
Table 3. 1 The average, standard deviation, maximum and minimum 
of each limb potential and Wilson centre terminal among 147 
patients. All results presented in mV. 
 LA RA LL WCT 
Average 0.56 0.47 0.09 0.27 
Standard deviation 0.33 0.23 0.08 0.17 
Maximum 1.56 1.35 0.64 0.90 
Minimum 0.08 0.10 0.02 0.03 
 
The minimum changes in the ECG signal amplitude to be considered clinically relevant is 
0.1 mV. This value is the current visualization scale in clinical ECG recording and is 
equivalent to 10 mm in the standard ECG graph paper. In other words, the uncertainly of the 
ECG amplitude measurement on the medical scale is 0.1 mV. Therefore, we chose 0.1 mV as 
a threshold to highlight the difference between limb potential. In other words, the peak-to-
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peak difference amplitude of two signals should be at least 0.1 mV to consider them having 
different amplitudes. Our results show that the left leg has the smallest amplitude among 
Einthoven limbs potential for all patients. Furthermore, the RA potential is higher than the 
LA potential for 47 patients (see Figure 3.1). The RA and LA have negligible different 
amplitudes for 31 patients due to having a less than 0.1 mV potential difference (|RA-
LA|<0.1 mV). Finally, the LA has a higher amplitude than the RA for 69 patients. Figure 3.2 
is an example of a patient having the RA potential near four times greater than the LA 
potential. 
 
Figure 3. 1 Patient with the RA potential higher than the LA potential (47 in total) with 0.1 mV threshold. The 
average of three peak to peak amplitude of the RA and the LA measured for each patient. 
 
 
Figure 3. 2 The comparison of Einthoven limbs’ potential. The LA, RA, and LL amplitudes are 0.124, 0.464 and 
0.038 mV. The LA and RA are shifted 0.2 mV from the original place for better visualization. Recorded from 





















































































































































As it was presented in Table 3.1, the LL has an average amplitude of 0.09 mV among all 
patients. Although the LL has the smallest potential amplitude among three limbs, it still 
required investigation to see whether its amplitude is negligible. Furthermore, we cannot rely 
on each limb potential, as all three limbs potential can be relatively high or low in different 
patients. Consequently, we measured the relative LA (rLA), relative RA (rRA) and relative 
LL (rLL) by dividing the RA, LA, and LL by their sum for each patient (Eq. 3.7).  
𝑟𝐿𝐴 = 𝐿𝐴 (𝐿𝐴 + 𝑅𝐴 + 𝐿𝐿)⁄  
(3.7) 𝑟𝑅𝐴 = 𝑅𝐴 (𝐿𝐴 + 𝑅𝐴 + 𝐿𝐿)⁄  
𝑟𝐿𝐿 = 𝐿𝐿 (𝐿𝐴 + 𝑅𝐴 + 𝐿𝐿)⁄  
Figure 3.3 presents the relative amplitudes of three limb potential for all patients. 
 
Figure 3. 3 The relative limb potential of each patient. 
3.5 The WCT and aVF resemblance 
It could be inferred from Figure 3.3 that the LL has a relatively small amplitude for most of 
the patients, which results to have a less impact on the shape and amplitudes of the WCT, II, 
and III. Nevertheless, the LL still has a relatively high amplitude for some patients. These 
two groups of the patients required independent analysis to reach a more precise conclusion. 
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Therefore, we divided our data into two groups using the threshold value of 0.1 for the 
relative LL amplitude. In other words, patients were grouped, which their LL amplitude 
shape at least 10 percent of the WCT. This threshold was chosen heuristically to maximize 
the correlation and minimise the root mean square error (RMSE) within each group. The 
class of patients with relatively small LL amplitude (< 0.1) contains 112 patients, while only 
35 patients belonged in a class with relatively high LL potential. Figure 3.4 shows the relative 
average amplitudes of limbs’ potential for each group.  
  
Figure 3. 4 The relative average amplitudes of limbs potential: (a) patients having relatively small LL 
amplitude (minimum: 0.01, maximum: 0.09, average: 0.06); (b) patients having relative high LL 
amplitude (minimum: 0.10, maximum: 0.28, average: 0.15). 
These two groups were analysed independently using the cross-correlation (Corr) and root 
mean square error (RMSE). Since the left leg is the reference point to measure leads II and 
III, and it is also used in WCT measurement, I intend to investigate the influence of the LL 
potential in measuring these three signals. Therefore, three sets of signals were compared 
together refer to Eq. 3.2, 3.3 and 3.4: (WCT, -2/3aVF), (III, -LA), and (II, -RA). As can be 
inferred from Table 3.2 and Table 3.3, the correlation is dropped considerably, and the RMS 
is increased in the patients with relatively high LL potential.   
Table 3. 2 The correlation and root mean square error for 35 patients 
with relatively high LL potential  
 𝐶𝑜𝑟𝑟𝜇 𝐶𝑜𝑟𝑟𝜎 𝑅𝑀𝑆𝐸𝜇 𝑅𝑀𝑆𝐸𝜎 
(WCT, -2/3aVF) 0.56 0.30 0.15 0.28 
(II, -RA) 0.74 0.31 0.13 0.28 
(III, -LA) 0.74 0.27 0.14 0.28 
 
Table 3. 3 The correlation and root mean square error for 112 
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patients with relatively small LL potential 
 𝐶𝑜𝑟𝑟𝜇 𝐶𝑜𝑟𝑟𝜎 𝑅𝑀𝑆𝐸𝜇 𝑅𝑀𝑆𝐸𝜎 
(WCT, -2/3aVF) 0.81 0.20 0.08 0.06 
(II, -RA) 0.91 0.13 0.05 0.05 
(III, -LA) 0.93 0.11 0.05 0.05 
 
Figures 3.5 and 3.6 demonstrate two patients having relatively low and high potential in the 
left leg. As can be seen in Figure 3.5, the potential of the LA, RA, and LL are 0.98 mV, 
1.21 mV and 0.09 mV, respectively. Therefore, the LL potential amplitude in respect to two 
other limbs is negligible, and consequently, these three set signals are highly correlated. 
Figure 5 demonstrates a patient with the high LL potential (0.47 mV) while the LA and RA 
have the potential of 1.20 mV and 0.91 mV. Consequently, the LL has a considerable impact 











































































Figure 3. 5 The influence of the LL potential on leads II, III, and WCT. To have a better visualization 
leads II, III, WCT are shifted 0.5 mV from the original place: (a) the average peak to peak potential of 
the LL among three beats is 0.09 mV which shape 4 percent of the WCT signal; (b) the correlation 
between lead III and -LA is 0.99 (RMS error: 0.02); (c) the correlation between lead II and -RA is 1 
(RMS error: 0.02); (d) the correlation between -2/3aVF and the WCT is 0.99 (RMS error: 0.11); 
Recorded from 59 years old male (Patient ID 27). 
Although the LL potential has the smallest amplitude among three limbs, it does not 
necessarily mean that it has a minor impact on the WCT shape and amplitude. Figure 3.7 
demonstrates a patient with the LA, RA and LL amplitudes of 0.23 mV, 21 mV, and 
0.09 mV, respectively. Since the LA and RA has almost the same peak-to-peak potential with 
inverse deflection, the LL has a major influence on the WCT signal. Therefore, the 
correlation between the WCT and -2/3aVF is very small (0.08). Since the WCT has a 













































































Figure 3. 6 The influence of the LL potential on leads II, III, and WCT. To have a better visualization 
leads II, III, WCT are shifted 0.5 mV from the original place: (a) the average peak to peak potential of 
the LL among three beats is 0.47 mV which shape 18 percent of the WCT signal; (b) the correlation 
between lead III and -LA is 0.94 (RMS error: 0.09); (c) the correlation between lead II and -RA is 0.91 
(RMS error: 0.09); (d) the correlation between -2/3aVF and the WCT is 0.82 (RMS error: 0.22). 
Recorded from 72 years old male (Patient ID 141). 
Figure 3.7 is a good example to justify the major impact of LL on the WCT signal compare to 
leads II and III. As it can be seen in Table 3.2 and 3.3, the correlation values between (II, -
RA) and (III, -LA) are higher than that between (WCT, -2/3aVF), while the RMS error 
between these three set of signals are not significantly different. 
This chapter aims to statistically investigate the Einthoven limb potential hypothesis. 
Therefore, we did not clinically study the influence of the LL on lead II, III, and the WCT 
signals, which is required increasing the number of patients to have a well-powered study for 
each cardiac disease [105]. This research is also limited by recording from patients with 
cardiac diseases admitted at the hospital with the average and standard deviation age of 64.85 
and 13.56, respectively. Our analysis shows that the LA has the highest potential among 
Einthoven limbs in only 47 percent of the patients (67 out of 147). Furthermore, the LL has 
the lowest amplitude among the Einthoven limb potential. Still, the LL amplitude could not 
be considered negligible for at least 24 percent of the patient (35 out of 147), consequently 
the WCT cannot be replaced by the -2/3aVF for all patient according to the derived statistical 
information. However, it does not necessarily mean that the difference between the WCT and 
-2/3aVF is clinically important, which requires more recordings for clinical investigation.  





































Figure 3. 7 The influence of the LL potential on leads II, III, and WCT. To have a better visualization leads 
II and III are shifted 0.2 mV, and the WCT is shifted 0.05 from the original place: (a) the average peak to 
peak potential of the LL among three beats is 0.09 mV which shape 17 percent of the WCT signal; (b) the 
correlation between lead III and -LA is 0.96 (RMS error: 0.06); (c) the correlation between lead II and -RA 
is 0.98 (RMS error: 0.06); (d) the correlation between -2/3aVF and the WCT is 0.08 (RMS error: 0.6). 
Recorded from 84 years old female (Patient ID 40). 
3.6 Conclusion 
In this chapter, the Einthoven limbs’ potential hypothesis is evaluated to find the relation 
between three limbs’ potential and investigate whether the WCT and aVF are proportional. 
The recorded data from the 15-lead ECG device is are used, which include 92 records from 
WCTECGdb and 55 recently recorded data. The obtained results show that unlike the initial 
assumption, the left arm has the highest potential among the three limbs in only 47 percent of 
the patients and the potential of the left leg is not negligible for all patients. Furthermore, the 
left leg has a considerable amplitude for 25 percent of patients, which consequently 
influences the shape and amplitude of the WCT. Therefore, the WCT and -2/3aVF has a 








































Chapter 4 Clinical investigation of Wilson Central 
Terminal 
This chapter presents nine case reports, which were recorded from NSTEMI patients. The 
clinical analysis of unipolar chest leads and the clinical impacts of the left leg potential on the 
chest leads are discussed using these recordings.  
Some of the work presented in this chapter has been submitted as a journal paper: 
• Hossein Moeinzadeh, Gaetano D Gargiulo, Paolo Bifulco, Mario Cesarelli, Alistair L 
McEwan, Aiden O'Loughlin, Ibrahim M Shugman, Jonathan C Tapson, Aravinda 
Thiagalingam, “ECG abnormalities detected in Non-ST-segment Elevation 






In patients presenting with chest pain, the electrocardiogram (ECG) and cardiac biomarkers 
(such as troponin) are the core tests used to diagnose non-ST-segment elevation myocardial 
infarction (NSTEMI). In current practice, the ECG is available in real-time whilst there is a 
time delay before cardiac biomarker results are available. ECG changes may include ST-
segment depression and inverted or biphasic T-waves [107]. However, often patients with 
NSTEMI do not show any changes in their ECG. In this chapter, a series of case reports are 
presented to show the influence of the WCT signal on precordial leads, and to investigate 
whether the WCT and -2/3aVF are clinically equivalent.  
4.2 Introduction 
The precordial leads (V1: V6) of current ECG devices measure the potential of the six 
electrodes on the chest with reference to Wilson Central Terminal (WCT). The WCT is 
obtained by averaging the potential of limb electrodes (Eq. 4.1) and assumed to have a zero 
potential. However, this assumption has been found to be incorrect by many researchers, 
including Wilson himself [16]. 
Chapter two and three discussed two assumptions in electrocardiogram. In chapter two, the 
legitimacy of WCT zero potential theory is investigated using the recently published dataset 
(WCTECGdb). This dataset contains 92 patients, which were recorded between 2016 and 
2018. It is shown that the patients could be divided into three groups with zero, negligible, 
and significant WCT error. The results show that only 28% of patients have the WCT with 
zero or negligible impacts on the precordial leads; therefore, unipolar chest leads (UV1: UV6) 
and precordial leads (V1: V6) are expected to be identical or to have small differences in those 
patients. The rest of the patients are categorized as having significant WCT error. These 
recordings require a clinical investigation to measure the real impact of this error on 
precordial leads and thus the diagnosis of cardiac diseases. In the third chapter of this thesis, 
the influence of left leg on the WCT is discussed. The left leg is commonly assumed to have 
a near zero potential; therefore, the WCT and -2/3aVF are highly similar (Eq. 4.2). It is 
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shown that the left leg has a considerable amplitude for 25% of the patients, and consequently 




(𝐿𝐴 + 𝑅𝐴 + 𝐿𝐿) (4.1) 
𝑎𝑉𝐹 = LL −
1
2
(RA + LA)    
𝐿𝐿≅0




In this chapter, the standard precordial leads (V1: V6) are compared with unipolar chest leads 
(UV1: UV6) to present the clinical impacts of the WCT on precordial leads. Furthermore, the 
similarity of the WCT and -2/3aVF is clinically analysed and showed whether the left leg 
signal has any important clinical influences on shaping the WCT signal. In the case that the 
left leg has a zero potential, the unipolar chest leads can be reconstructed by adding -2/3aVF 
to the standard precordial leads (Eq. 4.3). Consequently, comparison of the unipolar chest 
leads (UV1: UV6) and the reconstructed unipolar chest leads (UV1(R): UV6(R)) is provided to 
present the clinical influence of the left leg on the unipolar chest leads.  




The WCTECGdb dataset, in addition to the recent recordings (2018-2019) are used in this 
chapter. Only patients diagnosed with NSTEMI are used in this analysis as their precordial 
leads may present abnormalities such as ST-segment depression, ST-segment elevation, 
inverted or biphasic T-waves (see Figure 4.1) [107]. We do not investigate the clinical 
impacts of WCT on the ECG recordings from patients diagnosed with other cardiac diseases 
as only specific cardiac diseases causes abnormalities in precordial leads, and we only have 
enough ECG recordings from NSTEMI patients. In this chapter, nine patients are included in 








Figure 4. 1 ECG abnormalities in NSTEMI patient, adopted from [108] 
 
4.3 Clinical case reports 
Case 1. A 52 year old male presented with chest pain, on a background of hypertension and 
smoking. The high-sensitivity troponin-T on presentation was elevated at 34 ng/L 
(normal <15ng/L) and subsequently peaked at 1130 ng/L. Coronary angiography 
demonstrated a proximal left anterior descending lesion involving the first diagonal branch 
requiring percutaneous coronary intervention.  
Standard 12-lead ECG demonstrated sinus rhythm with anterior T-wave inversion. Figure 4.2 
(top and middle panels) shows the standard precordial leads (V1: V6) and unipolar precordial 
leads (UV1: UV6), recorded simultaneously. Whilst both ECGs have T-wave abnormalities, 

















of the WCT signal in the unipolar recording. The WCT modifies the ST segment as well as 
T-wave in unipolar chest leads. Therefore, the WCT induces the appearance of ST-elevation 
in unipolar leads with a more prominent T-wave inversion in the unipolar chest leads. 
Figure 4.2 (bottom panel) presents the reconstructed unipolar leads (UV1(R): UV6(R)), which 
lost the ST-segment elevation in all six leads. This is due to the differences between the WCT 
and -2/3aVF. 
As it can be referred from Figure 4.3, the ST is elevated near 3 mm (or mV) in the WCT 
signal, while the ST has near-zero amplitude in -2/3aVF. The left leg is the only difference 
between the WCT and -2/3aVF (Eq. 4.2); therefore, the shape and amplitude of the left leg 
potential add important clinical information to the unipolar chest leads (Figure 4.4). This case 
clearly contradicts to the common assumption about the similarity between WCT and  




Figure 4. 2 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar chest 
leads (UV1: UV6) (middle panel), and reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom 






Figure 4. 3 Comparison of the WCT and -2/3aVF. Recorded from a 52 years old male (PID 97).  
 
 
Figure 4. 4 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 52 
years old male (PID 97).  
Case 2. A 70 year old male presented with one hour of chest pain. The high sensitivity 
troponin-T was subsequently found to be elevated with a peak of 509 ng/L. Coronary 
angiography showed a proximal left anterior descending artery (LAD) lesion with 90% 
stenosis requiring percutaneous coronary intervention.  
As it can be seen from Figure 4.5, the shape and amplitude of the WCT and -2/3aVF are 
almost the same. It is due to the low amplitude of the left leg, which has almost zero 




Figure 4. 5 Comparison of the WCT and -2/3aVF. Recorded from a 72 years old male (PID 75). 
 
 
Figure 4. 6 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 72 years 
old male (PID 75). 
Figure 4.7 (top panel) shows subtle biphasic T waves in leads V2: V4. In the unipolar leads 
(Figure 4.7 middle panel) and reconstructed chest leads (Figure 4.7 bottom panel), there are 
much more obvious T-wave changes suggestive of Wellens’ syndrome [109]. Adding WCT 
and -2/3aVF to the standard precordial leads results in the appearance of prominent T-wave 
inversion in UV3 (Figure 4.7, middle panel) and UV3(R) (Figure 4.7, bottom panel), which 
demonstrates the clinical utility of our unipolar leads in the diagnosis of ischemia when 




Figure 4. 7 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar chest leads 
(UV1: UV6) (middle panel), and reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom panel). 
Recorded from a 72 years old male (PID 75). 
Case 3. A 51 year old male presented with chest pain at the emergency department. Coronary 
angiography showed a proximal LAD lesion with 70% stenosis requiring percutaneous 
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coronary intervention. Figure 4.8 demonstrates the three limbs potential, which reconstruct 
the WCT signal. The LA, RA, and LL present near 1 mm (or 1 mV) positive deflection on T-
wave, which cause having biphasic T-wave on the WCT signal (see Figure 4.9). Furthermore, 
the -2/3aVF does not show T-wave positive deflection, which confirms the influence of the 
left leg potential on the WCT signal and consequently on the precordial leads. 
 
Figure 4. 8 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 51 years 
old male (PID 94). 
 
Figure 4. 9 Comparison of the WCT and -2/3aVF. Recorded from a 51 years old male (PID 94). 
Figure 4.10 (middle panel) shows subtle biphasic T-waves in leads UV2: UV6, while standard 
precordial leads (top panel) and reconstructed unipolar leads (bottom panel) present normal 
upright T-waves. This difference is due to the incorporation of the WCT signal in the 




Figure 4. 10 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar 
chest leads (UV1:UV6) (middle panel), and reconstructed unipolar chest leads (UV1(R): 
UV6(R)) (bottom panel). Recorded from a 51 years old male (PID 94). 
Case 4. A 54 year old male presented with chest pain at the emergency department. His 
angiography showed proximal to mid LAD stenosis, which was subsequently stented (after 
optical coherent tomography (OCT) imaging). As seen in Figure 4.11, the WCT includes a 
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biphasic T-wave with an amplitude of 1 mm (or 1 mV) in both positive and negative 
deflections, while T-wave in -2/3aVF signal has only negative deflection with an amplitude 
of 0.5 mm (or 0.5 mV). This difference is clearly caused by amplitude of T-wave in the left 
leg potential (see Figure 4.12). The standard precordial leads and reconstructed unipolar chest 
leads are almost identical as the amplitude of -2/3aVF signal is negligible in T-wave section 
(see Figure 4.13). Nevertheless, the accumulation of WCT and standard precordial leads 
yields more markedly biphasic T-waves in UV1: UV3. The biphasic T-waves in UV1: UV3 
typically suggests proximal LAD disease which is known as Wellens Syndrome [109]. This 
was not apparent on the precordial leads but was predictive of the underlying culprit lesion. 
 
Figure 4. 11 Comparison of the WCT and -2/3aVF. Recorded from a 54 years old male (PID 85). 
 
Figure 4. 12 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 54 




Figure 4. 13 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar chest 
leads (UV1: UV6) (middle panel), and reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom 
panel). Recorded from a 54 years old male (PID 85). 
Case 5: A 52 year old gentleman presented to the emergency department with central chest 
and epigastric pain over three hours. This patient was on a background of hypertension, 
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central obesity ad fatty liver disease. His chest pain resolved with a glyceryl trinitrate (GTN). 
Blood tests showed an elevated troponin (high-sensitive) of 264 ng/L with a peak troponin T 
(high-sensitive) of 527 ng/L. He was treated as a NSTEMI with aspirin, clopidogrel and low-
molecular weight heparin infusion. A coronary angiogram was performed which 
demonstrated moderate left main disease (50% stenosis), an occlusion of the LAD 
proximally, and an ostial left circumflex artery (LCx) lesion (80% stenosis). He was referred 
and underwent coronary artery bypass grafting (CABG). As it can be seen in Figure 4.14, the 
left leg has near zero potential in P-wave and T-wave sections; therefore, the shape and 
amplitude of WCT and -2/3aVF are identical (see Figure 4.15).  
 
Figure 4. 14 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 52 
years old male (PID 56). 
 
Figure 4. 15 Comparison of the WCT and -2/3aVF. Recorded from a 52 years old male (PID 56). 
Furthermore, the WCT presents T-wave inversion, which modifies the T-wave on unipolar 
chest leads. Figure 4.16 (middle panel) presents inverted T-wave on UV2:UV3, and biphasic  
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T-wave on UV4, while standard precordial leads present less ischemic abnormalities. As seen 
in Figure 4.16 (top panel), V2:V3 present biphasic T-wave, and V4 shows upright T-wave. 
Therefore, the WCT clearly adds important clinical features to the precordial leads. 
 
Figure 4. 16 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar chest leads 
(UV1:  UV6) (middle panel), and the reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom panel). 




Case 6: A 75 year old lady presented to the emergency department with chest pain on 
exertion that had been occurring over the last three weeks and worsened on day of 
presentation. She had a background history that included cardiac risk factors of hypertension 
and hyperlipidaemia. Cardiac biomarkers were elevated with troponin T (high-sensitive) of 
316 ng/L and peaking at 517 ng/L. She was treated for NSTEMI and underwent coronary 
angiography that revealed an occluded proximal D1, with moderate proximal LAD and LCx 
disease. As it can be referred from Figure 4.17, the left leg presents small variation on  
T-wave section. Therefore, the WCT and -2/3aVF are the same (see Figure 4.18).  
 
Figure 4. 17 Comparison of left arm (LA), right arm (RA) and left leg (LL) potentials. Recorded from a 75 
years old female (PID 94). 
 
Figure 4. 18 Comparison of the WCT and -2/3aVF. Recorded from a 75 years old female (PID 94). 
The standard precordial leads do not present any ischemic abnormalities, while UV1: UV2 
include T-wave inversion, and UV3 presents with biphasic T-wave. Reconstructed unipolar 
 
 75 
leads (UV1(R): UV6(R)) and unipolar chests leads (UV1: UV6) have the same clinical 
interpretation, as the WCT and -2/3aVF are identical. 
 
Figure 4. 19 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar 
chest leads (UV1: UV6) (middle panel), and reconstructed unipolar chest leads (UV1(R): UV6(R)) 




Case 7: A 67 year old lady with a background of hyperlipidaemia presented to the emergency 
department with a two weeks history of worsening angina that became constant over the two 
days prior. Cardiac biomarkers were elevated at 118 ng/L and peaked at 627 ng/L. She was 
treated for NSTEMI and underwent coronary angiography that demonstrated a severe 
proximal first obtuse marginal artery (OM1) lesion (95%) for which she underwent 
angioplasty. The left leg presents with zero amplitude on T-wave; therefore, the WCT and -
2/3aVF are clearly identical (see Figure 4.20 and Figure 4.21).  
 
Figure 4. 20 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 67 years 
old female (PID 58). 
 
Figure 4. 21 Comparison of the WCT and -2/3aVF. Recorded from a 67 years old female (PID 58). 
As it can be seen in Figure 4.22, the standard precordial leads present biphasic T-wave on V1: 
V5 and upright T-wave on V6. Since the WCT presents with T-wave inversion, the 
accumulation of the WCT and precordial leads only reduces the positive deflection in 
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unipolar chest leads. Therefore, the UV1: UV4 show biphasic T-wave, while UV5 and UV6 
present upright and flattened T-waves, respectively. 
 
Figure 4. 22 Comparison of the standard precordial leads (V1: V6) (top panel), unipolar chest leads (UV1: UV6) 
(middle panel), and the reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom panel). Recorded from a 




Case 8: A 55 year old male with previous history of ischemic heart disease (NSTEMI with 
PCI to LAD) presented with chest pain at rest, which lasted for 15 minutes. Cardiac 
biomarkers were elevated with troponin T (high-sensitive) 55 ng/Ln on presentation and peak 
Troponin T (high-sensitive) of 1079 ng/L. He was treated for NSTEMI. A coronary 
angiogram was performed which demonstrated a severe mid LAD lesion (95% stenosis) for 
which he underwent angioplasty, as well as a proximal D2 stenosis (70%) that was treated 
medically. As it can be referred from Figure 4.23, the WCT and -2/3 aVF present the same 
shape and amplitude. This is due to the negligible amplitude of the left leg potential (see 
Figure 4.24).  
 
Figure 4. 23 Comparison of the WCT and -2/3aVF. Recorded from a 55 years old male (PID 93). 
 
Figure 4. 24 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 55 




The standard precordial leads show T-wave inversion on V2: V6. Since the WCT has a small  
T-wave inversion (see Figure 4.25), the unipolar chest leads (UV1: UV6) and standard 
precordial leads (V1:  V6) present with the same abnormalities. 
 
Figure 4. 25 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar chest leads (UV1: 
UV6) (middle panel), and reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom panel). Recorded from a 




Case 9: A 75 year old lady with a background history of small cell lung cancer for which she 
was receiving palliative chemotherapy was admitted with chest pain; cardiac biomarkers 
were elevated with troponin of 33 ng/L on presentation with a peak of 104 ng/L. She was 
treated for NSTEMI. A coronary angiogram was performed which demonstrated a critical 
proximal LAD lesion with 99% stenosis for which she underwent successful angioplasty. As 
can be seen in Figure 4.26, the left leg has a near-zero potential. Therefore, the WCT and  
-2/3aVF are almost identical (see Figure 4.27), and consequently, the unipolar chest leads 
(UV1: UV6) and reconstructed unipolar chest leads (RUV1(R): UV6(R)) have the same 
clinical interpretation (see Figure 4.28). The WCT signal presents with a flat T-wave; 
therefore, the unipolar chest leads do not show any clinical advantages.  
 
Figure 4. 26 Comparison of left arm (LA), right arm (RA) and left leg (LL) potential. Recorded from a 75 
years old female (PID 100). 
  





Figure 4. 28 Comparison between the standard precordial leads (V1: V6) (top panel), unipolar chest leads 
(UV1: UV6) (middle panel), and the reconstructed unipolar chest leads (UV1(R): UV6(R)) (bottom panel). 





The ECG is the key real-time diagnostic test to diagnose acute coronary syndromes in 
patients presenting with chest pain. However, often the ECG is normal in patients with 
NSTEMI. This chapter presented nine NSTEMI cases, which have ECG recorded just before 
undergoing angiogram. The unipolar chest leads (UV1: UV6), reconstructed unipolar chest 
leads (UV1(R): UV6(R)), and standard precordial leads (V1: V6) are compared for each 
patient. The medical assessment shows that the unipolar chest leads are more sensitive to 
show abnormalities for six patients, while the standard precordial leads and unipolar chest 
leads present the same features for only three patients. Furthermore, it is shown that the 
potential of the left leg can be medically relevant, as important clinical features are lost in the 
reconstructed unipolar chest leads for these three patients. 
The difference between the novel and standard ECG devices is in the recordings of the 
precordial leads, which look at the septum and anterolateral parts of the left ventricle, 
supplied by the left anterior descending coronary artery. Given the prognostic significance of 
left anterior descending coronary artery disease, improvement in ECG sensitivity as shown 
by this ECG device is likely clinically significant.  
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Chapter 5 The minimisation of the Wilson’s 
Central Terminal voltage potential via a genetic 
algorithm 
This chapter introduce an expert approach to minimise the Wilson’s Central Terminal using 
the genetic algorithm.  
Some of the work presented in this chapter has been published in: 
• H. Moeinzadeh, G. D. Gargiulo, P. Bifulco, M. Cesarelli, A. L. McEwan, A. 
O'Loughlin, M. I. Shugman, J. C Tapson, and A. Thiagalingam,“Computing a new 
central terminal for ECG recording using combined genetic algorithm and linear 
regression from real patient data”. In: Proceedings of the Genetic and Evolutionary 
Computation Conference Companion (GECCO17). 2017. p. 293–4. 
• H. Moeinzadeh, G. D. Gargiulo, P. Bifulco, M. Cesarelli, A. L. McEwan, A. 
O'Loughlin, M. I. Shugman, J. C Tapson, and A. Thiagalingam,“Minimize Wilson 
Central Terminal Using Genetic Algorithm”. Hear Lung Circ . 2018 Jan 1;27:S330.  
• H. Moeinzadeh, P. Bifulco, M. Cesarelli, A. L. McEwan, A. O'Loughlin, M. I. 
Shugman, J. C Tapson, A. Thiagalingam, and G. D. Gargiulo, “Minimization of the 
Wilson’s Central Terminal voltage potential via a genetic algorithm”. BMC Res 






The Wilson Central Terminal (WCT) is an artificially constructed reference for surface 
electrocardiography, which is assumed to be near zero and steady during the cardiac cycle; 
namely it is the simple average of the three recorded limbs (right arm, left arm and left leg) 
composing the Einthoven triangle and considered to be electrically equidistant from the 
electrical centre of the heart. This assumption has been challenged and disproved in 1954 
with an experiment designed just to measure and minimise WCT. Minimisation was 
attempted varying in real time the weight resistors connected to the limbs. Unfortunately, the 
experiment required a very cumbersome setup and showed that WCT amplitude could not be 
universally minimised, in other words, the weight resistors change for each person. Taking 
advantage of modern computation techniques as well as of a special ECG device that aside of 
the standard 12-lead electrocardiogram (ECG) can measure WCT components, a software 
minimisation method is proposed using data recorded from 72 volunteers. 
5.2 Background 
The ‘zero’ reference for the precordial leads was introduced by F. N. Wilson in 1931 and 
named after him as Wilson’s Central Terminal (WCT). It is derived by averaging three limb 
leads and was assumed to be steady and of negligible amplitude during the cardiac cycle. 
However, WCT is neither steady nor of negligible amplitude [60]. To quantify the WCT, 
Wilson proposed immersing the body in a large homogeneous conductor and stated that 
0.15 mV was its maximal value [16], [77]. Following this recommendation, Bayley and 
Kinard [65], [70] encased the body of volunteers inside a metal structure (called integrator 
electrode) that was immersed it in water for the duration of the recording. This set-up allowed 
them to compute what they called “zero of the potential for the human body”. With this 
experiment, they determined that the WCT is non-stationary during the cardiac cycle and its 
amplitude could be as large as 40% of Einthoven’s ECG signals [65], [70]. During the WCT 
measurement experiment, Bayley and Kinard also attempted a real-time minimisation of the 
WCT amplitude to bring it below a non-influent value [70]. During the experiment, they 
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made use of three rheostats instead of fixed resistors and adjusted the weights of the three 
WCT components continually reporting the achieved new amplitude.  
This chapter describes an expert approach which similarly to the originally attempted 
minimisation, performs a weighted average of the WCT components. The WCT minimisation 
performed using the genetic algorithm (GA) [110]. The WCT minimization approach 
currently is a post processing method, and it is not built inside our new ECG device. The GA 
is a heuristic search method for finding the optimal answer for problems with high 
computational complexity. This approach is used for those problems, that either lacks a 
deterministic solution or a deterministic polynomial time complexity solution. This algorithm 
is called “genetic” because is based on the concept of the biological evolution of individuals 
within a population where “chromosomes” mutates to achieve the survival of the fittest. A 
“chromosome” represents a possible solution to the problem that can mutate from one 
population of chromosomes to the next population (generation) by using a “selection” 
procedure. The chromosomes that are selected to be in the next generation also could be 
changed or become parents of new chromosomes in the process of “mutation”, and 
“crossover” [110]. 
5.3 WCT minimisation method 
This work aims to make feasible the idea that the WCT amplitude can be personalized and 
minimised during the recording. Taking advantage of our newly developed ECG device [80], 
a personalized (to the patient) software minimisation of the WCT is performed. To our 
knowledge, this is the first attempt since Bayley and Kinard’s effort in 1954 [70]. Figure 5.1 
demonstrates the schematic view of the hardware which measures the voltage of right arm 
(RA), left arm (LA) and left leg (LL) and the proposed approach to estimate M-WCT 
(whereas M stands for minimised) according to the following main criteria: 
1) Less variation than WCT during a cardiac cycle.  
2) Possibly be zero or near zero. 
3) In any case (worst case scenario), M-WCT amplitude should be less than 0.1 mV, so 




Figure 5. 1 Hardware (shaded square) and software (red circle) principle diagram, adapted from 
In order to fit the M-WCT into the genetic algorithm paradigm, it is needed to formalize the 
problem in terms of population, mutation, crossover and fitness function. Recalling that the 
WCT is the average of the limbs’ electrodes, the M-WCT is defined as the weighted mean of 
the WCT’s components. In other words, weights different from 1/3 are applied to the right 
arm, left arm, and left leg potentials (weights are labelled as: 𝛼, 𝛽, 𝑎𝑛𝑑 𝛾). These weights 
are constrained to be positive, non-null and less than one, such that the summation of these 
weights is equal to one. More formally: 
𝑀‐𝑊𝐶𝑇 = 𝛼∅𝐿 + 𝛽∅𝐹 + 𝛾∅𝑅       (5.1) 
0 < 𝛼, 𝛽, 𝛾 < 1   (5.2) 
𝛼 + 𝛽 + 𝛾 = 1   (5.3) 
Therefore, our method will minimise (5.1) according to the three main criteria enounced 
above respecting the constraints (5.2) and (5.3).  
5.3.1 Fitness function 
The role of the fitness function is to measure the quality of each chromosome (possible 
solution), in other words, the fitness function ensures “the survival of the fittest” hence 
converging towards the solution. Because the goal is to find the three weighted factors that 
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minimise WCT, the M-WCT (Eq. 5.1) could be, in the first instance, considered as the fitness 
function. However, the following Eq. 5.4 works better as the fitness function. This is because 
its shape and its nonlinearity provide an increase in the probability of having M-WCT with 
smaller values; in other words, it encourages the algorithm to converge more rapidly. The 




Figure 5. 2 Nonlinear fitness function is used to encourage individuals to have smaller M-WCT 
As shown in Figure 5.2, the slope of fitness function is non-linearly increased for the M-
WCT values less than 0.1 mV. Consequently, individuals with a medically irrelevant value 
(< 0.1 mV) are encouraged to be produced for the next population. 
5.3.2 Population  
The population represents all possible answers (chromosomes). A new population is 
generated during each iteration of the GA. Each individual represents a possible answer 
which contains three weighted factors (𝛼, 𝛽, 𝛾) and 80 individuals are chosen as population 
size. The first population is initialized by the WCT chromosome (𝛼 = 𝛽 = 𝛾= 1/3) and the 




The role of the crossover operation is to build the next population based on selected 
chromosomes of the current population. The single point [111] and averaging crossover [112] 
methods are used randomly to populate the next generation. In single point crossover, two 
parents are split from the same location, and each child gets right sub-chromosome of one 
parent and left sub-chromosome of another parent [111]. We also use the average crossover, 
which in every child is the outcome of averaging two random chromosomes [112]. 
5.3.4 Mutation 
The genetic algorithm exploits a mutation operator to avoid trapping into local optima while 
searching a diversity of possible answers. The permutation algorithm is used to change the 
position of three parameters in a selected chromosome. 
To ensure the genetic algorithm converges to an optimal solution, the elite member of each 
population is moved to the next generation directly. We also constantly preserve the WCT 
chromosome in each population. We apply our method to every voltages sample and compute 
three parameters to have the M-WCT trace during the cardiac cycle. 
5.4 Results and Discussion 
For this study, 72 patients from WCTECGdb [99] are used. Each patient selected data excerpt 
has a normalized length of 10 seconds. As mentioned earlier, three weighted factors (𝛼, 𝛽,
𝑎𝑛𝑑 𝛾),  are calculated using the GA to minimise Wilson Central Terminal. In Table 5.1, the 
average values of the three weights (𝛼, 𝛽, 𝑎𝑛𝑑 𝛾)  are reported. Furthermore, the average 
number of iterations that the GA needs to converge for each patient is included in Table 5.1. 
As it can be seen in Table 5.1, the GA converges to its best with an average number of 




Table 5. 1 Average of three achieved parameters (alpha, beta, and gamma), and the number of GA iteration for 
each patient. 
Patient ID Age Gender Alpha Beta Gamma GA Iteration 
P001 69 F 0.33 0.40 0.26 249.98 
P002 56 M 0.30 0.33 0.35 235.43 
P003 71 F 0.33 0.20 0.46 182.52 
P004 78 M 0.26 0.35 0.38 246.66 
P005 73 M 0.35 0.32 0.33 263.03 
P006 89 M 0.27 0.37 0.36 208.37 
P007 72 M 0.31 0.31 0.37 277.99 
P008 80 M 0.26 0.30 0.43 258.03 
P009 53 M 0.29 0.43 0.27 200.19 
P010 65 M 0.27 0.33 0.39 225.71 
P011 62 M 0.28 0.36 0.36 258.74 
P012 52 M 0.30 0.37 0.32 256.34 
P013 45 M 0.37 0.27 0.35 156.07 
P014 88 F 0.21 0.26 0.52 212.91 
P015 63 F 0.32 0.36 0.32 260.94 
P016 70 F 0.22 0.28 0.49 187.13 
P017 85 M 0.25 0.30 0.45 203.88 
P018 52 F 0.31 0.39 0.29 229.00 
P019 59 M 0.24 0.28 0.47 181.31 
P020 68 M 0.29 0.23 0.49 133.43 
P021 63 F 0.30 0.36 0.33 230.38 
P022 51 F 0.31 0.35 0.34 176.66 
P023 65 F 0.24 0.30 0.46 212.53 
P024 71 M 0.26 0.20 0.54 142.75 
P025 52 M 0.29 0.17 0.54 140.99 
P026 81 F 0.21 0.31 0.47 262.09 
P027 43 M 0.32 0.33 0.34 254.86 
P028 68 F 0.23 0.31 0.46 142.50 
P029 72 F 0.28 0.36 0.35 246.08 
P030 59 M 0.13 0.13 0.74 161.74 
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P031 54 F 0.31 0.19 0.49 122.83 
P032 67 M 0.31 0.35 0.33 204.84 
P033 55 F 0.21 0.13 0.67 119.09 
P034 58 M 0.26 0.20 0.54 128.99 
P035 56 M 0.25 0.29 0.45 239.17 
P036 70 M 0.16 0.29 0.55 143.35 
P037 52 M 0.29 0.21 0.50 143.28 
P038 74 F 0.28 0.27 0.45 133.95 
P039 76 F 0.25 0.25 0.49 154.59 
P040 53 F 0.21 0.30 0.49 207.53 
P041 76 M 0.24 0.18 0.57 238.04 
P042 78 M 0.18 0.29 0.52 177.94 
P043 94 M 0.22 0.22 0.55 230.17 
P044 82 F 0.30 0.33 0.36 225.20 
P045 66 M 0.18 0.18 0.64 221.82 
P046 59 M 0.29 0.16 0.55 176.14 
P047 64 M 0.20 0.30 0.50 147.33 
P048 75 M 0.27 0.29 0.43 253.13 
P049 83 M 0.23 0.28 0.49 191.23 
P050 73 M 0.28 0.35 0.36 198.35 
P051 59 M 0.18 0.29 0.52 200.31 
P052 57 M 0.28 0.30 0.41 202.55 
P053 66 M 0.18 0.21 0.60 182.24 
P054 84 F 0.29 0.31 0.40 157.48 
P055 70 M 0.21 0.28 0.51 203.28 
P056 58 M 0.25 0.33 0.41 140.74 
P057 59 M 0.18 0.23 0.59 172.85 
P058 66 F 0.21 0.26 0.52 207.90 
P059 51 M 0.23 0.29 0.48 219.87 
P060 61 M 0.19 0.19 0.62 217.25 
P061 68 F 0.37 0.28 0.34 183.96 
P062 56 F 0.30 0.32 0.37 159.35 
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P063 61 M 0.26 0.22 0.52 179.82 
P064 84 M 0.14 0.15 0.70 206.60 
P065 65 M 0.26 0.26 0.47 224.30 
P066 53 F 0.20 0.15 0.65 177.41 
P067 69 M 0.27 0.37 0.35 202.11 
P068 47 M 0.25 0.32 0.43 204.21 
P069 82 F 0.18 0.21 0.61 250.19 
P070 71 F 0.20 0.26 0.54 170.94 
P071 73 M 0.15 0.15 0.69 181.70 
P072 77 M 0.33 0.34 0.32 255.95 
       
Average 66.35  0.26 0.28 0.46 199.39 
Total: 72 patients               35% Females    
The WCT and M-WCT amplitudes were measured for each subject and reported as a 
percentage of lead II. We then averaged the measured amplitudes over five consecutive beats. 
In Table 5.2 we report the amplitude of the M-WCT and the WCT for each patient (both 
reported as a relative percentage to lead II). Our results show that the M-WCT relative 
percentage has a mean value of 7.45% with a standard deviation value of 9.04%, while the 
WCT relative percentage has a mean value of 58.85% with a standard deviation of 30.84%.  
Based on our measurements, the WCT recorded is highly individual, and can have standard 
ECG characteristics, such as a P-wave and a T-wave. Individuality was also found in the M-
WCT, as we show in Figure 4 and Table 2. However, due to the negligible general amplitude 
of M-WCT, we conclude that the clinical impact of the M-WCT is negligible with respect to 
the WCT. To show the characteristics of WCT and M-WCT signals, we measured the number 
of irrelevant points (amplitude < 0.1 mV) in both M-WCT and WCT signals and showed the 
decrease percentage of irrelevant points in Table 5.2. The ideal reference point has a value 
near zero with minimum variation during the cardiac cycle, consequently the number of 
points that are equal to zero (corresponding to iso-electric) also calculate for both WCT and 




Table 5. 2 Comparison of the WCT and M-WCT amplitudes in relation to lead II. 
Patient 
ID 
WCT amplitude as 
% of lead II 
M-WCT amplitude 




points decrease [%] 
P001 43.32 25.22 21.35 7.67 
P002 67.08 8.26 27.55 3.90 
P003 34.19 2.41 50.24 5.85 
P004 44.22 2.75 22.63 9.16 
P005 104.37 18.73 15.77 7.37 
P006 77.77 26.67 39.06 1.50 
P007 22.35 0.00 9.40 6.99 
P008 55.19 11.93 17.91 16.14 
P009 91.05 0.00 42.68 7.86 
P010 14.40 2.96 31.63 0.84 
P011 34.35 11.06 17.15 10.56 
P012 16.47 1.78 18.65 8.17 
P013 22.25 0.00 61.35 0.31 
P014 115.21 17.63 37.36 12.27 
P015 35.97 8.54 16.67 2.34 
P016 59.80 6.52 48.16 2.54 
P017 30.40 1.08 41.01 0.64 
P018 114.07 31.65 30.37 2.04 
P019 134.30 28.12 49.64 2.12 
P020 34.34 0.38 69.52 3.81 
P021 38.80 4.95 29.10 3.07 
P022 34.21 0.27 51.47 2.37 
P023 41.77 5.11 36.52 3.14 
P024 43.10 1.45 65.69 0.00 
P025 45.27 3.59 66.44 0.00 
P026 43.73 13.74 15.82 12.00 
P027 21.46 8.16 18.86 6.89 
P028 40.03 1.11 65.75 3.20 
P029 42.85 12.20 22.47 9.59 
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P030 58.59 3.13 58.96 18.67 
P031 25.77 0.38 73.82 2.26 
P032 49.53 0.00 39.76 1.20 
P033 41.64 0.34 76.63 5.76 
P034 29.87 0.20 71.54 2.20 
P035 78.56 10.56 25.38 14.66 
P036 56.36 1.08 65.92 2.96 
P037 35.47 0.94 65.39 1.39 
P038 33.71 0.00 69.37 1.87 
P039 42.46 0.53 60.90 5.24 
P040 36.86 4.84 39.57 1.26 
P041 71.01 10.81 26.52 15.32 
P042 111.88 18.45 52.29 9.79 
P043 91.78 13.06 29.78 6.37 
P044 52.80 3.60 31.97 4.75 
P045 75.27 11.70 33.45 24.50 
P046 59.21 2.79 52.91 7.75 
P047 56.56 5.72 65.27 4.70 
P048 83.31 11.25 19.99 6.17 
P049 24.86 0.00 46.37 0.00 
P050 118.82 11.04 43.39 5.22 
P051 123.12 25.31 42.77 3.82 
P052 74.55 7.49 41.58 4.65 
P053 86.42 5.11 49.64 8.22 
P054 10.65 0.53 59.39 0.79 
P055 68.50 3.18 40.61 6.54 
P056 88.95 1.33 66.47 6.32 
P057 70.29 0.21 53.51 6.86 
P058 82.20 2.90 38.52 4.97 
P059 68.92 8.43 33.58 6.84 
P060 53.92 0.70 34.85 5.69 
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P061 28.19 1.59 49.59 0.17 
P062 16.16 0.56 59.97 0.36 
P063 34.43 1.39 51.26 2.24 
P064 87.98 5.12 40.58 18.82 
P065 83.79 12.31 32.48 1.05 
P066 42.83 1.46 52.56 6.32 
P067 143.06 47.01 41.83 3.20 
P068 91.86 7.02 40.91 5.86 
P069 77.69 8.60 21.42 20.97 
P070 34.22 6.07 55.09 2.15 
P071 60.17 1.86 50.98 11.26 
P072 72.72 21.43 18.82 7.64 
      
Average 58.85 7.45 42.58 5.96 
Figure 5.3 shows an example of WCT in which a broader QRS feature with amplitude even 
higher than Lead II is observed. However, as one can infer comparing M-WCT and WCT 
(bottom panel), the relative amplitude of M-WCT has highly decreased compared to WCT 
relative amplitude. 
An example of the WCT signal with a marked T-wave is visible in Figure 5.4. As it can be 
seen, a marked T-wave deflection on the WCT trace (bottom panel) is synchronized with the 
T-wave on lead II (top panel). The WCT trace in Figure 5.4 is also an excellent example of a 
highly variable WCT and an almost steady M-WCT. In one single cardiac cycle, the 
deflection’s polarity of the WCT changes at least three times, and its amplitude reaches 
45.27% of lead II (average), while the M-WCT amplitude is 3.59% of lead II. 
Figure 5.5 is an example of high WCT amplitude with negative deflection. As seen, WCT has 




Figure 5. 3 Example of positive deflection WCT. M-WCT is 11.04% of lead II amplitude, while WCT is 
118.82% of lead II amplitude (average); the recording is from a 73-year-old male patient admitted at the 
hospital (Patient ID: P050). 
 
Figure 5. 4 Example of neutral deflection WCT. WCT is 45.27% of lead II amplitude, while M-WCT is 3.59% 
of lead II amplitude (average); the recording is from a 52-year-old male patient admitted with chest pain (Patient 





Figure 5. 5 Example of negative deflection WCT. WCT is 59.21% of lead II amplitude, while M-WCT is 2.79% 
of lead II amplitude (average); the recording is from a 59-year-old male patient admitted with chest pain (Patient 
ID: P046). 
5.5 Conclusions 
In this chapter, a software approach is proposed to minimise the reference potential for 
precordial ECG leads, which referred as the Minimised Wilson Central Terminal (M-WCT). 
Historically, minimisation and true measurement of WCT was attempted using a metal 
structure to encase the patient and submerged in water for the duration of the recording while 
operators adjusted manually reostats to vary the value of the averaging resistors. With this 
method, minimisation is personalized to the patient and obtained using a genetic algorithm 
applied to three components of the WCT. The M-WCT has near zero amplitude with small 
variation during the cardiac cycle. The measurements on 72 patients demonstrate that the 
average of the M-WCT amplitude relative to lead II is 7.45% with a standard deviation of 
9.04%, while the average relative WCT amplitude is 58.85% with a standard deviation 
30.84%.  These results are associating with the aforementioned characteristics of M-WCT 




Chapter 6 Discussion and Future Directions 
This chapter provides a summary of the work presented in this thesis by briefly discussing the 
motivation, objectives, and achievements of the presented work. It is followed by a list of 






6.1 Summary of Contributions 
The surface electrocardiography (ECG) is the most widespread method to diagnose cardiac 
diseases. As discussed in the previous chapters, some assumptions and hypothesis at the base 
of electrocardiography, have been known to be incorrect even before the standardization of 
12-leads electrocardiography and, thus, challenged several times during the years after 
standardization. Although there were some efforts to suggest different setups to record the 
heart rhythm, these studies were limited and consequently did not get enough attention. This 
research aimed to introduce a new setup to record precordial leads, which is more sensitive to 
show the abnormalities in patients with Non-ST segment elevation myocardial infarction 
(NSTEMI) and it uses the same 12-lead electrodes setup. To some extent this system can be 
seen as an extension of the current practice which provides the opportunity to record the 
Wilson’s Central Terminal (WCT) and investigate the so-believed assumptions in regards 
with the reference point of the precordial leads preserving the well-known 12-lead system 
that doctors and technicians are well trained to use. The main outcomes of the presented work 
are listed below: 
1- A comprehensive literature review in evolution of electrocardiography is presented in 
chapter one. This review highlights the studies which lead to choose Wilson’s Central 
Terminal as the standard reference point to record precordial leads. Furthermore, the 
new electrocardiogram device is introduced in detail in chapter one. This ECG device 
uses the right leg as a new reference point to record the chest leads, and it also records 
the standard precordial leads simultaneously. 
2- The Wilson Central Terminal ECG database (WCTECGdb) is introduced in chapter 
two. I have recorded the ECG using our new ECG device for about three years at 
Campbelltown hospital. The first two years (2016:2018) recordings were published on 
the Physionet platform. This dataset includes three limb leads, standard six precordial 
leads in addition to the potential of three limbs’ and six chest electrodes referred to 
the right leg. More importantly, the WCT signal is presented for each patient in this 
dataset. Therefore, I was able to investigate the legitimacy of WCT assumptions. The 
results show that the WCT is characterised as a systematic error, which has a different 
influence on recording the precordial leads in every individual. Therefore, the patients 
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were classified into three groups, which have zero, negligible, and significant WCT 
error. 
3- The Einthoven limbs’ potential assumptions are investigated in chapter three using the 
data from 147 patients recorded during (2016-2019). Furthermore, the authentication 
of relationship between the WCT and aVF is analysed as an alternative way to 
estimate the WCT signal. The obtained results show that unlike the initial assumption, 
the left arm has the highest potential among the three limbs in only 47 percent of the 
patients and the potential of the left leg is not negligible for all patients. Furthermore, 
the left leg has a considerable amplitude for 25 percent of patients, which 
consequently influences the shape and amplitude of the WCT. Therefore, the WCT 
and -2/3aVF have- a relatively small correlation and large RMS error in this group of 
patients. 
4- A series of case reports are presented to show the medical implications of the WCT 
and -2/3aVF. Only patients diagnosed with non-ST-segment elevation myocardial 
infarction (NSTEMI) were selected for this study, this is because it is well-known that 
12-lead ECG is not a sufficient diagnostic tool for this cardiac disease. For these 
patients. the WCT was found having important clinical features. Therefore, the 
unipolar chest leads are more sensitive to present abnormalities in these patients. 
Furthermore, the results show that the -2/3aVF is not medically equivalent to the 
WCT. Therefore, the left leg presents with important clinical features, which 
contradicts to previous assumption about the left leg potential. Once again, it is 
important to stress that the proposed system is envisioned to flank the well-known  
12-lead ECG and not to replace it in the clinical practice. 
5-  Chapter five presents a novel computational approach to reduce the Wilson Central 
Terminal amplitude and fall back under the Wilson postulate that declared this 
amplitude as irrelevant with respect to the ECG leads amplitude. The problem of 
WCT relative large amplitude was known before the standardization of precordial 
leads, and prior to this attempt, there was only one attempt to reduce its amplitude 
optimizing (in real time) the weight resistors that compose the WCT itself. This study 
included a cumbersome setup and could not be performed practically for every 
subject. In our approach, we used genetic algorithm to find three weighted factors for 
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the three limbs’ potential in order to minimise the WCT amplitude. This approach is 
highly individual, and the three weighting factors are different from one patient to 
another. 
Overall, the work presented in thesis is a step towards the validation of new 
electrocardiogram device that using the same ten electrodes of the 12-lead system, could 
flank it and be used to validate/verify if the current patient falls under the fundamental 
Wilson/Einthoven hypothesis such as negligible LL amplitude and act promptly i.e. 




6.2 Future Directions 
There are number of points, which should be considered in future extension of this thesis: 
1- This study is very depending on the number of recordings taken using our new ECG 
device. Therefore, it is required to record the ECG from varieties of patients, and 
healthy volunteers. Since the unipolar chest leads are more sensitive to show the 
abnormalities for patients diagnosed with NSTEMI, it is required to record from more 
NSTEMI patients to establish a well-powered study. Although I recorded from more 
than thirty NSTEMI patients, only nine patients were recorded just before proceeding 
for angiogram. The recording time for all NSTEMI patients should be similar, and 
just before proceeding for angiogram. 
2- In addition to point (1), since that the embedded information in the unipolar chest 
leads showed potential for an early diagnosis of NSTEMI. The unipolar chest leads 
might also contain beneficial information in regards with other cardiac diseases. 
Future work could include investigation of the clinical value of unipolar chest for 
other cardiac diseases. 
3- Future research would examine whether the position of limb electrodes can influence 
the precordial leads. Many believe that the precordial leads changes by moving the 
limb electrodes toward the torso (proximal recordings). This assumption is based on 
the fact that the WCT is the average potential of the limbs ‘electrodes. Since our ECG 
device can measure the WCT signal, the influence of different arrangement of limb 
electrodes on the precordial leads can be investigated performing several recordings 
of the same patients with progressively proximal limb electrodes placements. 
4- Future research would synthesise the WCT for every ECG device. Since the WCT can 
only be recorded by our developed ECG device, the machine learning framework can 
be developed to reconstruct the WCT using the standard 12-lead ECG. Therefore, this 
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Appendix A  Graphical User Interfaces and User 
Guidelines 
A.1 User Guide for the ECG Visualization 
• The Matlab script in section A.2 is named ECG_Visualization.m. 
• Run ECG_Visualization.m and the GUI will open as shown in Figure A.1. Once you 
run the GUI, you can open the patient file by clicking on the “open” button.: 
 
Figure A. 1 ECG visualization GUI opened. 
 
 A-2 
• Each patient may have more than one segment, which has a length of ten seconds. 




Figure A. 2 Select a segment using segment menu 
 
• By clicking on the “Save As” button, the displayed leads will be saved as a picture 
with jpeg file extension. 
• In the bottom panel of the GUI, moving the sliding button enables to move forward in 





Figure A. 3 The slide bar enables to move forward or backward in each segment. 
 
• Since the WCTECGdb enables synthesis chest leads in reference to every desired 
point, you can select different leads to display and compare on the GUI (see Figure 
A.4). The list is presented as below: 
o V1:V6 (WCT): The chest leads in reference to the WCT. 
o UV1:UV6 (RL): The chest leads in reference to the right leg (RL). 
o UV1:UV6(-2/3aVF): the synthesised unipolar chest leads using -2/3aVF. 
o V1:V6 (LA): The chest leads in reference to the left arm (LA). 
o  V1:V6 (RA): The chest leads in reference to the right arm (RA). 
o V1:V6 (LL): The chest leads in reference to the left leg (LL). 
o I, II, III, aVR, aVL, aVF: three limbs ‘lead and augmented leads. 
o LA, RA, LL, WCT, aVF: three limb potential, Wilson Central Terminal, 










A.2 ECG Visualization Graphical User Interface 
function varargout = ECG_visualization(varargin) 
% ECG_PRINT MATLAB code for ECG_visualization.fig 
%      ECG_visualization, by itself, creates a new ECG_visualization or raises the  
%       existing singleton*. 
% 
%      H = ECG_visualization existing returns the handle to a new ECG_PRINT or the  
%      handle to the existing singleton*. 
% 
%      ECG_visualization ('CALLBACK',hObject,eventData,handles,...) calls the local 
%      function named CALLBACK in ECG_visualization.M with the given inputargument. 
% 
%      ECG_PRINT('Property','Value',...) creates a new ECG_PRINT or raises the 
%      existing singleton*.  Starting from the left, property value pairs are 
%      applied to the GUI before ECG_print_OpeningFcn gets called.  An 
%      unrecognized property name or invalid value makes property application 
%      stop.  All inputs are passed to ECG_print_OpeningFcn via varargin. 
% 
%      *See GUI Options on GUIDE's Tools menu.  Choose "GUI allows only one 
%      instance to run (singleton)". 
% 
% See also: GUIDE, GUIDATA, GUIHANDLES 
  
% Edit the above text to modify the response to help ECG_print 
  
% Last Modified by GUIDE v2.5 12-Jun-2020 15:15:15 
  





gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @ECG_print_OpeningFcn, ... 
                   'gui_OutputFcn',  @ECG_print_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 




    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code - DO NOT EDIT 
  
  
% --- Executes just before ECG_print is made visible. 
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function ECG_print_OpeningFcn(hObject, eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to ECG_print (see VARARGIN) 
global myindex2print 
myindex2print=0; 
% Choose default command line output for ECG_print 
handles.output = hObject; 
  








% --- Outputs from this function are returned to the command line. 
function varargout = ECG_print_OutputFcn(hObject, eventdata, handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
  
% --- Executes on slider movement. 
function slider1_Callback(hObject, eventdata, handles) 
% hObject    handle to slider1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of slider 
  
  
% --- Executes during object creation, after setting all properties. 
function slider1_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to slider1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




% --- Executes on button press in pushbutton_open. 
function pushbutton_open_Callback(hObject, eventdata, handles) 
% hObject    handle to pushbutton_open (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
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global pstart slider_start slider_end  ECG_allsection Unip_allsection index 
Foldername Filename 
  
str= mfilename( 'fullpath' ); 
index=1; 
[file,path] = uigetfile(str,'*.mat'); 
  
if file==0 
    return; 
else 




names=split(address_input,'/'); %Mac user 
if length(names)==1 











 for i=1:length(ECG_allsection) 






 set(handles.edit_loc, 'String', num2str(pstart)); 
  
 slider_start=1; 
 slider_end=size(ECG_allsection{index},1)-2000; %2000: fs*2.5 




   
  
function plot_newecg(handles) 
    global ECG_allsection Unip_allsection index plotID pstart 
    Data=[ECG_allsection{index},Unip_allsection{index}]; 
    aVR=Data(:,11)-(Data(:,12)+Data(:,10))/2;  % using unipolar LA, RA, LL 
    aVL=Data(:,10)-(Data(:,11)+Data(:,12))/2; 
    aVF=Data(:,12)-(Data(:,11)+Data(:,10))/2; 
    pos1=[0.001,0.251,0.501,0.751]; 
    Fs=800 
    f=Fs*2.5; 
    start_p=1; 
    leads=[Data(:,1:3),aVR,aVL,aVF,Data(:,4:9)]; 
    mylegends={'I','aVR','V1','V4','II','aVL','V2','V5','III','aVF','V3','V6'}; 
    leads=leads(:,[1,4,7,10,2,5,8,11,3,6,9,12]); %order of leads to plot (hint: 
similar to legend) 
    leds_clean=DC_removal(leads(start_p:start_p+f-2,:)); 
    set(handles.edit_loc, 'String', num2str(pstart)); 
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    for i=1:12 
        h=subplot(3,4,i); 
  
        p = get(h, 'pos'); 
        if rem(i,4)==0 
            p(1) = pos1(4); 
        else 
            p(1)=pos1(rem(i,4)); 
        end 
        p(3) = p(3)+0.09; 
        p(4)= p(4)+0.05; 
        set(h, 'pos', p); 
  
        plotID(i)=plot(leds_clean(:,i),'k','LineWidth',1); 
        axis([0,f,-2,2]); 
        set(gca,'XTick',(0:160:f)) 
        set(gca,'YTick',(-2:0.5:2)) 
        grid on; 
        grid minor; 
        set(gca, 'XColor', 'r') 
        set(gca, 'YColor', 'r') 
        set(gca,'xticklabel',[])      
        set(gca,'yticklabel',[]) 
        legend(mylegends{i}); 
  
    end 
  
  
function plt_leads(leads, legends, Fs,start_p, panel_ID) 
    % plot precordial signals V1:V6 
    f=Fs*2.5; %number of points to plot 
    leds_clean=DC_removal(leads(start_p:start_p+f-2,:)); 
  
    set(panel_ID(1),  'YData', leds_clean(:,1));  
    legend(panel_ID(1),legends{1}) 
    set(panel_ID(2),  'YData', leds_clean(:,2));   
    legend(panel_ID(2),legends{2}) 
    set(panel_ID(3),  'YData', leds_clean(:,3));  
    legend(panel_ID(3),legends{3}) 
    set(panel_ID(4),  'YData', leds_clean(:,4));   
    legend(panel_ID(4),legends{4}) 
    set(panel_ID(5),  'YData', leds_clean(:,5));   
    legend(panel_ID(5),legends{5}) 
    set(panel_ID(6),  'YData', leds_clean(:,6));  
    legend(panel_ID(6),legends{6}) 
  
function plot_selection(panel_Fig_index,myIndex) 
% panel_Fig_index: the reference to each six plots 
% myIndex: selected plot 
    global ECG_allsection Unip_allsection index pstart 
    Data=[ECG_allsection{index},Unip_allsection{index}]; 
    aVR=Data(:,11)-(Data(:,12)+Data(:,10))/2;  % using unipolar LA, RA, LL 
    aVL=Data(:,10)-(Data(:,11)+Data(:,12))/2; 
    aVF=Data(:,12)-(Data(:,11)+Data(:,10))/2; 
    WCT=mean(Data(:,10:12),2); 
   
    Fs=800;   
    
    switch (myIndex) 
        case 1 % V1:V6 using WCT as reference point 
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            led=Data(:,4:9); 
            legends={'V1','V2','V3','V4','V5','V6'}; 
        case 2 %UV1:UV6 using RL as reference point 
            led=Data(:,13:18); 
            legends={'UV1','UV2','UV3','UV4','UV5','UV6'}; 
        case 3 %UV1:UV6 using -2/3aVF as reference point 
            led=Data(:,4:9)-2*aVF/3; 
            legends={'UV1 (aVF)','UV2 (aVF)','UV3 (aVF)','UV4 (aVF)','UV5 
(aVF)','UV6 (aVF)'}; 
        case 4 %V1:V6 using LA as reference point 
            led=Data(:,13:18)-Data(:,10); 
            legends={'UV1 (LA)','UV2 (LA)','UV3 (LA)','UV4 (LA)','UV5 (LA)','UV6 
(LA)'}; 
        case 5 %V1:V6 using RA as reference point 
            led=Data(:,13:18)-Data(:,11); 
            legends={'UV1 (RA)','UV2 (RA)','UV3 (RA)','UV4 (RA)','UV5 (RA)','UV6 
(RA)'}; 
        case 6 %V1:V6 using LL as reference point 
            led=Data(:,13:18)-Data(:,12); 
            legends={'UV1 (LL)','UV2 (LL)','UV3 (LL)','UV4 (LL)','UV5 (LL)','UV6 
(LL)'}; 
        case 7 
            led=[Data(:,1:3),aVR,aVL,aVF]; 
            legends={'I','II','III','aVR','aVL','aVF'}; 
        case 8 
            led=[Data(:,10:12),WCT,-2*aVF/3,WCT]; 
            legends={'LA','RA','LL','WCT','-2/3aVF','WCT'}; 
            
        case 9 
             figure (2) 
             
       
            
  
    end 
     
    if myIndex~=9 
  
        plt_leads(led, legends, Fs,pstart,panel_Fig_index) 
    end 
         
  
  
% text for text boxes: 
%txt='Speed: 25 mm/s (1 square = 5 mm) Limbs/Chest: 10 mm/mV  F 50~ 0.15-150 Hz '; 
  
  
% --- Executes on slider movement. 
function slider2_Callback(hObject, eventdata, handles) 
% hObject    handle to slider2 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of slider 











set(handles.edit_loc, 'String', num2str(pstart)); 
  
listbox_leftPanel_Callback(hObject, eventdata, handles) 





% --- Executes during object creation, after setting all properties. 
function slider2_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to slider2 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




% --- Executes during object creation, after setting all properties. 
function popupmenu_sections_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to popupmenu_sections (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: popupmenu controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




% --- Executes on button press in pushbutton_saveas. 
function pushbutton_saveas_Callback(hObject, eventdata, handles) 
% hObject    handle to pushbutton_saveas (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 





filter = {'*.jpeg';'*.*'}; 
[file,name,path]=uiputfile(filter,'File Selection',[Filename,'.jpeg']); 
if path==0 % pressed cancel buttom 















figure('units','normalized','outerposition',[0 0 1 1]) 
plot_newecg(handles); 
txt=['   Precordial leads (V1:V6)     ',newline,'Speed: 25 mm/s (1 square = 5 mm) 
Limbs/Chest: 10 mm/mV  F 50~ 0.15-150 Hz ']; 






% print unipolar 
set(handles.radiobutton_uni,'value',1); 
first_run=1; 
figure('units','normalized','outerposition',[0 0 1 1]) 
plot_newecg(handles); 
txt=['   Unipolar leads (UV1:UV6)     ',newline,'Speed: 25 mm/s (1 square = 5 mm) 
Limbs/Chest: 10 mm/mV  F 50~ 0.15-150 Hz ']; 







% print unipolar using aVF 
set(handles.radiobutton_uniavf,'value',1); 
first_run=1; 
figure('units','normalized','outerposition',[0 0 1 1]) 
plot_newecg(handles); 
txt=['   Unipolar leads using -2/3aVF (UV1:UV6)     ',newline,'Speed: 25 mm/s (1 
square = 5 mm) Limbs/Chest: 10 mm/mV  F 50~ 0.15-150 Hz ']; 
















     set(handles.radiobutton_pre,'value',1); 
    elseif print_unipolar==1 
      set(handles.radiobutton_uni,'value',1); 
    else 





plotID=temp_plotID; % as the plot ID was changed by calling the function twice 
  
  
function popupmenu_sections_Callback(hObject, eventdata, handles) 
% hObject    handle to popupmenu_sections (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: contents = cellstr(get(hObject,'String')) returns popupmenu_sections 
contents as cell array 
%        contents{get(hObject,'Value')} returns selected item from 
popupmenu_sections 
global index pstart slider_start slider_end ECG_allsection 
 pstart=1; 
 slider_start=1; 
 slider_end=size(ECG_allsection{index},1)-2000; %2000: fs*2.5 
 set(handles.slider2, 'value', 0); 
index=get(handles.popupmenu_sections,'value'); 
listbox_leftPanel_Callback(hObject, eventdata, handles) 




function edit_loc_Callback(hObject, eventdata, handles) 
% hObject    handle to edit_loc (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of edit_loc as text 
%        str2double(get(hObject,'String')) returns contents of edit_loc as a double 






if val<min || val>max  




set(handles.slider2, 'Value', progress); 
plot_newecg(handles); 
  
% --- Executes during object creation, after setting all properties. 
function edit_loc_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit_loc (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




% --- Executes when figure1 is resized. 
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function figure1_SizeChangedFcn(hObject, eventdata, handles) 
% hObject    handle to figure1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
  
% --- Executes on selection change in listbox_leftPanel. 
function listbox_leftPanel_Callback(hObject, eventdata, handles) 
% hObject    handle to listbox_leftPanel (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: contents = cellstr(get(hObject,'String')) returns listbox_leftPanel 
contents as cell array 
%        contents{get(hObject,'Value')} returns selected item from 
listbox_leftPanel 
  global plotID 
  myindex=get(handles.listbox_leftPanel,'value'); 
  Fig_index=[1,5,9,2,6,10]; % right panel index 
  Panel_Fig_index=plotID(Fig_index); 
  plot_selection(Panel_Fig_index,myindex) 
  
% --- Executes during object creation, after setting all properties. 
function listbox_leftPanel_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to listbox_leftPanel (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: listbox controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




% --- Executes on selection change in popupmenu_rightPanel. 
function popupmenu_rightPanel_Callback(hObject, eventdata, handles) 
% hObject    handle to popupmenu_rightPanel (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: contents = cellstr(get(hObject,'String')) returns popupmenu_rightPanel 
contents as cell array 
%        contents{get(hObject,'Value')} returns selected item from 
popupmenu_rightPanel 
  global plotID 
  myindex=get(handles.popupmenu_rightPanel,'value'); 
  Fig_index=[3,7,11,4,8,12]; % right panel index 
  Panel_Fig_index=plotID(Fig_index); 





% --- Executes during object creation, after setting all properties. 
function popupmenu_rightPanel_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to popupmenu_rightPanel (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
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% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: popupmenu controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




lamda=0.98; % remember what we said about it!! 
b = [1 -1]; 
a = [1 -lamda];  
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Abstract: Modern electrocardiography (ECG) uses a constructed reference potential for the majority
of leads. This reference potential, named after its inventor as the Wilson central terminal, is assumed
to have negligible value and to be stationary during the cardiac cycle. However, the problem
of its variability during the cardiac cycle has been known almost since the inception of 12-lead
electrocardiography. Due to the cumbersomeness of the measurement system required to fully
appreciate these variations, this topic has received scant research attention during the last 60 years.
Taking advantage of modern electronic amplifiers’ capability to detect small voltages, drawing only
femtoamperes from physiological equivalent signal sources and of the right-leg connection availability,
we developed a complete electrocardiography device that, aside from the eight independent signals
of the standard 12-lead ECG, allows direct recording of the Wilson central terminal components.
In this paper, we present details of the circuit together with its initial clinical evaluation. For this trial,
we recorded data from 44 volunteer patients at Campbelltown Hospital (Campbelltown, Australia)
and we found that the Wilson central terminal amplitude, as foreseen by Frank and others in the
1950s, is not negligible, its amplitude in relation to the lead II is, on average, 51.2%, and thus it may
be clinically relevant.
Keywords: electrocardiography; Wilson Central Terminal; potential reference
1. Introduction
The majority of modern-day clinicians and researchers appear to have forgotten that at the base
of modern electrocardiography (ECG) is a largely simplifying assumption, that reduces the extremely
complex electrical activity of the heart to a single equivalent electrical dipole rotating in the chest
around a fixed point. This simplifying assumption, formulated in the 1930s by Wilson [1], allowed
Machines 2016, 4, 18; doi:10.3390/machines4040018 www.mdpi.com/journal/machines
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assessment of cardiac electrical activity in the whole body space rather than in its two-dimensional
(2-D) projection over the limbs, as originally outlined by W. Einthoven in 1906 [1]. In other words,
Wilson devised a virtual stationary fixed point (which was named after him: Wilson central terminal
or simply WCT) as a current average of Einthoven’s limb electrodes [1].
The assumption of a single dipole rotating around Wilson’s virtual fixed point was soon
recognized to be the source of potential errors for ECG. In 1954, Frank, in his famous dissertation
“General Theory of Heart-Vector Projection” [2] warned clinicians about the use of this oversimplifying
assumption. Empirical confirmation of Frank’s hypotheses about the amplitude and variability of
the WCT came almost simultaneously when measurements of WCT (requiring the human body to be
encased in a metal structure totally submerged in water for the duration of the recording), showed
that Wilson’s central point is non-stationary during the cardiac cycle and has a large amplitude (up
to 40% of Einthoven’s ECG signal amplitudes). Details of these results were published by both H.C.
Burger and R. Bayley et al. [3,4]. However, until now, without a valid alternative, this largely simplified
hypothesis still lies at the base of modern clinical practice.
In the late 1950s, the electronic amplifier substituted the original string galvanometer, leading to
the ECG gaining in popularity, reducing its cumbersomeness, and allowing simultaneous observation
of more than one lead. However, electronic amplifiers required the addition of a further limb to the
ECG measurement that original inventors of the system had not taken into account: the “right leg.”
Remembering that electronic amplifiers, by construction and design, are better equipped to measure
voltages rather than currents [5–7], and also bearing in mind that an additional reference terminal may
be required for common mode signal rejection reasons, particularly at power-line frequencies [7–10],
it was a natural choice for engineers to connect this additional terminal to the right leg [8,9]. The right
leg was traditionally excluded from the original Einthoven/Wilson ECG model because the string
galvanometer measures directly the current circulating into the surrounding tissues as a consequence
of the shift in the electromagnetic field impressed by the heart’s activation. Therefore, the original
ECG electrical model is arranged as a closed circuit (Einthoven’s triangle) and each of its branches
includes the heart in the current pathway. As can be inferred from the original model, there is no
evident current pathway between the heart and the legs (see Figure 1) [1,11–15].
Taking advantage of the right-leg connection and of the negligible load upon equivalent
physiological signal sources offered by modern voltage amplifiers (in the order of femtoamperes [10–15]),
we developed a full 15-lead ECG device that, aside from the standard 12-lead signals, can record the
independent voltages of the right arm, left arm and left leg. These additional independent voltages
(directly referred to the right leg) can be used to:
1) Measure the WCT amplitude without the need to encase the patient into a metal structure
submerged in water.
2) Correlate the amplitude of the WCT to the cardinal limb leads.
In this paper, we detail the hardware used together with the results of our clinical evaluation.
For this clinical evaluation, we recorded data from 44 patients at Campbelltown Hospital (NSW) and
we measured the amplitude of the WCT and correlated it with the amplitude of lead II. We found
that the amplitude of the WCT could exceed the amplitude of lead II and on average across our
entire population, WCT amplitude is 51.2% of lead II. All the patients volunteered for this study
and gave written consent (this study was approved on 23 September 2015 with the protocol number
HREC/15/LPOOL/302).
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Figure 1. ECG conduction model evolution: Original Einthoven model (top), which included only the 
three limbs that form a triangular circuit around the heart, whereas the heart is included in each 
branch current pathway; Wilson’s precordial leads (bottom) with WCT definition as current return 
formed as the center of Einthoven’s triangle (bottom right). Modified from [1]. 
2. Methods  
We designed our hardware around the instrumentation amplifier INA116 [16], manufactured 
by Texas Instruments, Dallas, TX, USA (Burr-Brown series). According to the chip specifications, its 
bias current (i.e., the load to the physiological signal source) is typically only 5 fA. This 
extraordinarily small value is achieved by the combination of an extremely high input impedance 
with a relatively small parasitic capacitance and embedded active guard ring buffer (see technical 
documentation [16] for precise details). In order to preserve the mentioned characteristics, the 
printed circuit board is designed to take advantage of the embedded active guard ring amplifier on a 
Teflon substrate. Although the guard ring amplifier’s primary job is to reduce the noise pick-up at 
cable and board connections, because this offers a replica of the input signal, we also use it to 
measure the raw voltage of the WCT components [17–20].  
To ensure high conductivity of connections between pins and exposed pads on the board, the 
latter are silver-plated by immersion during manufacturing. To avoid smearing of solder under the 
chip body and between pins during soldering, the chip body is sealed in position prior to soldering, 
using a suitable printed circuit board non-conductive epoxy resin. As an additional precaution, the 
conductivity between electrode connections and chip pins is verified prior to soldering, using a 
multimeter. Each pin of the INA116 is then manually soldered to the pad using lead-free 
silver-based paste with a 0.2 mm diameter hot iron tip. To further minimize parasitic capacitance at 
board level, the guard ring pattern is repeated on each layer of the board and aside from the chips’ 
necessary connections, no other traces are routed in the area under each INA116. As a last 
Figure 1. ECG conduction model evolution: Original Einthove model (top), which included only the
three limbs that form a triangular circuit around the heart, whereas the heart is included in each branch
current pathway; Wilson’s precordial leads (bottom) with WCT definition as current return formed as
the center of Einthoven’s triangle (bottom right). Modified from [1].
2. Methods
We designed our hardware around the i strume tation amplifier INA116 [16], manufactured by
Texas Instruments, Dallas, TX, USA (Burr-Brown series). Acco ding to the chip specifications, its bias
current (i.e., the load to the physi logical signal source) is typically only 5 fA. This extraordinarily small
value is achieved by the combination of an xtremely high put impedance with a relatively small
parasitic capacit nce and embedded active gu rd ring buffer (see te hnical documentation [16] for
precise details). In order to preserv th mentioned cha acteristics, the print d circu t board is designed
to take advantage of the embedded active guar ring amplifier on a Teflon substrate. Although the
guard ring amplifier’s primary job is to reduce the nois pick-up at cable and board co nections,
because this offers a replica of the input signal, we also use it to measure the raw voltage of the WCT
components [17–20].
To ensure high conductivity of connections between pins and exposed ads on the board, the
latter are silver-plat d by immersion duri g ma ufacturing. To avoid smearing of solder un the
chip body and between pins during soldering, the chip body is sealed in position pri r to s ldering,
using a suitable printed circuit board non-conductive epoxy resin. As an dditional precaution,
the conductivity between electrode connections and chip pins is verifi d prior to soldering, using
a multi eter. Each pin of the INA116 is then manually soldered to the pad using lead-free silver-based
paste with a 0.2 mm diameter hot iron tip. To fu t er mi imize parasitic capacitance at board level,
the guard ring pat ern is repeated on each layer of the board and aside fr m the chips’ necessary
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connections, no other traces are routed in the area under each INA116. As a last precaution, as
recommended in the existing literature, wire connections to the chip are directly soldered to the board
on the top layer (no thru-hole connections) [10,21–23]. Finally, the assembled board is coated with
conformal coating to protect it from moisture that could contaminate the board due to its use in the
hospital environment (frequent cleaning and wiping of the enclosure/cables with disinfectant).
The simplified schematic of the hardware, limited to the four limbs and one of the precordials,
is depicted in Figure 2. Protection from electrostatic discharges is achieved by interconnection
of a single high-precision low-noise Panasonic surface mount ECG series 100 kΩ resistor.
Protection against defibrillation discharges and simultaneous high-impedance biasing of the INA116
electrodes’ connections is achieved by parallel connection of low-voltage activation gas discharge tubes;
with an arc voltage as low as 15 V [24] they protect the sensitive chip inputs even for voltages that are
lower than the embedded overvoltage protection [24]. Discharge tubes also offer the perfect biasing
pathway for INA116 due to their nominal resistance >10 GΩ and a negligible parasitic capacitance.



























































This part of the circuit is replicated six times (one for each precordial lead)
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Non-amplified WCT reference signal for precordials 10 [V/V]
BP filter
100 [V/V]
































Figure 3. Active band-pass filter gain cell, see Table 1 for components’ values. 
Table 1. Summary of components’ values for the gain cells. 
Component  10 V/V Gain Version 100 V/V Gain Version 
C-HiP 47 µ 47 µ  
R-HiP 100 kΩ 100 kΩ 
C-LowP 15 nF 1.5 nF 
R-F 100 kΩ 1 MΩ 
R-gain 10 kΩ 10 kΩ 
 
Figure 2. Si plified sche atic li ited to li bs’ connections and one of the precordials.
As mentioned, and as it is possible to infer from the schematic, the guard buffer of the left-leg,
left-arm and right-arm electrodes are also used to directly measure the WCT components’ voltages.
The gain set for the INA116 chips is 1 V/V, achieved by leaving pins 1 and 8 floating (not noted in
Figure 2). Necessary gain and band bass filtering is achieved by two AC coupled active non-inverting
low-pass filters gaining 10 V/V and 100 V/V, respectively. Each gain cell is designed around the
amplifier chip OPA140 [25]. Aside from its very low-noise figure, the OPA140 has been selected
because of its high slew rate, immunity from phase inversion and very low current-bias. Owing to
these characteristics, we have designed a high-gain non-inverting band-pass filtering gain cell that
does not require additional biasing and copes well with the frequent swings between saturation
voltages due to ECG artefacts. Aside from the value of some passive components to achieve different
gains, the gain cells are identical. The simplified schematic of the gain cell is depicted in Figure 3.
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In order to achieve a diagnostic quality ECG, both the high-pass and low-pass corner frequencies of
the gain cell are set with capacitors whose value has been selected to be larger than the theoretical
values. In this way, even in the worst case scenario of a −10% value due to the capacitor tolerances,
the required bandwidth is assured. Frequency content normalization to the diagnostic bandwidth is
operated via software after signal acquisition. Components’ values are reported in Table 1 for both gain
cells. Differences between values of components are highlighted in bold. As an additional precaution,
high-precision Murata ceramic capacitors have been used.
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Table 1. Summary of components’ values for the gain cells.
Component 10 V/V Gain Version 100 V/V Gain Version
C-HiP 47 µ 47 µ
R-HiP 100 kΩ 100 kΩ
C-LowP 15 nF 1.5 nF
R-F 100 kΩ 1 MΩ
R-gain 10 kΩ 10 kΩ
As noted in Figure 2, the circuit includes a modified voltage bootstrap circuitry [18,20,26–28]
that directly drives the reference voltage of the circuit with a damped version of the average of all
the electrodes. This solution proved successful in all of our past circuit implementations [18,20,29],
particularly when the right-leg connection is included in the average. However, for this implementation
we introduced a driven-right-leg circuitry designed and dimensioned to contain current drive to
20 µA [8,30,31]. The input signal for the driven-right-leg circuitry is the non-amplified average of the
measurement electrodes (see Figure 2).
The entire circuit is powered by a dual 9 V power supply formed by two 9 V batteries in series
that proved sufficient for a day of recordings in the hospital. Digital conversion and data logging is
operated at a 16-bit depth over the range of ±5 V at the sample rate of 800 Hz by the BIOADC [32],
powered directly by the USB connection to a host laptop computer (battery-powered). Necessary
anti-aliasing low-pass filtering at the Nyquist frequency is embedded in the BIOADC. The entire
system is hosted on a standard hospital instrumentation trolley that allows easy transportation of the
device around rooms and ambulatories for the recording. More details pertaining to the hardware
tests are reported in Appendix A.
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Recorded data have been firstly assessed for quality, comparing visually the shapes and amplitude
of 12-lead ECG traces recorded by our machine with the one obtained from the resident device used
for routine investigation. Data sets, whose amplitude and shapes passed the visual test, have been
included in this database (100% inclusion). For this study, we measured the WCT amplitude and
reported it as a percentage of lead II in 44 patients who had volunteered for the study. We also report
the polarity of the WCT based upon the orientation of the QRS feature present in the signal. Similarly to
previous studies [3,4], we noted that with “N” signals, polarity is not clearly positive or negative
i.e., the positive deflection amplitude almost matches the negative deflection at the QRS feature.
Reported amplitude measurements are averaged across at least five consecutive beats. To compare
the WCT’s amplitude we selected lead II because, according to the circuit principles applied to the
electrocardiography (see Figure 1), lead II is the result of the sum of lead I and lead II. Therefore, lead
II should be the largest of the limb leads [1]. Furthermore, lead II is used as a calibration signal from
many patient simulators used in standard engineering practice and often represented, at the bottom of
the standard clinical ECG diagnostic sheets, longer traces for cardiac rhythm assessment.
3. Results
Bench tests of the assembled prototype show that the gain of each channel is 1023 ± 5% V/V
and the bandwidth contains the diagnostic ECG frequency [1,8]. A custom-made import script takes
into account precise measured gains, normalizes the frequency content to 0.05–150 Hz via a 50th
order Infinite Impulsive Response (IIR) band-pass filter; and removes power-line noise at 50 Hz and
harmonics up to the Nyquist frequency, via a batch of 50th order IIR notch filters each with a quality
factor of 35. All filters have been implemented as “non-causal” to avoid introducing phase delays.
As mentioned, only data sets that passed the visual inspection test (see Methods section) have
been included in this data set. A total of twelve recordings have been discarded due to the necessity
to abort the recording (i.e., patient required transportation to other wards for procedures) or due to
the presence of large artifacts or the persistent presence of pacemaker activations on the recorded
traces. Of the 44 recordings, 17 patients were female. The average age of the study’s patient population
is 66.8 years (with a standard deviation of 13.4 years); the majority of the patients have a history of
cardiac disease and have been admitted to the hospital from the emergency department because of
difficulties in breathing and/or chest pain.
The summary of our measurement results is reported in Table 2 for each patient. Amplitude of
the WCT is measured as a relative percentage of lead II. The average WCT amplitude for our data
set is 51.2% of lead II with a standard deviation of 27.4%, which is slightly larger than that described
in the existing literature [1,8], where relative amplitudes of up to the 40% are reported. However,
those studies used a different and cumbersome setup and date back to the 1950s. Nevertheless, to our
surprise, for several patients, the amplitude of the WCT is as large as lead II, with several beats in which
WCT’s amplitude exceeds lead II by up to 20%; in Table 2, all of the cases where the WCT’s average
amplitude was larger than 99% of lead II, were approximated with 100%. Although positive deflection
of WCT seems to be the majority (see Table 2), with only a handful of neutral (noted with N) polarities,
it is not possible to find characteristic or uniform shapes of WCT. Based upon our measurements, WCT
is highly individual, can have standard ECG characteristics, such as a p-wave and a t-wave, and thus
should be included in the ECG signal space used for diagnosing diseases.
An example of the WCT signal with a marked t-wave is visible in Figure 4. As can be seen,
a marked t-wave deflection on the WCT trace (bottom panel) is synchronized with the t-wave on lead
II (top panel). The WCT trace in Figure 4 is also a good example of a highly variable WCT, which in
one single cardiac cycle changes the deflection’s polarity at least three times, with an amplitude that
reaches 65% of lead II (average).
An example of high-amplitude WCT is depicted in Figure 5. As can be seen, the amplitude
of the WCT (positive deflection) has a similar amplitude to the lead II with a broader QRS feature.
In Figure 6 we present an example of multimodal WCT: for this patient, on average the WCT has
Machines 2016, 4, 18 7 of 13
a positive deflection, and shape alteration is observable during ectopic beats, where the WCT exhibits
a broader QRS. Other examples of WCT which mutate from positive deflection to almost neutral and
fully negative during ectopic beats are depicted in Figures 7 and 8.
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Figure 6. Example of multimodal WCT with severe alteration during ectopic beats (noted with a 
black arrow). WCT is 45% of lead II amplitude (average); recording is from a 72-year-old female 
patient admitted from the emergency department with severe chest pain. 













































Figure 7. Example of positive WCT that mutates into almost neutral (almost identical value for 
positive and negative peak) during an ectopic beat (noted by the arrow). WCT amplitude also varies 
from >100% of lead II amplitude (average) to approximately 50% of lead II during the ectopic beat; 
recording is from an 85-year-old male patient admitted from the emergency department with severe 
chest pain and unconfirmed myocardial infarction. 
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Figure 7. Example of positive WCT that mutates into almost neutral (almost identical value for positive
and negative peak) during an ectopic beat (noted by the arrow). WCT amplitude also varies from
>100% of lead II amplitude (average) to approximately 50% of lead II during the ectopic beat; recording
is from an 85-year-old male patient admitted from the emergency department with severe chest pain
and unconfirmed myocardial infarction.
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Figure 8. Example of positive WCT that mutates into negative during an ectopic beat (noted by the 
arrow). WCT amplitude also varies from 65% of lead II amplitude (average) to 33% of lead II during 
the ectopic beat; recording is from a 79-year-old male patient admitted due to arrhythmia. 









































Figure 9. Example of multimodal WCT with evident features in correspondence with “p” and “t” 
waves. WCT is 23% of lead II amplitude (average); recording is from a 63-year-old female patient 
admitted from the emergency department with severe chest pain 
In Figure 9, we show an example of WCT that exhibits all of the characteristics of an ECG trace. 
For this patient, the WCT has a marked p-wave and t-wave that, for some beats, have a larger 
amplitude than the multimodal QRS complex. This is another example of highly variable WCT, 
which in this case changes deflection polarity at least five times into a single cardiac cycle. Of note, 
Figure 8. Example of positive WCT that mutat i t ti e during an ectopic beat (noted by the
arrow). WCT amplitude also varies fro 65 f lea II a litude (average) to 33% of lead II during
the ectopic beat; recording is from a 79-year-old ale patient ad itted due to arrhythmia.
In Figure 9, we show an example of WCT that exhibits all of the characteristics of an ECG trace.
For this patient, the WCT has a marked p-wave and t-wave that, for some beats, have a larger amplitude
than the multimodal QRS complex. This is another example of highly variable WCT, which in this
case changes deflection polarity at least five times into a single cardiac cycle. Of note, from Table 2 it is
possible to observe that the relative amplitude of the WCT, with respect to lead II, is below 15% for
only one patient.
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Table 2. Summary of measurement results. WCT relative amplitudes are approximated to the nearest
integer and capped to 100% for the measurements larger than 99% (see text).
Patient ID Age (y.o.) Gender WCT Amplitude As %of Lead II WCT Polarity Figure
P001 63 F 27 +
P002 51 F 40 +
P003 65 F 35 −
P004 63 F 30 +
P005 88 F 90 +
P006 52 F 90 +
P007 70 F 59 +
P008 55 F 44 +
P009 82 F 12 −
P010 71 F 23 +
P011 69 F 19 +
P012 89 F 25 −
P013 63 F 23 + Figure 9
P014 70 F 41 N
P015 72 F 45 + Figure 6
P016 70 F 65 − Figure 4
P017 82 F 100 + Figure 5
P018 59 M 100 −
P019 68 M 33 −
P020 79 M 65 + Figure 8
P021 55 M 50 +
P022 71 M 40 N
P023 52 M 60 +
P024 45 M 20 −
P025 79 M 50 +
P026 85 M 22 +
P027 52 M 30 +
P028 62 M 41 −
P029 64 M 31 −
P030 25 M 50 −
P031 76 M 46 −
P032 56 M 51 −
P033 78 M 57 +
P034 73 M 100 +
P035 85 M 100 + Figure 7
P036 89 M 75 +
P037 72 M 25 +
P038 56 M 48 +
P039 60 M 20 +
P040 65 M 27 +
P041 80 M 48 −
P042 53 M 95 +
P043 53 M 100 +
P044 75 M 100 +
Average 66.8 51.2
Polarity distribution N: 4.5%;Negative: 29.5%
Total: 44 38% Females
4. Conclusions
We presented a viable solution for the measurement of the WCT amplitude in a clinical setting.
Our electrocardiographic device does not require the patient to be encased in a metallic structure
submerged in water. Employing the latest components and printed circuit board technologies, we
produced a compact design that employs standard ECG cables and electrode placement. Our ongoing
clinical trial using this device has already confirmed the inadequateness of the WCT as a neutral
reference for ECG signals. Our measurements performed on 44 volunteer patients confirmed that
the WCT amplitude relative to lead II amplitude (average across the entire study’s population), is
51.2% (standard deviation of 27.4%), with peaks of over 100%. Our measurements also confirmed, as
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foreseen by Frank in the 1950s, that the WCT is another ECG lead with a high amplitude and typical
characteristic waveforms, hence it should be included in the signal space used to diagnose diseases.
We are currently assessing the clinical implications of our finding and continuing the data-recording
campaign with the aim of collecting a larger, statistically significant sample of recordings, which will
be released to researchers upon request.
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Appendix A
Reconstruction of cardinal leads from limb components
As mentioned in the methods section, device bandwidth and gains have been verified using
a proper signal generator, capable of generating 1 mVpp sine waves (Medi Cal Instruments model 220
Biomedical Function Generator) [26]. In addition, we assessed the point to point correlation between
limb leads reconstructed using the limb components and limb leads that are recorded directly.
To reconstruct the limbs, we simply operated a point by point subtraction between recorded signals and
assessed the correlation between signals using the embedded MATLAB correlation function [19,20].
As an example (see Figure A1) we can compute lead I from simple subtraction of the WCT’s
components Left Arm(LA) and Right Arm (RA) (lead I = LA – RA [1]). In all the assessed cases,
correlation scored in excess of 99% and signals cannot be distinguished unless labeled and plotted on
different axis. We conclude that the LA, RA and LL components that we record with our device are the
actual components of the WCT.
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ABSTRACT 
Modern electrocardiography (ECG)1 uses the Wilson Central 
Terminal (WCT) as a reference point for the majority of leads. 
WCT is assumed to be near zero and steady during the cardiac 
cycle. However, due to the measurement encumbrances of the 
real amplitude of WCT, this assumption has never been verified 
in clinical practice. Using our own recently developed 15-lead 
ECG device that can measure WCT components in addition to 
12-lead ECGs in a clinical setting, we propose a framework to 
derive a New Central Terminal (NCT) with demonstrated less 
variation and near zero amplitude during the cardiac cycle. Our 
method is based upon application of a Genetic Algorithm (first 
1000 samples), and then a linear regression to calculate the NCT 
for the rest of the recording. 
CCS CONCEPTS 
Computing Methodology → Machine learning; Machine 
learning approaches • Applied Computing → Health
informatics
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Wilson Central Terminal 
1 INTRODUCTION 
1 Permission to make digital or hard copies of part or all of this work for personal 
or classroom use is granted without fee provided that copies are not made or 
distributed for profit or commercial advantage and that copies bear this notice and 
the full citation on the first page. Copyrights for third-party components of this 
work must be honored. For all other uses, contact the owner/author(s). 
GECCO '17 Companion, July 15-19, 2017, Berlin, Germany
© 2017 Copyright is held by the owner/author(s).
ACM ISBN 978-1-4503-4939-0/17/07.
http://dx.doi.org/10.1145/3067695.3076090
In 12-lead electrocardiogram (ECG) recordings, precordial leads 
are measured as the potential differences between each of the six 
exploring electrodes on the chest and a virtual reference point 
known as the Wilson Central Terminal (WCT) which was 
described in 1931[1]. It is defined as the voltage average of right 
arm (∅"), left arm (∅%), and left leg (∅&),	  and assumed to be 
near zero and steady during the cardiac cycle (Eq. 1) with 
condition c1.  
𝑊𝐶𝑇 = 𝛼∅% + 𝛽∅" + 𝛿∅& (1) 
𝛼,𝛽, 𝛾 = 1/3 (c1) 
However, this assumption was proved wrong and has been 
recognized as a source of potential error in ECG [2]. In 1954, 
Frank was the first researcher who raised concern about WCT 
amplitude and variation. He warned clinicians that WCT is not 
null or steady during the cardiac cycle, and how it can bias ECG 
measurement [3]. Later, Bayley and Kinard were able to measure 
the raw amplitude by putting a human being inside a metal 
structure and immersing it into the water during the 
measurement of ECG [4, 5]. Due to the difficulties of the real 
WCT measurement, the WCT assumptions as they have been 
conceived by Wilson, have been widely accepted and considered 
as a systematic error in ECG recording. 
We recently proposed a new ECG device that could record 12-
lead ECG together with the raw voltages of the WCT 
components (right arm, left arm, and left leg) [6, 7]. Our results 
confirm the previous findings in 1954 by Bayley, and show that 
WCT amplitude is in average as large as 51.2% of lead II [6] 
Whereas lead II is the voltage difference between left arm (∅%), 
and left leg (∅&). 
In this paper, we address the problem of the high variability of 
WCT in ECG recording, and propose a new reference point for 
human body.  
2 PROPOSED METHOD 
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Availability of raw WCT components allows us to propose a new 
framework to compute a New Central Terminal (NCT) using a 
combination of the Genetic Algorithm (GA) and the Linear 
Regression model (LRM) that ultimately may lead to the use of 
NCT in real time data acquisition.  
Recalling that WCT is the average of limb electrodes, NCT is 
defined as weighted mean of WCT components. We use a GA to 
compute the three weighted factors (𝛼, 𝛽, 𝛾) (neglectting c1 in 
Eq.1) with constraints of being non-zero, positive, and less than 
one in module. Our ideal reference point has a small variation, 
near zero amplitude during the cardiac cycle; in other words, 
NCT amplitude should be less than 0.1 mV to be considered 
clinically irrelevant. Off-note, WCT optimization using weighted 
resistors was also attempted in real time during the original 
experiment performed in 1954 with little success [4]. During this 
remarkable experiment, researchers attempted real-time changes 
of the summing resistors of WCT components whilst recording.  
With our method, we compute (GA) the prototype of NCT for 
the first 1000 recorded samples (1.25 s) of WCT components. 
NCT is then refined and computed for the full signal using LRM 
(Fig.1). The population size contains 80 individuals, each of 
which is a vector of float in interval (0, 1). In every iteration, elite 
members are moved to the next generation, and if unchanged 
changed after five consecutive iterations, it was considered as 
the optimum answer. In this paper, we use data recorded from 29 
volunteer patients (written consent), age range: 45-89 years 
(average 66; 38% females) (study protocol number 
HREC/15/LPOOL/302). 
 
Figure 1 : The flowchart of NCT computation 
3 Results 
The average number of iterations necessary for the method to 
converge is quite small (16.36 in average). Since linear regression 
has linear time complexity, the overall performance of our 
proposed algorithm can be considered as time efficient.  
Our assessment shows that while WCT exhibits proper ECG 
characteristics such as a P-wave and a T-wave, a large amplitude 
and variability (including random polarity), NCT is more close to 
the ideal reference point as it is almost steady with little 
variation during the cardiac cycle and has less medically relevant 
points. In comparison with WCT, NCT average relative 
percentage to lead II is 2.76% with standard deviation 3.68%, 
while WCT relative percentage to lead II has a mean value of 
48.31% with a standard deviation 25.67%.  
Table 1: Summary of measurement results. WCT and NCT 
relative amplitudes to lead II 
Patient 
ID Age Gender 
WCT 
amplitude as 
% of lead II 
NCT 
amplitude as 





P001 63 F 27 1 -0.06 
P002 51 F 40 2 -0.04 
P003 65 F 35 5 -0.26 
P005 88 F 90 12 -0.24 
P006 52 F 90 3 -0.19 
P007 70 F 59 3 -0.20 
P010 71 F 23 0 -0.06 
P012 89 F 25 1 -0.20 
P013 63 F 23 1 0.00 
P014 70 F 41 3 -0.08 
P016 70 F 65 1 -0.15 
P018 59 M 100 7 -0.05 
P019 68 M 33 0 -0.11 
P020 79 M 65 1 -0.18 
P021 55 M 50 1 -0.30 
P022 71 M 40 1 0.00 
P023 52 M 60 0 -0.09 
P024 45 M 20 0 -0.01 
P025 79 M 50 5 -0.29 
P026 85 M 22 0 -0.01 
P027 52 M 30 1 -0.15 
P028 62 M 41 5 -0.48 
P033 78 M 57 1 -0.25 
P034 73 M 100 13 -0.35 
P037 72 M 25 0 -0.02 
P038 56 M 48 0 0.00 
P039 60 M 20 1 -0.34 
P040 65 M 27 1 -0.01 
P042 53 M 95 11 -0.09 
Average 66.07 48.31 2.76 -0.14 
  
  
Polarity distribution N: 6.9%;  Negative: 24.1% 
Total: 29  38% Females 
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neous coronary intervention. He remained headache free at
2-year follow-up.
The case serves as an excellent opportunity to highlight this
uncommon, but potentially life-threatening disorder. The dis-
cussion reviews available literature on the pathophysiology,
incidence and prognosis, before looking at the current diag-
nostic criteria, as well as in whom to consider the diagnosis.
Distinguishing cardiac cephalgia from migraine is important,
as vasoconstrictive treatments (e.g., triptans) would be con-
traindicated. Clues to diagnosis include: exertional headache,
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Introduction: Cardiovascular disease is the leading cause
of death in the Western world. Diabetes mellitus confers a
doubling in risk of cardiovascular disease. Computed tomo-
graphic (CT) coronary calcium scoring (CCS) is an effective
method for cardiovascular risk stratification in asymptomatic
individuals. The rate of progression of coronary calcium
on consecutive CT scans provides further cardiovascular
disease-risk stratification capabilities. Patients with no pro-
gression of their CCS are at low risk of cardiovascular
disease events [1]. There are no known therapies that prevent
vascular calcification (VC). 18F-Sodium Fluoride Positron
Emission Tomography is a novel molecular imaging modal-
ity that identifies regions of vascular calcification activity
that subsequently develop into established macrocalcifica-
tions, allowing a unique approach for clinical trials studying
potential modifiers of CCS [2].
Interventions: Inflammation is a key trigger for the devel-
opment of VC. Colchicine is a unique anti-inflammatory agent
with promising plaque-modifying capabilities [3]. In addi-
tion, a deficit in VC-specific inhibitors is thought to promote
further propagation of VC. Incomplete activation of Matrix-
GLA protein, a potent local inhibitor of VC that requires
Vitamin-K-dependent carboxylation, may also contribute to
VC. This study aims to test whether Colchicine or vitamin K
could halt the progression of coronary artery calcification.
Population and Study Design: This double-blinded ran-
domised 2 × 2 factorial placebo controlled trial will include
154 participants with diabetes mellitus and elevated coro-
nary calcium scores who will receive Colchicine 0.5mg and
Phytomenadione 10 mg (vitamin K) and matching placebos.
Outcomes: A change in vascular 18F-Sodium Fluoride PET
activity from baseline will be assessed after 3 months.
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A Modern Wilson’s Central Terminal
Electrocardiography Database
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Wilson’s Central Terminal (WCT) is an artificially
constructed virtual reference potential for surface electrocar-
diography (ECG). It is derived by averaging the voltage of
the right arm (R), left arm (L), and left leg (F), and is
assumed to be steady and with negligible amplitude during
the cardiac cycle. In order to measure WCT, in 1954, Bayley
and Kinard encased volunteers inside a metal structure that
was immersed in water for the duration of the recording. Due
to the impracticality in measuring WCT using this method, it
is an accepted methodological error in modern ECG.
This study employed a novel ‘15-lead ECG device’ in which
the ‘right leg’ is used as the ground reference terminal for
measuring all signals. It was able to record WCT components
(R, L, and F) and a 12-lead ECG. Data from 85 patients
(35 (41%) patients were female) at Campbelltown Hospital
were recorded. Patients with pacemakers were excluded from
the dataset. The average age of the study population was
65.31 years (SD 11.59). The absolute average amplitudes of
WCT components among all patients were (R = 0.076 mV,
L = 0.070 mV, and F = 0.044 mV). Ten-second periods of
recording without any artefacts was selected, and 413 10-
second periods were extracted. It was found that recorded
WCT is highly individual, and has standard ECG character-





A Partner in Medication Management and
Safety: A Review of the Addition of a
Pharmacist to Cardiology Out-Patient
Clinics
L. Steel ∗, J. Eglington
RBWH, Brisbane, Australia
Background: Cardiology patients often have high medi-
cation burden; hence, they are at high risk of medication
misadventure. Worldwide studies have demonstrated that
pharmacists, through a number of activities including inter-
ventions, improve medication management and patient
safety.
Method: A pharmacist was added to the cardiology outpa-
tient clinic at a tertiary Queensland hospital. The pharmacist
recorded all interventions in the first 12 months, classified
the nature and risk rated the interventions based on a val-
idated risk scoring tool. The benefit of the pharmacist was
also assessed through a survey completed by cardiology clinic
staff.
Results: The pharmacist conducted 1072 reviews and
recorded 429 interventions. Of these, 4.2% were risk rated
as extreme, 23.1% high, 52.4% moderate and 20.2% low. An
example of an extreme risk intervention was pharmacist iden-
tification of a patient taking twice the maximum daily dose
of flecainide. The nature of interventions was also recorded
with non-adherence, non-cardiac medication interventions
and medication counselling making up the top three classes
of interventions: 16.5%, 13.9% and 11.4% respectively. The
medication counselling cohort largely included the pharma-
cists counselling on the importance of medication adherence
post myocardial infarction. From the staff survey, all respon-
dents agreed that the addition of the pharmacist to the clinic
was valuable to both clinicians and their patients with 100%
requesting that the service continue.
Conclusion: With a significant number of interventions
recorded and positive feedback in the survey it was sugges-
tive that the addition of a pharmacist to the cardiology clinic




A Rare Case of Corynebacterium
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A 26-year-old gentleman presented with a 1-month his-
tory of fevers, malaise and weight loss. He was born in
China and had moved to Australia during his childhood. He
was appropriately vaccinated. There was no history of recent
dental procedures or illicit drug use. On examination, the tem-
perature was 39 ◦C. Heart rate, blood pressure and oxygen
saturations were normal. There was a pan-systolic murmur
over the apex. There were small, non-tender, erythematous
macules over both palms consistent with Janeway lesions.
Neurological examination was unremarkable. Blood tests
revealed raised inflammatory markers (C-reactive protein
87 mg/L). Four separate sets of blood cultures at admis-
sion isolated Corynebacterium pseudodiphtheriticum, sensitive
to penicillin. Urgent transthoracic echocardiography revealed
a large vegetation (11 × 9 mm) attached to the anterior
mitral leaflet with associated moderate-severe regurgitation.
Left ventricular function was preserved. The patient was
commenced on empirical therapy for endocarditis, subse-
quently rationalised to intravenous benzylpenicillin. Embolic
workup revealed multiple cerebral lesions suspicious for
mycotic aneurysms and a small subacute infarction in the
right frontal lobe. He underwent mechanical mitral valve
replacement after 2 weeks of intravenous antibiotic therapy.
Valve tissue and subsequent blood cultures were negative
and the patient was discharged home following a 6-week
admission.
This study reports a case of Corynebacterium pseudodiph-
theriticum endocarditis in an immunocompetent individual
without traditional risk factors. This is a nasopharyngeal com-
mensal, which is a rare cause of native valve endocarditis,
with predilection for causing metastatic infections. Surgical




A Rare Case of Very Late Recurrent
Multivessel Spontaneous Coronary Artery
Dissection in a Postmenopausal Woman
A. Dina ∗, C. Chow, L. Ponnuthurai, W. van
Gaal
Northern Hospital, Epping, Australia
A 60-year-old lady with a background history of hyperten-
sion, hyperlipidaemia, and an ex-smoker presented to this
hospital with a 2-day history of chest pain. She had pre-
viously been diagnosed with acute coronary syndrome in
2009 following an angiogram, which revealed severe dif-
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Minimization of the Wilson’s Central 
Terminal voltage potential via a genetic 
algorithm
Hossein Moeinzadeh1* , Paolo Bifulco2, Mario Cesarelli2, Alistair L. McEwan3, Aiden O’Loughlin4, 
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Abstract 
Objective: The Wilson Central Terminal (WCT) is an artificially constructed reference for surface electrocardiography, 
which is assumed to be near zero and steady during the cardiac cycle; namely it is the simple average of the three 
recorded limbs (right arm, left arm and left leg) composing the Einthoven triangle and considered to be electrically 
equidistant from the electrical center of the heart. This assumption has been challenged and disproved in 1954 
with an experiment designed just to measure and minimize WCT. Minimization was attempted varying in real time 
the weight resistors connected to the limbs. Unfortunately, the experiment required a very cumbersome setup and 
showed that WCT amplitude could not be universally minimized, in other words, the weight resistors change for 
each person. Taking advantage of modern computation techniques as well as of a special ECG device that aside of 
the standard 12-lead Electrocardiogram (ECG) can measure WCT components, we propose a software minimization 
(genetic algorithm) method using data recorded from 72 volunteers.
Result: We show that while the WCT presents average amplitude relative to lead II of 58.85% (standard deviation of 
30.84%), our minimization method yields an amplitude as small as 7.45% of lead II (standard deviation of 9.04%).
Keywords: Electrocardiography, Wilson Central Terminal, Genetic algorithm, Potential reference
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Introduction
The very first surface electrocardiogram was conceived 
and outlined by E. Einthoven in the 1900s, and entered 
clinical practice in the 1940s as 12-lead-Electrocardio-
gram (ECG). Since then, it is still the most popular non-
invasive diagnostic tool for cardiac assessment [1, 2].
The 12-lead ECG is composed of twelve signals or 
‘leads’ measured from the limbs and six positions on the 
chest called precordials. The precordials (1/2 of the sig-
nals) are measured as the potential difference between 
each exploring electrode located on the chest, and an 
assumed constructed ‘zero’ reference. This ‘zero’ refer-
ence was introduced by F. N. Wilson in 1931 and named 
after him as Wilson’s Central Terminal (WCT) [1]. By 
definition, it is the simple average of the three exploring 
electrodes connected to the right arm (RA), left arm (LA) 
and left leg (LL) and it is assumed to be steady and of 
negligible amplitude during the cardiac cycle.
However, the WCT voltage is neither steady nor of neg-
ligible amplitude [3]. Frank [4] was the first to undermine 
the idea of having a constant WCT during the cardiac 
cycle and discussed how this variation could affect the 
ECG measurement [2, 4–6]. Later, Burger clarified the 
true meaning of zero potential and defined the WCT as 
the average of the three limb leads which is symmetrical 
with respect to the limb leads [3]. To quantify the WCT 
voltage, Wilson proposed immersing the body in a large 
homogeneous conductor and theorized that 0.15 mV was 
its maximal value [7, 8].
Following this recommendation, Bayley and Kinard [9, 
10] encased the body of volunteers inside a metal struc-
ture (called integrator electrode) that was immersed 
in water for the duration of the recording. With this 
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experiment, they determined that the WCT is non-sta-
tionary during the cardiac cycle and its amplitude could 
be as large as 40% of Einthoven’s ECG signals [9, 10]. Dur-
ing this experiment, Bayley and Kinard also attempted a 
real-time minimization of the WCT amplitude to bring it 
below a non-influent value [10]. To achieve minimization 
they made use of three rheostats instead of fixed resis-
tors and adjusted the weights of the three WCT compo-
nents continually reporting the achieved new amplitude. 
To Achieve the WCT recording for the minimization, 
the volunteer was encased by a metal structure that was 
submerged in the water for the duration of the recording 
[10].
Although the notion that a large WCT voltage may 
be affecting the clinical recordings, aside from the few 
notable research studies [11, 12], all recording methods 
currently employed use the raw WCT as a reference for 
precordials. Eventually, after an initial wave of interest, 
the WCT has received scant research attention during 
the past decades [2]. Recently Gargiulo et al. [2, 12] pro-
posed a way to record unipolar ECG without using the 
WCT and suggested a new device and a method to meas-
ure and store the WCT components. Taking advantage 
of the availability of these unique recording we present a 
software minimization for the WCT.
Our method similarly to the originally attempted 
minimization performs a weighted average of the WCT 
components. To achieve this goal we use a genetic algo-
rithm (GA) [13]. The GA is a heuristic search method for 
finding the optimal answer for problems with high com-
putational complexity. This approach is used for those 
problems, like ours, that either lacks a deterministic solu-
tion or a deterministic polynomial time complexity solu-
tion. This algorithm is called “genetic” because is based 
on the concept of the biological evolution of individuals 
within a population where “chromosomes” mutates to 
achieve the survival of the fittest. A “chromosome” repre-
sents a possible solution to the problem that can mutate 
from one population of chromosomes to the next popu-
lation (generation) by using a “selection” procedure. The 
chromosomes that are selected to be in the next genera-
tion also could be changed or become parents of new 
chromosomes in the process of “mutation”, and “crosso-
ver” [13]. In this paper, we show results of our minimi-
zation method applied to data recorded from 72 patients 
(25 female, age average 66.35  year-old ± 11.46  year-old), 
at Campbelltown Hospital, New South Wales, Australia.
Main text
To our knowledge, this is the first attempt to the WCT 
minimization employing new data since Bayley and 
Kinard’s effort in 1954 [10]. The proposed approach to 
estimate M-WCT (whereas M stands for minimized) is 
engineered to fulfill:
1. Possibly be zero or near zero;
2. In any case (worst case scenario), M-WCT amplitude 
should be less than 0.1 mV, so that it can be consid-
ered clinically irrelevant and smaller than Wilson 
estimation of max amplitude [14].
In order to fit the M-WCT into the genetic algorithm 
paradigm, we need to formalize our problem regarding 
population, mutation, crossover and fitness function. 
Recalling that the WCT is the average of the limbs’ elec-
trodes, we can define M-WCT as the weighted mean of 
the WCT’s components (weights can be different from 
1/3, positive, not null and add up to one). More formally:
whereas α,β , and γ are the minimization parameters; 
∅L, ∅R and ∅F are the raw potential of the limb electrodes 
placed on LA, RA, and LL respectively; thus α,β , and γ 
are related to LA, RA and LL respectively, and will 
replace the averaging 5 kΩ resistors in our minimization.
To summarize, our method minimizes (1.1) according 
to the three main criteria enounced above constrained by 
(1.2) and (1.3).
Fitness function
As mentioned, the role of the fitness function is to ensure 
“the survival of the fittest” hence converging towards the 
solution. Equation  (1.4) is selected as the fitness func-
tion. This is because its shape and its nonlinearity pro-
vide an increase in the probability of having M-WCT 
with smaller values; in other words, it encourages the 
algorithm to converge more rapidly to amplitudes smaller 
than 0.1 mV. The plot of the fitness function is depicted 
in Fig. 1.
Population
Represents all possible answers (chromosomes), a new 
population is generated during each iteration where each 
individual is a tern of weighted factors (α,β , γ ) . 80 indi-
viduals are chosen as population size. In the first popu-
lation, only one chromosome is initialized by the WCT 
chromosome ( α = β = γ = 1/3) and the rest are gener-
ated randomly constrained only by the conditions (1.2) 
and (1.3). Also, (1) the elite members of each population 
are moved to the next generation directly; (2) the WCT 
chromosomes are preserved in each population.
(1.1)M-WCT = α∅L + β∅R + γ∅F
(1.2)0 < α,β , γ < 1
(1.3)α + β + γ = 1
(1.4)Fitness = log0.00001 |M-WCT |
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Crossover
The role of the crossover operation is to build the next 
population based on selected chromosomes of the cur-
rent population. We use single point and averaging 
crossover methods randomly to populate the next gen-
eration. For details see [15, 16].
Mutation
To avoid trapping into local optima the permuta-
tion algorithm is used to change the position of three 
parameters in a selected chromosome (mutation prob-
ability is equal to 0.1).
This method is applied to every voltages sample of 
the recording and computes three parameters to have 
the M-WCT trace during the cardiac cycle. For this 
study, we included data from 72 patients; each selected 
data excerpt has a normalized length of 10 s. As men-
tioned earlier, three weighting factors α,β , and γ are 
calculated using the GA to minimize Wilson Central 
Terminal. In Additional file  1: Table  S1, we report the 
average values of the three weights and the average 
number of iterations that the GA needs to converge for 
all patients.
Similarly to previous studies [9, 10], the WCT and 
M-WCT amplitudes are measured averaging five con-
secutive beats for each dataset and reported as a per-
centage of lead II. We used the orientation of the QRS 
complex to report the polarity of the WCT. “N” denotes 
signals with an unclear polarity in which the posi-
tive deflection amplitude closely matched the negative 
deflection at the QRS. In Fig.  2, we report the ampli-
tude of the M-WCT and the WCT for each patient 
as well as the average across the full 10  s of the three 
weighting parameters. As it can be seen in Fig. 2b, the 
variation of each parameter is too high among all the 
patients, and three optimal parameters cannot be found 
for all the patients. Summary of our findings are sum-
marized in Additional file 1: Table S1.
Similarly, to previous studies, we found a variety of the 
WCT shapes and polarities (slightly in favor, see Addi-
tional file  1: Table  S1, for positive polarity) hence it is 
possible to say that the WCT is highly individual, and can 
have standard ECG characteristics, such as a P-wave and 
a T-wave. Individuality was also found in the M-WCT, as 
we show in Fig. 3. However, due to the negligible general 
amplitude of M-WCT (see Fig. 2), we conclude that the 
clinical impact of the M-WCT is negligible with respect 
to the WCT.
Figure 3 shows an example of WCT in which a broader 
QRS feature with amplitude even higher than Lead 
II. However, as one can infer comparing M-WCT and 
WCT (bottom panel), the relative amplitude of M-WCT 
has highly decreased compared to the WCT relative 
amplitude.
An example of the WCT signal with a marked 
T-wave is visible in Additional file  2: Figure S1. As it 
can be observed, a marked T-wave deflection on the 
WCT trace (bottom panel) is synchronized with the 
T-wave on lead II (top panel). The WCT trace in Addi-
tional file 2: Figure S1 is also an excellent example of a 
highly variable WCT and an almost steady M-WCT. In 
one single cardiac cycle, the deflection’s polarity of the 
Fig. 1 Nonlinear fitness function is used to encourage individuals to 
have smaller M-WCT 
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Fig. 2 Direct comparison of the WCT and M-WCT (a); average of 
weighing parameters (b). a Direct comparison of M-WCT (bold trace) 
and WCT relative to lead II amplitude. b Trend of the three (average 
across the full 10 s) weighting parameters
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WCT changes at least three times, and its amplitude 
reaches 45.27% of lead II (average), while the M-WCT 
amplitude is 3.59% of lead II. Additional file 3: Figure 
S2 is an example of high WCT amplitude with nega-
tive deflection. As seen, the WCT has an amplitude 
of 59.21% of lead II, while M-WCT amplitude is only 
2.79% of lead II.
Recall that there was an attempt to measure and 
minimize the WCT in 1954 with a peculiar experi-
ment which required a very cumbersome setup [9, 
10, 17]. Minimization was attempted by varying the 
weight resistors connected to the limbs in real time, 
and it showed that the WCT amplitude could not be 
universally minimized (see Additional file  4: Figure 
S3). They found out the value of the WCT is zero for 
half of their subjects when the three resistors were 
chosen as (r = l = 2.6f ) . Unfortunately, this resistors 
selection, for the other tested subjects) decreased the 
WCT amplitude to less than 50% when compared to 
an unweighted terminal selection 
(
r = l = f
)
 [17]. 
Our results (see Fig. 2b) shows that to minimize WCT 
amplitude, different weights should be used similarly 
to Bayley et al. experiment [17]. Additionally, we found 
that γ  (the weighting factor of ∅F  ) have usually larger 
amplitudes in comparison with α and β . However, as 
the WCT component signals ( ∅L, ∅R and ∅F  ) are highly 
individual, the computed weighted factors are also dif-
ferent for each patient. In our dataset, the ratio of γ  to 
α is in the range of [0.78, 5.69], and the ratio of γ  to β is 
in the range of [0.62, 5.69] (see Fig. 2).
Limitations
Although with this work we overcome the need to sub-
merge the patients in water and use manual rheostats 
actually achieving a real minimization, probably the 
largest limitation is represented by the need to col-
lect an excerpt of data that need to be used for the GA. 
For this work, we used a data excerpt of 10 s that at a 
sample rate of 800 Hz means a buffer for 8000 samples. 
Although this may seem like a small number, consider-
ing that to converge our GA takes 200 ± 41 iterations 
requiring few minutes on an average computer before 
that the new precordials can be computed adding con-
siderable delay to the ECG diagnosis. To improve our 
method, we are currently working on faster minimiza-
tion techniques that could make the use of M-WCT 
viable in clinical practice.
Additional files
Additional file 1: Table S1. Measurements summary.
Additional file 2: Figure S1. Example of negative deflection WCT. WCT 
is 59.21% of lead II amplitude, while M-WCT is 2.79% of lead II amplitude 
(average); the recording is from a 59-year-old male patient admitted with 
chest pain.
Additional file 3: Figure S2. Example of negative deflection WCT. WCT 
is 59.21% of lead II amplitude, while M-WCT is 2.79% of lead II amplitude 
(average); the recording is from a 59-year-old male patient admitted with 
chest pain.
Fig. 3 Example of positive deflection WCT. M-WCT is 11.04% of lead II amplitude, while WCT is 118.82% of lead II amplitude (average); the recording 
is from a 73-year-old male patient admitted at the hospital
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Additional file 4: Figure S3. Comparison of three resistors for right hand, 
left hand, and foot electrodes for 33 patients, experiment done by Bayley 
and Schmidt.
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Abstract: Since its inception, electrocardiography has been based on the simplifying hypothesis
that cardinal limb leads form an equilateral triangle of which, at the center/centroid, the electrical
equivalent of the cardiac activity rotates during the cardiac cycle. Therefore, it is thought that the
three limbs (right arm, left arm, and left leg) which enclose the heart into a circuit, where each branch
directly implies current circulation through the heart, can be averaged together to form a stationary
reference (central terminal) for precordials/chest-leads. Our hypothesis is that cardinal limbs do
not form a triangle for the majority of the duration of the cardiac cycle. As a corollary, the central
point may not lie in the plane identified by the limb leads. Using a simple and efficient algorithm,
we demonstrate that the portion of the cardiac cycle where the three limb leads form a triangle is,
on average less, than 50%.
Keywords: basic cardiology science; ECG; Wilson Central Terminal; Einthoven triangle
1. Introduction
Modern electrocardiography (ECG) is still based upon the simplified assumption that the electrical
activity of the heart can be reduced to that of a single electrical dipole rotating around a fixed point in
the chest, the projection of which constitutes the so-called 12-lead ECG on the direction identified by
pairs of electrodes [1]. This assumption was formulated in the 1930s by F.N. Wilson, who introduced
the so-called precordials, or chest leads. In modern electrocardiography, precordials are voltage
measurements. Having said that, at the time, precordials were measured as the current circulating
into a circuit composed of one out of six pre-defined positions on the chest, and an estimation of the
fixed point around which the equivalent heart dipole is supposed to rotate during the cardiac cycle [1].
Wilson himself defined this reference point as the average of the Einthoven limb electrodes: Left Arm
(LA), Right Arm (RA), and Left Leg (LL), whereas the average is simply operated by connecting the
three electrodes to a single common point via three identical, “high value” resistors [1].
Sensors 2018, 18, 2353; doi:10.3390/s18072353 www.mdpi.com/journal/sensors
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As one may note, the Right Leg (RL) is not included in the original electrical activity of the heart
model [1–3]. This is because the original instrument used to demonstrate the limbs’ ECG by Einthoven
was an extremely sensitive galvanometer (Ampere-meter) [1,4]. Therefore, also the limbs’ ECG at the
time was, by definition, a measure of the tiny current impressed from the heart to the limbs. Because
there is no direct current pathway between the RL and LL that includes the heart, the circulating
current is measured only between the arms, and between each arm and the LL.
In summary, it is possible to conclude that ECG recordings were originally a measure of the
net current impressed by the electrical activity of the heart circulating into an external circuit closed
by the measurement instrument. With this assumption, it was natural for Wilson to complete the
transformation from the triangle (Einthoven’s triangle) to the equivalent star circuit when he faced
the problem of finding a reference for his chest leads (see Figure 1 panel (a)). In theory, if each of the
Einthoven leads measures the net current impressed by the heart between two limbs, averaging all the
electrodes together should give the best approximation of the point of origin: the neutral point of the
cardiac electrical activity. In honor of his measurements and experiments, this reference terminal was
named after him (Wilson’s central terminal, or simply WCT), and the term ‘unipolar’ was introduced
for precordial leads.
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In this framework, with this study we will demonstrate the following research hypothesis:
Voltage measurement of limb leads, although measured in a closed circuit, does not form a triangle for
the majority of the duration of a cardiac cycle; hence, a centre and centroid that constitute the WCT
cannot be identified, as per Wilson’s hypothesis.
We prove this research hypothesis by analysing a total of 599 12-lead ECG recordings that include
549 recordings taken from the PTB database (freely available of Physionet [5]), and 50 recording taken
the pilot study for our ECG device which is capable of recording the components of the WCT [2,6].
Using these recordings, we first assess where the limb leads form a triangle, and calculate the inner
angles. Assessment of WCT amplitude is performed only for the 50 recordings where this is available.
2. Materials and Methods
For this paper, we employed a total of 599 ECG recordings. The first 549 were taken from the
online Physionet databank [5] PTB database [7], while the remaining 50 were selected from one of our
recent studies [2]. All subjects volunteered for our study and gave written consent (this study was
approved on 23 September 2015 by the National Human Ethics Committee of Liverpool Hospital with
the protocol number HREC/15/LPOOL/302).
This method section is divided into three parts. In the first part, we introduce the theoretical
background and principles of physiological measurements of Voltage/Current for electrocardiography
that form the context of our research hypothesis; in the second, we delve into the details of the
equilateral triangle hypothesis which is at the base of the standard ECG theory (this is used to
demonstrate the study hypothesis); in the third and the final parts of this method section we give a
summary of the hardware used for the 50 recordings where WCT components are available.
During the work for this paper, we produced a very large amount of processed data and figures.
As we aim to make our research entirely reproducible, the necessary processing scripts are included,
together with the results of the processing for each single dataset we employed as additional material.
The new data that we recorded during our clinical evaluation [2] are also available for download in
Matlab format upon request.
2.1. Methodology Background: Principles of Voltage/Current Measurement in Electrocardiography
Before delving into the full explanation of our method, we must mention that Wilson’s hypothesis
and the related triangle to star transformation has been challenged at both the theoretical [8–13]
and practical level [2,3,6,10,11,13–21] several times in the past 80 years, with several researchers
confirming that, contrary to what Wilson’s principal postulates [1,22,23], the amplitude of the WCT
can be comparable to (or even larger than) the limb leads, and can exhibit variability during the
cardiac cycle similar to any other ECG signal [2,8,10,16,24–28]. Still, as already mentioned, one may
note that the original instrument that both Einthoven and Wilson used to formalize the triangular
ECG model and the WCT was measuring the current impressed by the heart to the body surface,
while modern electrocardiography uses voltage amplifiers [28]. Therefore, it is possible to evince that,
contrary to the original definition of WCT, in modern ECG devices the WCT used is the instantaneous
average of the voltages of the three limbs (RA, LA, and LL) relative to a reference voltage (see Figure 1
panel (b)) [3,17].
Moreover, once again we must stress the consequences of exchanging voltage measurements for
current ones, as this difference is crucial for our method. Although it is clear that there is a well-known
relationship of cause and effect between the voltage potential measured between two points of a
circuit and the current circulating in the circuit itself, one must not forget that voltages are relative
measurements performed by differential reading with respect to a reference point assumed to be
neutral (or steady). Even the so-called “true differential” electronic amplifiers require a reference
point to operate correctly [29–31]. In biomedical applications, particularly ECG, this reference is
created virtually by the internal circuitry (i.e., voltage supply bootstrap [32]), and one may have the
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impression that the amplifier works off the two points of connection in a true differential manner,
i.e., this is only an impression, as the virtual reference voltage “moves” within the power supply rails
according to the estimated common mode. This solution is often employed in single-lead ECG designs.
In multiple-lead designs, this reference point is a true reference point on the body, and usually this
additional connection is used also to re-inject a part of the measured signal inside the body to increase
the signal-to-noise ratio at certain frequencies (i.e., power line frequencies). In both cases, the selected
reference point on the human body is placed at the RL, and the circuitry designed to re-inject the signal
inside the body is known as the Right Leg Driver (RLD), or Driven Right Leg (DRL) [32–35]; for this
reason, in Figure 1, panel (b), the reference point for voltage measurements is noted on the RL [3,17].
Due to the natural link between voltage and current, and to the impractical use of sensitive
current-measuring devices, cardiologists became used to referring to all measurements pertaining
to ECGs in mV, neglecting the fact that measuring voltages rather than current implies having to
deal with the different impedances of body sections. Taking Ohm’s law into account, which states
that the voltage is the product of current and resistance (Voltage = Resistance × Current), each lead
can be interpreted as the voltage drop across a composed resistance (impedance, as a matter of fact)
due to the net current impressed by the heart to the points of measurement. As an example, lead I
(see Figure 2) can be interpreted as the voltage drop across the sum of the contact impedance at both
electrodes, the impedance of each arm, and the variable impedance of the chest (due to respiration)
across the shoulder.
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constant proportion between the values of current and voltages, these are perfectly interchangeable. 
However, in real life recordings, this is not always the case, and often, impedance/contact impedance 
imbalance between ECG electrodes is not verified, or is fixed. Impedances which are not purely 
resistive or homogeneous can alter the phase relationship between voltage and current, adding a 
Figure 2. Direct comparison of idealized (left) measurement of lead I as voltage VS real measurement
(right) that takes into account contact impedances (Zc1 and Zc2), different limbs impedance (Z1 and
Z2) and the variable torso impedance (Zt) which changes rhythmically following the respiration.
Of course, evoking the simplifying hypothesis that the body is a homogeneous volume conductor,
and hence, limb electrodes are all placed at an equal distance on a homogeneous conductor (constant
resista ce), with no (or negligible) contact impedance aside from a simple constant proportion
bet een the values of current and voltages, these are perfectly interchangeable. However, in real life
recordi gs, this is ot always the case, a d often, impedance/contact impedance imbalance between
Sensors 2018, 18, 2353 5 of 14
ECG electrodes is not verified, or is fixed. Impedances which are not purely resistive or homogeneous
can alter the phase relationship between voltage and current, adding a delay variable with frequency;
this may affect the limb leads which are measured across different portions of the torso that change
in shape with respiration and body posture. Altered phase relationships may also affect raw limbs’
potential to form the WCT. Because RA, LA, and LL potentials are first measured as voltage potential
difference between the reference point (RL) and the other limbs’ electrodes, different body impedances
and contact impedances may impose different delays upon the signals, thus affecting the final WCT
shape in an unpredictable manner [3,17].
2.2. Study Hypothesis: On the Equilateral Triangle Hypothesis
If the three cardinal leads are indeed on a plane and form a triangle (even if not equilateral), in
order to obtain a WCT which is at least at the centroid of the triangle (center coincide with centroid
only in equilateral triangles), the three cardinal limbs need to satisfy the basic condition of a triangle.
This is because, under the original Einthoven/Wilson assumption, the equivalent electrical activity
of the heart is entirely projected into the geometrical plane identified by the limbs [1,4,36]. In other
words, the ECG values need to satisfy the so-called triangular inequality which states that the sum of
any two of the three lengths that are candidates for the triangle must be greater than the third. If this is
satisfied, it is then possible to calculate the inner angles.
In order to prove this hypothesis with a computationally efficient method, we assumed that at




p(p − a)(p − b)(p − c) (1)
where a, b and c are the three measurements of the sides and p indicates half of the perimeter:
p =
a + b + c
2
(2)
Obviously, if a, b, and c do not form a triangle, the area calculated using (1) is either null or a
complex number. We proceeded to calculate the inner angles only for those terns of points constituting
a triangle or, in other words, where (1) gives a positive result. To our calculation script, we passed the
cardinal leads following their cardinal order (I, II and III), and received the calculated angles with the
following order: ‘opposed to lead I’, ‘opposed to lead II’, and ‘opposed to lead III’.
Because the ECG has some brief iso-potential segments (i.e., following the p-wave), we expected
some percentage of points within each cardiac cycle where (1) is not satisfied (i.e., the same iso-potential
value for all three leads), as well as some iso-potential segments between beats. While there is nothing
that we can do to remove the iso-potential segment between ECG characteristic waveforms, we can
remove the one between beats, limiting the calculation to one single cardiac cycle. According to the
existing literature, flat iso-potential segments between characteristic waveforms can account for up to
40% of the length of a single beat [1]. Therefore, it would be normal to find (1) satisfied only in roughly
60% of the points for each cardiac cycle. Namely, we expect (1) to have a solution only during the QRS,
p-wave, and T-wave. Furthermore, because noise, particularly baseline drift/wandering, could alter
the ECG, we removed such noise using a zero phase lag non-causal filter with a cut-off frequency at
0.6 Hz. To minimize the effect of artifacts and power-line noise, the signals are also filtered using an
array of zero phase lag non-causal notch filters at power-line and harmonics frequencies, together with
a low pass filter at 149 Hz. For each of the 599 recordings, a single beat was selected manually from
the cleaned signal. We attempted to select a beat with the following characteristics:
High signal-to-noise ratio: no muscles/movements artifacts
Avoid pacemaker where possible
Avoid multiple p-waves in case of atrial flutter
Avoid ectopic where possible.
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Once the selected beat is isolated, Equation (1) is applied to each tern of points corresponding to
each of the signal samples. The percentage of points where (1) is satisfied, together with the length of
each beat, is stored in a separate variable, and the inner angles are calculated only where (1) is satisfied
(non-null real value).
2.3. A Brief Summary of the Hardware Used
Full details of the hardware we used to record the data can be found in our previous publications.
In particular, the general description of the true unipolar recording channel can be found in [2].
We want to highlight that our hardware can also record true unipolar precordials (see Figure 3).
In other words, similar to what we have done to record the WCT components, we record and store
the voltage potential of each of the precordial electrodes as directly referred to the RL. This allows us
to calculate new precordials, i.e., to subtract in the post-process a reference potential different from
the WCT. Coherence between the true unipolar leads and 12-lead ECGs is ensured by the extremely
high correlation between the recorded 12-lead signal and the calculated 12-lead signal. In other words,
using lead I as an example, we ensured that:
Correlation([RA − LA], I12lead) > 98%
As shown in the block diagram of Figure 3, each exploring electrode is connected to the
non-inverting input of one instrumentation amplifier. For our design we selected the INA116 by
Texas Instruments. This peculiar amplifier includes a special buffer for each input (see the dashed
rectangles around each electrode connection in Figure 3) that allows direct measurement of the
electrode potential, signal duplication [2], as well as input shielding [2,30].
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Figure 3. Block diagram of the employed hardware (adapted from [2]).
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The signal supplication feature is directly employed for the limb electrodes to create direct limb
leads. For instance, as it is possibly to infer from Figure 3, once duplicated by the buffer inside the
INA11,6 the Left-Leg electrode signal is connected to the last instrumentation amplifier on the diagram
to create Lead III. In this way, due to our design choice of connecting electrodes only to non-inverting
inputs, some leads (i.e., Limb III) output negative values. The negative leads are multiplied by −1
by the recording software [2]. The complete circuit uses a voltage supply bootstrap and a Driven
Right-Leg circuitry (calibrated to contain leakage current below 100 µA) to minimize noise pick-up
and increase the signal to noise ratio [2,4,32].
3. Results
As expected, Equation (1), when applied to a single beat for all 599 datasets, produced correct
results only for a fraction of the points. In Figure 4, we present the detailed histograms of the
distribution of the percentage of points within each beat that satisfy (1). For this measurement we
accepted (considered satisfied) any small positive result obtained by application of (1); in other words,
we compared directly with zero. In Figure 4a, we depict the general histogram for all 599 datasets;
histograms for the PTB dataset alone, and for fifty recordings constituting our Dataset 2, are shown
in Figure 4b,c respectively. The averages where (1) is satisfied are 49% (STD = 12) for the total, 49%
(STD = 11) for the PTB database and 46% (STD = 15) for Dataset 2 (values rounded to the nearest
integer, interpolations with normal distribution have been implemented using the statistical fitting
tool included with Matlab®). As can be inferred from the histograms, for the majority of the datasets,
the percentage of points where (1) is satisfied is below 50%, which is below what should be expected
(~60%) from the theory.
For this reason, we restricted our investigation to the QRS only, where there are no iso-electric
segments. From the application of Equation (1) to the QRS only (see Figure 4 panels d to e), we found
that, similar to what we observed for the full beat, Equation (1) is satisfied on average for only 48% of
the points composing the QRSs with even larger standard deviations. In detail, the averages where (1)
is satisfied are 48% (STD = 22) for the total, 48% (STD = 21) for the PTB database, and 47% (STD = 26)
for our study.
When we looked at the inner angles, although their values (in average) are quite close to the
theoretical value of 60 deg, particularly for the QRS (see Table 1), the standard deviations are very high.
Full histograms of the inner angles for the full beat, and one single QRS, are depicted in Figure 5; as it
is possible to infer from the histograms, the distributions of the bins are very wide, with many bins
with similar height.
An example of how the points where Equation (1) is satisfied distribute in one single cardiac cycle
is given in Figure 6. In Figure 6, the points within the cardiac cycle where the absolute value of the
three leads do not form a triangle have been “zeroed”; as it is possible to observe from the figure, these
sections also affect the QRS region. These seem to be due to a specificity of the patient, and do not
vary much in different recordings of the same patient; please compare Figure 6, panel b with the panel
belonging to the same PTB database patient recorded on different days. One might also observe that
the inner angles of the triangle vary a lot during the cardiac cycle and the QRS (please compare bottom
traces of the Figure 6 panels). This suggests that the triangle, when closed, changes shape during the
cardiac cycle, and in some cases, it can become quite “open”, with one of the angles exceeding 100 deg.
Once again, as it is possible to see from Table 2, there is a lot of variability around the mean for the
inner angles.
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Figure 4. Percentage of points where Equation (1) is satisfied within one beat (panels a to c) and one
QRS (panels d to e): (a) total, mean 49%; (b) PTB t ase, mean 49%; (c) our study only, mean 46%;
(d) total, mean 48%; (e) PTB d tabase, mean ; (f) our study only, mean 47%.
Table 1. Summary of inner angles.
Angle
Opposed to Lead I [deg] Opposed to Lead II [deg] Opposed to Lead III [deg]
Mean STD Mean STD Mean STD
One beat 59 31 70 36 51 30
One QRS 64 40 66 41 50 37
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Figure 5. Angle opposed to cardinal leads where Equation (1) is satisfied within one beat (panels a to c)
and withi one QRS (panels d to f): (a) osed to lead I, mean 59 deg; (b) opposed to lead II, mean
70 deg; (c) pposed to lead III, 5 eg; (d) opposed to lead I, mean 64 deg; (e) opposed t lead II, mean
66 deg; (f) opposed to lead III, mean 50 deg.
The amplitude of WCT relative to lead II has been measured for this study too. On average, the
WCT amplitude is 78% of lead II, with a standard deviation of 42%. These results are discussed further
in the following section.
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1 1.02 118 152 117 70 F
2 0.48 333 283 95 53 M
3 1.55 87 82 77 80 M
4 0.52 240 285 174 85 M
5 1.19 126 43 45 69 F
6 0.83 105 113 52 78 M
7 0.46 199 235 120 73 M
8 0.94 160 121 57 55 F
9 0.20 202 176 114 52 F
10 0.88 158 170 60 70 F
11 1.12 57 115 82 79 M
12 0.58 217 125 56 51 F
13 0.30 123 88 45 52 M
14 1.28 71 46 59 88 F
15 0.77 176 100 30 68 F
16 0.45 222 153 101 49 M
17 0.78 180 122 60 67 M
18 0.70 246 170 206 60 F
19 0.99 105 21 24 54 F
20 0.86 104 32 29 58 M
21 1.13 78 134 63 56 M
22 0.42 136 111 53 70 M
23 1.35 107 78 42 55 F
24 1.18 134 97 38 76 F
25 0.65 81 46 37 74 F
26 0.60 331 385 151 53 M
27 0.87 126 67 26 48 M
28 0.86 177 168 74 57 M
29 0.67 300 267 88 44 M
30 1.81 41 90 56 59 M
31 0.62 144 67 21 84 F
32 0.92 76 133 70 70 M
33 0.66 287 256 79 58 M
34 0.92 141 168 91 51 M
35 0.55 98 193 110 66 F
36 0.41 108 127 117 96 M
37 0.57 170 108 82 53 M
38 0.55 130 159 80 59 M
39 1.06 55 56 50 61 M
40 0.38 136 62 64 68 F
41 0.70 193 106 58 52 F
42 0.92 115 88 49 61 M
43 0.30 115 126 144 70 M
44 1.29 65 55 52 53 F
45 0.32 194 226 173 69 M
46 0.68 299 221 73 47 M
47 0.92 62 150 107 82 F
48 0.61 107 66 33 71 F
49 1.60 24 106 60 73 M
50 0.67 137 120 147 77 M
Means 0.80 148 133 78 64.48
STDs 0.36 75 75 42 12.19
M = 60%
4. Discussion
The small percentage of points where Heron’s formula is satisfied (Equation (1)) suggests that
the voltage potential of the CT can actually exceed the cardinal leads in the module, as this point may
be located external to the triangle, and may even be outside the geometrical plane identified by the
limb electrodes. This may explain why we found peak-to-peak amplitudes for the WCT larger than
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those reported in the literature in our previous study [2,6]. For this work, in light of our findings,
we re-evaluated the peak-to-peak amplitude of the WCT (we also added several patients to our
database). However, this time, we measured the amplitude of the WCT at its largest feature and in
one beat only, i.e., the one used for the triangle evaluation. The full summary of our measurements is
reported in Table 2, and as can be inferred from the table, for a few patients the WCT amplitude is
almost double that of lead II.
Since the introduction of the 12-lead ECG into medical practice, practitioners have learned how to
interpret the signals and make diagnoses based on the results of WCT. For this reason, it is extremely
difficult to formulate study hypotheses that, while backed up by a suitable statistical body of evidence,
can unveil the extent of the implications that the use of a signal this large (and laying on a different
geometrical plane) as a reference for precordials has on the practice. However, as it is possible to
observe in Figure 7, the WCT influences the precordials. For instance, in this case, while the QRS
complex results are slightly larger in the lead V2 (see peak to peak amplitude of dashed bold black
trace versus thin black trace) when WCT is subtracted from the v2 electrode, one can easily see that
the P-wave is greatly affected (almost erased from the lead V2). Suppression of waveforms, as well as
waveform alteration, can have severe implications for the diagnosis of cardiac diseases. For instance, as
it is possible to observe from Figure 7, the ST segment is also affected by the WCT, which superimpose
a ST depression to V2. ST segment alterations are normally linked to cardiac ischemia or other
myocardium illnesses [36]. For this reason, we are still collecting data with our device in a hospital
setting, in order to carefully assess the relationship between WCT and cardiac diseases.
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5. Conclusions
We presented a critical study of the triangular model of the ECG. Although we now have to
carefully assess the clinical relevance of our findings, we particularly need to build a solid database
of recordings where diagnoses are evaluated by comparing standard 12-lead ECG precordials and
precordials obtained using the new personalized CT. We conclude that the WCT introduced for current
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recordings, due to its large amplitude (sometimes larger than cardinal leads), should not be used as a
reference for precordials. Furthermore, our study assessment, based upon a simple method to evaluate
when three lengths form a triangle, shows that voltage measurements of cardinal leads fail to form a
triangle for the largest part of the duration of a single cardiac cycle, even when calculation is restricted
to the QRS complex only, suggesting that the so called ‘Central Terminal’ may actually be outside the
geometrical plane identified by the cardinal leads.
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We recently developed 15-lead ECG device that can record
the voltage of the right arm (R), left arm (L), and left leg
(F) aside 12-lead ECG. This device allows us to compute the
Wilson Central Terminal (WCT) trace for the first time after
Bayley and Kinard in 1954.
Since minimisation of the WCT will improve the signal to
noise ratio of electrocardiograms with ubiquitous potential
clinical applications, we developed a software approach to
minimize the amplitude of WCT according to the following
main criteria: (1) less variation than WCT during a cardiac
cycle; (2) to be possibly zero or near zero; (3) M-WCT ampli-
tude should be less than 0.1 mV to be considered clinically
irrelevant. In this approach, we used Genetic Algorithm
to find three weights (, , and 	) with the constraints of
(0 < ,, 	 < 1, and  +  + 	 = 1) to minimize WCT, to which we
referred as “Minimized Wilson Central Terminal” (M-WCT).
M-WCT = L + F + 	R
Our results, tested on the data recorded from 72 patients
confirmed that M-WCT better characterizes the ideal refer-
ence potential in terms of amplitude and variation during
the cardiac cycle compared to WCT. Specifically, for our
population, the WCT presents average peak to peak ampli-
Figure 1. Comparison of M-WCT (bottom) with WCT (middle), and Lead
II (top).
tude relative to Lead II of 58.85% with an averaged standard
deviation of 30.84%, while the M-WCT amplitude is as small




Mitral Valve Prolapse and Cardiac Arrest:
Defining Malignant Mitral Valve Prolapse
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Background: In an attempt to better understand malignant
mitral valve prolapse (MVP) syndrome, this study aimed to
comprehensively evaluate the scientific literature in relation
to case reports and series of MVP and cardiac arrest.
Method: A literature search of PubMed and Embase was
conducted using Preferred Reporting Items for Systematic
Reviews and Meta-Analyses guidelines. Included articles
were any cases of MVP with sudden death, or MVP with
survived cardiac arrest and documented rhythm reported in
English.
Results: There were 106 studies describing 149 cases.
Median age was 31 years and 68% of cases were female. A
total of 53% experienced palpitations and 33% had a history
of syncope. Cardiac arrest occurred during routine activities
in 45% of cases, and 22% were exertion related. T-wave inver-
sion in the inferior leads were described in 20% of cases.
On electrocardiogram, 51% had premature ventricular com-
plexes (PVCs), and 91% had PVCs, couplets or non-sustained
ventricular tachycardia (VT) on Holter monitoring. Cardiac
rhythms at the time of cardiac arrest were ventricular fibril-
lation (81%), VT (12%), torsade de-pointes (4%), and asystole
(3%). Leaflet involvement was predominantly bileaflet (73%)
or posterior leaflet (26%), and 55% had mild mitral regurgi-
tation (MR) or less.
Conclusion: This systematic review indicates that malig-
nant MVP syndrome predominantly affected females with
a median age of 31 years. The mitral valve was myxomatous
with bileaflet prolapse and variable degrees of MR. There was
a high incidence of PVCs on Holter monitoring, and cardiac
arrest usually occurred as a result of ventricular arrhythmias.
http://dx.doi.org/10.1016/j.hlc.2018.06.640
Unipolar cardiac leads between history 
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The surface electrocardiography (ECG) uses a virtual reference point to measure the potential of chest electrodes. 
This reference potential is known as Wilson central terminal (WCT) and is assumed negligible (near zero) in 
amplitude. Consequently, the precordial leads have been named as the unipolar leads. Although this assumption was 
found incorrect immediate after this reference potential was introduced, it was difficult to measure its real 
amplitude. We recently introduced a 15-lead electrocardiography device that can record the traditional ECG leads in 
combination to the raw potential of limbs and chest electrodes directly referred to the circuit grounding. 
Consequently, we are able to record the potential of the raw chest electrodes which we named as true unipolar chest 
leads. The aim of this study is to have a clear understanding of the WCT potential and its influence on the chest 
leads. Our records show that the true unipolar leads may be more sensitive for detecting cardiac diseases in the left 
anterior descending coronary artery in patients with non-ST elevation reported on chest leads. 
Keywords: Electrocardiography, Wilson Central Terminal, Unipolar leads, Limb Potential, Left Anterior 
Descending, Electrocardiography Database 
 
Introduction 
The heart impresses an electrical current that flows from the heart through the limbs, which can be used for 
examining the cardiac function (Webster 1978; Macfarlane et al. 2010). First Waller used two electrodes on the 
body and found changes in electrometer by heartbeat (Waller 1887; Malmivuo & Plonsey 1995). He applied 
electrodes on limbs to show the electrical activity of the heart. However, Einthoven made a major breakthrough in 
Electrocardiography by using the string galvanometer in 1901 (Malmivuo & Plonsey 1995). He used a silver-coated 
quartz filament (or string) in a strong magnetic field to measure the strength and direction of the current of the heart 
(Fye 1994). The string was moved in the magnetic field when the current of the heart moved through it (Fye 1994). 
The Einthoven’s device was very bulky and far from the hospital, hence, he used the telephone wire to receive the 
patients’ heart impulse from the hospital (Fye 1994; Macfarlane et al. 2010). Later, Einthoven introduced the 
mathematics relations between three limb leads, which has been known as Einthoven Triangle hypothesis 
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(Einthoven et al. 1913). The vertices of the Einthoven Triangle are electrodes placed on the right hand, left hand, 
and left leg which are used to measure the limb leads, known as the lead I, lead II and lead III (Einthoven et al. 
1913; Malmivuo & Plonsey 1995). In this theory, the human body is characterized as a two dimensional, 
homogeneous conductor, and part of infinity with the heart located in the centroid of the triangle (Macfarlane et al. 
2010; Malmivuo & Plonsey 1995).  
Lead I= Φ𝐿 − Φ𝑅 
Lead II= Φ𝐹 −Φ𝑅  
Lead III= Φ𝐹 −Φ𝐿 
(1) 
As the three limb leads construct a closed loop (Figure 1), the Kirchhoff’s voltage law can show the relation 
between the limbs (Eq. 2) (Macfarlane et al. 2010). 
𝐼 + 𝐼𝐼𝐼 = 𝐼𝐼 (2) 
Although some researchers suggested a different system to record the heart activity (Anon 1925; Waller 1887; 
Macfarlane et al. 2010), only the Einthoven limb leads had clinically used for three decades (Kossmann 1985; Fye 
1994; Macfarlane et al. 2010). Wilson highlighted the fact that the limb electrodes are far from the heart, and 
introduced the unipolar lead concept (Wilson et al. 1946; Fye 1994; Kossmann 1985; Wilson et al. 1934). In Wilson 
hypothesis, the electrical activity of the heart can be measured by the potential difference between six exploring 
electrodes on the chest and an indifferent electrode of zero potential, which is known as Wilson Central Terminal 
(WCT) (Wilson et al. 1934). These six leads are designated as unipolar precordial leads (V1:V6) as he assumed the 
WCT amplitude is equal to zero (Wilson et al. 1934; Macfarlane et al. 2010). The Wilson Central Terminal is 
measured by the average potential of the right arm (ΦR), left arm (ΦL) and left leg (ΦF) (Wilson et al. 1934; Wilson 




(ΦL +ΦR +ΦF) 
(3) 
𝑉1: 𝑉6 = ΦV1: ΦV6 −Φ𝑊𝐶𝑇 
(4) 
Wilson also proposed to use three unipolar limb leads (VR, VL, and VF), which were measured by difference 
potential of limbs’ electrode and the WCT reference point (Wilson et al. 1934).  
𝑉𝐿 = Φ𝐿 −Φ𝑊𝐶𝑇  
𝑉𝑅 = Φ𝑅 −Φ𝑊𝐶𝑇 
𝑉𝐹 = Φ𝐹 −Φ𝑊𝐶𝑇 
(5) 
Because the three unipolar limb leads had a small amplitude, Goldberger (Goldberger 1942) modified the WCT 
to increase these leads’ amplitude by 50%. The new leads are measured as the potential difference between each 
limb potential and the average of the other two limb potentials. These leads are known as augmented leads and 
named as aVR, aVL, and aVF (Goldberger 1942).  













The augmented leads were suggested in 1942 finalizing the development of the ECG lead system. The current 
ECG lead system consists of three Einthoven limb leads, three augmented leads, and six precordial leads (Figure 1) 
(Malmivuo & Plonsey 1995). 
 
Figure 1: Twelve lead electrocardiography 
Currently, the Electrocardiography is the most wide-spread non-invasive tool for diagnosis of cardiac diseases, 
currently in use in every clinical center. However, some of the aforementioned fundamental ECG hypotheses have 
been challenged either during the development of the Electrocardiography [1901-1942], or afterward. Therefore, we 
discuss two of these fundamental ECG hypotheses: the Einthoven equilateral Triangle hypothesis, and the Wilson 
hypothesis in order to make a tangible picture of the Wilson central terminal and its influence on the precordial 
leads.   
Wilson Central Terminal 
Wilson hypothesized that a neutral reference point of the human body could be measured by averaging the limb 
potentials. This reference point was introduced having null amplitude, being steady, and locating in the center of the 
Einthoven triangle (Wilson et al. 1934). The potential in the infinite medium has a null amplitude which could be 
considered as the ideal reference point. In physics, we can only measure the potential difference between two points. 
However, we can have the potential of one point in case the second point is located in the far distance (infinity) from 
the first (Burger 1955). Thus, Wilson used three large resistors through which a negligible current would pass (based 
on Ohm’s law) and consequently he was able to measure the limbs’ potential (Figure 2, panel a) (Wilson et al. 
1934). This assumption was found incorrect and absorbed immediate interests among researchers to measure this 
systematic error in the Electrocardiography. The proposed methods can be categorized into three different 
perspectives. 
In the first approach, the human body is immersed in a large homogeneous conductor to measure the potential 
difference between the WCT and the assumed zero potential (the water itself). In 1938, Eckey and Frohlich 
immersed a human body into a full bathtub and determined the WCT amplitude to be into a range of 0.2-0.3 [mV] 
(Eckey, P. & Fröhlich 1938). A year later, Burger conducted the same experiment and immersed five men into a 
bathtub filled by water and reported the WCT amplitude was 0.26 mV (Burger 1939). In 1946, Wilson submerged a 
human in the lake Michigan and found that the average absolute amplitude of the WCT could be as large as 0.15 mV 
(Wilson et al. 1946). Dolgin repeated the same experiment with different adjustment, and confirmed the previous 
finding (Dolgin et al. 1949). In 1954, Bayley et al. and Bayley and Kinard encased the body of volunteers inside a 
metal structure and immersed it in water for the duration of the recording (Bayley et al. 1954; Bayley & Kinard 
1954). They determined that the WCT is not steady and its amplitude could be as large as 0.4 of Einthoven’s leads 
during the cardiac cycle (Bayley & Kinard 1954; Bayley et al. 1954; Bayley & Schmidt 1955). Thus, they used three 
rheostats to adjust the weights of the three WCT components in order to minimize the WCT amplitude (Bayley & 
Kinard 1954). The legitimacy of the first approach was undermined by a variety of factors including the effect of 
water pressure on ECG recording and degree of the conductivity of surrounding water (Okamoto & Mashima 1998). 
Additionally, the zero potential of surrounding water (Wilson et al. 1946; Wolferth & Livezey 1944) and the 
widespread use of this method (Dower et al. 1959) have been questioned.  
In the second approach, the zero potential of human body was measured using numerical methods (Fischer et al. 
2002; Lynn & Timlake 1968; Wach et al. 1997; Macfarlane et al. 2010) or surface potential mapping (Miyamoto et 
al. 1996; Miyamoto et al. 1995; Hoekema et al. 1999). In these methods, the zero potential is not exactly aligned 
with the WCT definition; however, they referred to it as Wilson Center Terminal. The numerical methods are 
developed based on the theory that summation of the electrical potential at the body surface should be zero 
(Macfarlane et al. 2010). Miyamoto et al. used 128 electrodes placed on the thorax and averaged their potential to 
estimate the amplitude of human reference point. They reported the average value of the WCT as -0.169 mV in 10 
normal volunteers, and -0.051 mV in all 60 subjects including controls and patients (Miyamoto et al. 1995; Okamoto 
& Mashima 1998; Miyamoto et al. 1996).  
In a third approach, the potential of the right arm, left arm and left leg directly measured using right leg as a 
reference point (Figure 2, panel b) (Gargiulo et al. 2016). We recently developed a new Electrocardiography device 
that can measure nine unipolar leads including three limbs’ potential and six true unipolar limb leads, in addition to 
12 lead ECG (Gargiulo 2015; Gaetano D Gargiulo et al. 2013; Gaetano D. Gargiulo et al. 2013; Gargiulo et al. 2015; 
Gargiulo et al. 2016). Our results confirm the previous findings that the WCT is not steady and null, and we found 
out the WCT amplitude could exceed the amplitude of lead II (up to 247% of lead II).  
 
Figure 2. Traditional approach (panel a) in comparison with our approach (panel b) to measure the WCT. 
In our approach, the limb potential and unipolar chest lead are measured in respect to the right leg. 
True Unipolar ECG recording device 
Our ECG device is designed to record traditional ECG signals in addition to the nine true unipolar leads including 
three limb potentials and six unipolar chest leads. The true unipolar leads are the raw biopotential measured from the 
exploring electrodes directly referred to the right leg (RL). Although right leg was not included in the original ECG 
montage, it was added as necessary return grounding for voltage amplifier as well as a way to reduce the 
interference from external electric fields (Webster 2009). Reduction of interference from external electrical fields is 
usually achieved with a technique known as a driven right leg or right leg driver, which usually implies an injection 
of a small current into the body (via the right leg electrode) and measuring amplifier circuits (via their reference 
terminal). In some specific biopotentials applications, the right leg driver is avoided using a technique known as 
voltage reference bootstrap that might result of advantage to reduce common noise capture. (Macfarlane et al. 2010; 
Malmivuo & Plonsey 1995; Webster 2009). 
Driven right leg circuitries (DRLs) are widely used for the majority of the designs. Using the DRL increases 
patient safety because the human body is not directly grounded (Webster 2009; Malmivuo & Plonsey 1995; Winter 
& Webster 1983). Figure 3 shows an example of the DRL application. As can be seen, the human body is driven by 
a measure of the common mode signal at the measuring electrodes while the amplifier is directly grounded. The 
technical documentation of the INA118 can be found in (BurrBrown 2000).  
 
Figure 3. ECG amplifier using right leg driver (lead I) 
Our hardware system is developed around the INA116 instrumentation amplifier (BurrBrown 2008) from Texas 
Instruments (Burr-Brown series). This chip has typically a bias current of only handful of femto-Amperes and it 
incorporates a specialized guard ring amplifier which it is primarily used to preserve the signal to noise ratio (SNR). 
The guard ring amplifier is used to measure the WCT components, as it generates a replica of the input signal 
(Gaetano D. Gargiulo et al. 2013; G. Gargiulo et al. 2013; Gargiulo et al. 2015; Gargiulo 2015; Gargiulo et al. 
2016). Therefore, the WCT components’ voltages are directly measured by using the guard buffer of the limb 
electrodes. The INA116 chips have a gain set of 1 V/V; two AC coupled active non-inverting low pass filters with 
gains of 10 V/V and 100 V/V are used to provide the required gain and bandpass filtering. 
To ensure that the SNR of the measured signals is sufficient, specialized grounding circuitry is designed utilizing 
a combination of the right leg circuitry and a modified voltage bootstrap circuitry (Gargiulo 2015; Gargiulo, Paolo 
Bifulco, et al. 2014; G. D. Gargiulo et al. 2013; G. Gargiulo et al. 2013; Wilson et al. 1946). The non-amplified 
average of the measurement electrodes is directly inputted to the driven right leg circuitry which is designed to drive 
20 µA (Fisher et al. 2011; Madias 2008; Undar et al. 1997). 
This circuitry is battery powered, and the necessary analogue to digital conversion and data logging is operated 
by the BIOADC (Gargiulo, P. Bifulco, et al. 2014) which samples data with a 16-bit over a range of ±5 V with a 
sampling rate of 800 Hz. The BIODAC is directly (galvanically insulated USB HUB) connected to a battery-
powered laptop, and it comprises an anti-aliasing low-pass filter operating at the Nyquist frequency. Finally, a 
specialized importing script including a zero-phase lag 50th order bandpass filter (0.05-150 Hz), a zero-phase lag 
50th order 50 Hz and harmonics notch IIR filters are used to normalize the frequency components to the diagnostic 
ECG bandwidth of the acquired signal. Complete details can be found in our recent publication (Gargiulo et al. 
2016). 
 
Figure 4: Block diagram of the employed hardware (adapted from (Gargiulo et al. 2016)). 
 
True Unipolar leads 
We are able to record the three Einthoven unipolar limb lead (the voltage of right arm, left arm, and left leg) and 
six true unipolar precordial leads for the first time. We have recorded data from more than 100 patients at the 
Campbelltown hospital (NSW) over two years (2016-2018). All the patients volunteered for this study and gave 
written consent (this study was approved by the Ethics Committee of the South West Sydney Health District on 23rd 
September 2015 with the protocol number HREC/15/LPOOL/302). Some recordings have been removed from the 
dataset due to poor signal to noise ratio or because of abrupt interruption of the recording (emergency or patient 
being transferred to another department for an intervention/procedure). The published dataset2 (Gargiulo & 
Moeinzadeh 2019) contains 92 patients (27 were female) with an average age of 65.23 years and standard deviation 
of 12.12 years. The majority of the patients had a history of cardiac disease and were admitted to the hospital from 
the emergency department because of difficulties in breathing and/or chest pain. 
Einthoven unipolar limb lead 
We are able to measure the amplitude of Wilson Central Terminal by averaging the voltage of Einthoven limbs. 
In this part, we are trying to answer the question what is the Wilson Central Terminal? We investigate the 
legitimacy of two hypotheses:  
1- The WCT is null and steady during the cardiac cycle. 
2- The WCT and aVF are inversely proportional. 
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The first hypothesis is the Wilson assumption to measure the precordial leads, which has been proved incorrect 
by many researchers. However, their approaches were cumbersome, usually having small test case population, and 
more importantly their validity has been questioned (Wilson et al. 1946; Wolferth & Livezey 1944; Dower et al. 
1959). The second hypothesis assumes that the left leg potential has the smallest amplitude among the Einthoven 
limb potentials, as it has the longest distance from the heart. Hence, considering the assumption that the left leg has 
near zero amplitude (ΦF ≅ 0), the WCT can obtain using the right arm, and left arm. Consequently, the WCT and 
















To assess the credibility of these two theories, we calculated the average peak to peak amplitude of three beats for 
all patients. In Figure 5, We report the relative amplitude of the WCT, RA, LA, and LL with respect to lead II. As it 
is shown in Figure 5 (panel a), the minimum, maximum and average amplitude of the WCT in relation with lead II 
among all 92 patients are 0.11, 2.47, and 0.78 respectively. The left arm expected to have a higher potential than the 
right arm, as it is closer to the heart (Figure 4-panel b, c). The left arm in respect with lead II has the average of 1.61 
(within range of [0.038 6.41]), while right arm average is 0.88 (within range of [0.01 0.88]) for all 92 patients. 
Figure 5 (panel d) demonstrates the amplitude of the left leg in respect with lead II. Although the left leg has a small 
amplitude in comparison with the right and left arms’ potentials, it does not have zero amplitude. The left leg 
potential in relation to lead II is in the range of [0.007 1.78] with an average of 0.22 for all patients.  
 
Figure 5. The amplitude of the WCT, right arm, left arm and left leg with respect with Lead II.  
Our recording shows that the WCT does not have small amplitude and has ECG lead characteristics such as p-
wave or QRS complex. The WCT has neutral (Figure 6, 8), negative (Figure 7) or positive (Figure 9) deflection 
during the cardiac cycle. Figure 6 is an example of the WCT with large amplitude. The WCT signal is as large as 
2.41 of lead II and it exhibits all the characteristics of the ECG trace. 
 
Figure 6. Example of neutral WCT. The WCT is 2.41 of lead II amplitude (average); the recording is from a 80-
year-old male patient admitted from the emergency department with NSTEMI diagnosis.  
Figure 7 is an example of WCT with negative deflection. The left arm, right arm, and left leg show ECG features. 
Furthermore, the left leg has relatively small potential in comparison with the right arm, and left arm.  
 
 
Figure 7: Example of negative WCT. The WCT is 0.32 of lead II amplitude (average); the recording is from a 54-
year-old male patient admitted from the emergency department with ischemic cardiomyopathy diagnosis. 
As it can be referred from Eq. 6, the WCT and aVF are highly correlated in case the left leg potential has near 
zero amplitude. It can be understood from Figure 5 (panel d) that the left leg has small amplitude for most of the 
patients, however it also has a relatively big amplitude for some patients. Figure 8 and Figure 9 are an example of 
the WCT and aVF lead having low and high correlation. As can be seen in these figures, the RA, LA, and LL signals 
have the ECG characteristics. Figure 8, shows a low correlation between the aVF lead and the WCT signal, as the 
LL amplitude is as large as 0.22 of lead II. In contrast, the LL has a negligible amplitude in Figure 9, consequently 
the WCT and the aVF lead are highly correlated.  
 
Figure 8. Example of neutral WCT that mutates into positive and neutral. There is low a correlation (45%) between 




Figure 9. Example of positive WCT with small LL amplitude (0.032 of Lead II). The WCT and aVF are highly 
correlated (98%) as the amplitude of WCT is negligible.  
True unipolar precordial leads  
The true unipolar leads and precordial leads are referred as the same concept in the literature. However, it has 
been known that this terminology is incorrect. The precordial leads initially represent the difference potential 
between the electrodes placed on the chest and the WCT. Since Wilson assumed the WCT is null, the precordial 
leads have been referred as unipolar leads. However, our ECG device is able to record the potential of electrodes 
placed on the chest without using the WCT signal (Gargiulo et al. 2015; Gaetano D. Gargiulo et al. 2013; Gargiulo 
2015; Gaetano D Gargiulo et al. 2013). Therefore, we recorded the traditional precordial leads (V1:V6) and what we 
address as the true unipolar leads (UV1: UV6) at the same time for all patients.  
Our recording shows that the WCT is highly individual and has medically relevant amplitude, which 
impacts the precordial leads’ shape and resulting to lose important information in the precordial leads. 
We investigated the clinical features of true unipolar leads in comparison with precordial leads for all 92 patients. 
In this paper, we selected four patients from the WCTECGdb (Gargiulo & Moeinzadeh 2019) with Non-ST 
Elevation Myocardial Infarction (NSTEMI) diagnosis to show the influence of the WCT on precordial leads. Our 
records show that the unipolar ECG may be more sensitive for detecting disease in the left anterior descending 
(LAD) coronary artery in patients presenting with NSTEMI. We are currently recording more data to show the 
validity of this hypotheses. As the WCT has no effect in the limb leads and augmented leads, we do not include 
them in the Figure 10, 11, 12 and 13.  
• Patient75: He presented with a non-ST segment elevation myocardial infarction. In this type of myocardial 
infarction, the mechanism of injury is subendocardial myocardial infarction. As it can be referred from Figure 
10 (panel a), the t-waves are biphasic in leads V2:V4, while they are inverted in leads UV1:UV6. Consequently, 
the unipolar ECG may be more sensitive at detecting this type of injury than the standard ECG. As the only 
difference between unipolar chest lead, and precordial lead is the WCT signal (Eq. 4), the influence of the WCT 

































Figure 10. Panel (a): comparison of unipolar chest lead (UV1:UV6) with precordial leads (V1:V6). Panel (b): the 
influence of the WCT on V1; top panel is standard V1 precordial; middle is true unipolar UV1; bottom panel is the 
WCT signal. The t-wave is inverted in UV1. Recorded from 70 years old male, admitted to a hospital for NSTEMI 
(patient75). 
• Patient46: His angiography showed focal severe mid LAD stenosis which supplied a large collateral to a distal 
dominant right coronary artery (the native right coronary artery being completely occluded). The patient 
subsequently underwent coronary artery bypass surgery. As it can be seen in Figure 11, the true unipolar leads 
show loss of clear T waves which is suggestive of ischemia. 
 
Figure 11. Comparison of unipolar chest lead (UV1:UV6) with precordial leads (V1:V6). Recorded from 69 years 
old male, admitted to a hospital for NSTEMI (patient46). 
Patient85: His angiography showed proximal to mid LAD stenosis which was subsequently stented (after optical 
coherent tomography (OCT) imaging). As seen in Figure 12, the true unipolar leads show more markedly biphasic T 
waves UV1:UV3. In other words, biphasic T waves in VU1-UV3 typically suggest proximal LAD disease which is 




Figure12. Comparison of unipolar chest lead (UV1:UV6) with precordial leads (V1:V6). Recorded from 52 years 
old male, admitted to a hospital for NSTEMI (patient85). 
• Patient66: His angiography showed focal severe stenosis in distal RCA and proximal large diagonal branch 
stenosis of the LAD (both of which were stented). As it can be referred from Figure 13, the true unipolar leads 
show T wave inversion UV4:UV6 consistent with diagonal branch territory problem/ischemia. 
 
Figure 13. Comparison of unipolar chest lead (UV1:UV6) with precordial leads (V1:V6). Recorded from 41 years 
old male, admitted to a hospital for NSTEMI (patient66). 
The WCT Location 
In theory, the WCT is located in the centroid of the Einthoven triangle. However, a research conducted in 2005 
shows that many cardiologists do not have a clear understanding of unipolar leads and the WCT concept (Bacharova 
et al. 2005). As mentioned earlier, although there was an initial wave of interest working on the fault in the WCT 
assumption after Wilson hypothesized its concept, this error has been widely accepted and the topic received scant 
research attention. Furthermore, there is no consensus understanding of the Einthoven triangle, as its edges have 
been considered differently in the literature. Hence, a clear view of the Einthoven triangle hypothesis may lead to a 
more precise answer to the question, where is Wilson central terminal? 
Einthoven assumed the human body is two-dimensional conducting homogeneous medium with the shape of a 
triangle. The heart is regarded as a single dipole in the center of the triangle. The dipole changes its magnitude and 
direction in every moment which causes to change its electrical field. Considering these assumptions, the potential 
of every point in the body measured by Eq. 7 (Macfarlane et al. 2010), which Φ is the potential of a single current 






+ 𝑐 (7) 
R is the length of the vector ?⃗⃗? directed from dipole source location to the target point, and 𝜃 is the angle between 
vectors ?⃗? and ?⃗⃗?.  
As Goldberger discussed (Goldberger 1945), the distance between the limb electrodes and the dipole are 
equivalent; therefore the difference between the limb potential amplitudes is only dependent to angles 𝜃1, 𝜃2(𝜃1 +
120) and 𝜃3(𝜃1+ 240). It could be easily shown that for every direction of heart vector, the sum of the limb 
potential is equal to zero (Goldberger 1945). 
 
Figure 14. Einthoven assumed the potential of each limb only depends on the angle between ?⃗? and ?⃗⃗? vectors. 
The geometrical position of the limb electrodes shaped the Einthoven triangle (Burger et al. 1961; Einthoven 
1903; Goldberger 1945). Wilson assumed symmetrical orientation of the heart vector in respect to the electrodes on 
the limbs (Bayley & Kinard 1954) and hypothesized that the potential of the dipole (heart) is equal to zero and 
calculated by the average of the Einthoven limb potentials. Although the Einthoven hypothesis is the major 
breakthrough in electrocardiography, it has been known his assumptions are oversimplifying the human body, and 
the heart activity. The same argument can be made for the Wilson hypothesis.  
The WCT located in the centroid of Einthoven triangle, represents the potential of the single 
dipole, and its potential is equal to zero in case three electrodes are placed in the same distance 
from the heart, and all Einthoven assumptions are correct. 
However, as it can be referred from Eq. 7, in case the imaginary line between limb electrodes do not build up the 
equilateral triangle, the limb potentials depend on the 𝑅 amplitude and the angle (𝜃). Consequently, the centroid of 
the triangle cannot represent the dipole anymore. Furthermore, the other assumptions (the electrical activity of the 
heart is a single dipole which located in the center of the body, and the human body is a homogeneous conductor) 
are ill-posed models of the human body (Goldberger 1945). 
In some literatures, there is also a misunderstanding between geometrical space and electrical space. As an 
example, in the standard surface ECG representation it is possible to see that limb leads are the edges of the 
Einthoven triangle, this can be easily shown incorrect. The Einthoven law (Eq. 2) contradicts with the fact that 
equilateral triangle edges are in the same length, and more importantly three limb leads could only construct a 
triangle (not equilateral) for less than 50% of the cardiac cycle (Gargiulo et al. 2018). 
 
Discussion 
Originally, the heart was theorized to act as a current source and the electrocardiography model measured bio-
currents using a very sensitive galvanometer (string galvanometer). As there is no obvious current pathway that 
includes the heart when the instrument is connected between the two legs and the right leg is the most distant limb 
from the heart, Einthoven did not include the right leg in the cardiac conduction model. In other words, ECG 
recordings were intended as a measure of the net current impressed by heart circulating into an external circuit 
closed by the measurement instrument. Therefore, it was possible for Wilson to complete the transformation from 
the equilateral triangle (Einthoven’s triangle) to the equivalent star circuit (originating the augmented leads), when 
he faced the problem of finding a reference for precordials. In theory, if each of the Einthoven leads measures the 
net current impressed by the heart between the two limbs, averaging all the electrodes together should give the best 
approximation of the point of origin, the neutral point of the cardiac electrical activity. 
Impractical use of current measurement devices and the link between current and voltage resulted in replacement 
of all ECG current measurements with voltage, neglecting that measuring voltage instead of current requires dealing 
with the different impedances of body sections. In fact, each lead is interpreted as the voltage drop across a 
composed resistance (impedance, as a matter of fact) due to the net current impressed by the heart to the points of 
measurement based on Ohm’s law (Voltage = Resistance * Current]). For example, lead I (Figure 15) can be 
interpreted as the drop of voltage across the sum of the contact impedance at both electrodes that includes the 
impedance of the two arms and the impedance of the chest across the shoulders that changes with respiration.  
Of course, current and voltage measurements are perfectly interchangeable if the body is simply considered as a 
homogeneous volume conductor (constant resistance) with the limb electrodes placed at equal distance with no or 
negligible contact impedance. However, in real life recording the contact impedance imbalance between the ECG 
electrodes is often not verified. Additionally, the limb leads are measured across different sections of the chest, 
which are different in shape and their resistance changes with respiration and body posture resulting in adding a 
frequency-dependent delay and a phase difference between voltage and current. The modified phase relationship 
between voltage and current may also affect the limbs’ potential and consequently, the WCT. Moreover, as the 
voltage potential difference between the reference point (RL) and the other limb electrodes are used to measure the 
RA, LA and LL potentials, different body and contact impedances may impose different delays upon the limb 
potentials resulting to an unpredictable alteration of WCT (Gargiulo et al. 2015; Gargiulo 2015). 
 
Figure 15. Ideal measurement of lead I vs real measurement of lead I. Left panel shows idealized measurement of 
lead I as voltage; right panel refers to real measurements of lead I in which includes contact impedances (Zc1 and 
Zc2) and variable impedance of torso (Zt). 
Based on the Einthoven theory, if the limb electrodes placed on the same distance from the heart, the WCT 
presents the potential of the dipole. However, it is not the case in practice. The WCT amplitude is highly dependent 
on where the limb electrodes are placed (Eq. 7). Hence, it is obvious not to have a negligible amplitude in averaging 
the limbs’ potential. On the other hand, the location of the limb electrodes influences the shape and amplitude of 
precordial leads (Farrell et al. 2008). As our device use right leg as a reference point to measure the potential of the 
electrodes on the chest, the WCT variation does not affect the true unipolar leads. On the other hand, the true 
unipolar leads are robust and independent from the limb electrodes’ displacement. 
  
Conclusion 
The electrocardiography is the most common tool in the diagnosis of cardiac diseases. In this paper, we discussed 
two important hypotheses proposed by Einthoven and Wilson which shapes the currently in use electrocardiography 
tool. It has been known that these two theories simplify the heart activity, and do not provide a precise model for the 
human body. However, no one can really measure the influence of these false assumptions on the leads. As our ECG 
device is able to record the potential of the Einthoven limb electrodes and chest electrodes, we were able to show the 
impact of the WCT on precordial leads. Furthermore, we depicted a clear picture of the WCT concept by answering 
the questions what is the Wilson central terminal? and where is the Wilson central terminal? Our records show that 
the WCT is not null, and it has ECG features such as p-wave and QRS complex with clinically relevant amplitude 
(as high as 2.47 of lead II). We also compared the limb potential amplitudes. Our records show that the left arm has 









the left leg potential is not negligible for all the patient, and its amplitude with respect to lead II is in a range of 
[0.007 1.78] and with an average of 0.22 for all patients.  
We used two terminologies to address the chest leads, first, precordial leads (V1:V6) referring to the current 
approach used for recording the chest leads, second, the true unipolar leads (UV1:UV6) addressing our approach 
used for recording the chest electrodes’ potential. We show that the WCT signal is clinically relevant, and has an 
impact on precordial leads’ shape and amplitude. Our preliminary results show that the true unipolar leads may be 
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Abstract: Abnormal heart rhythms are one of the significant health concerns worldwide. The current
state-of-the-art to recognize and classify abnormal heartbeats is manually performed by visual
inspection by an expert practitioner. This is not just a tedious task; it is also error prone and,
because it is performed, post-recordings may add unnecessary delay to the care. The real key
to the fight to cardiac diseases is real-time detection that triggers prompt action. The biggest
hurdle to real-time detection is represented by the rare occurrences of abnormal heartbeats and
even more are some rare typologies that are not fully represented in signal datasets; the latter is what
makes it difficult for doctors and algorithms to recognize them. This work presents an automated
heartbeat classification based on nonlinear morphological features and a voting scheme suitable for
rare heartbeat morphologies. Although the algorithm is designed and tested on a computer, it is
intended ultimately to run on a portable i.e., field-programmable gate array (FPGA) devices. Our
algorithm tested on Massachusetts Institute of Technology- Beth Israel Hospital(MIT-BIH) database
as per Association for the Advancement of Medical Instrumentation(AAMI) recommendations. The
simulation results show the superiority of the proposed method, especially in predicting minority
groups: the fusion and unknown classes with 90.4% and 100%.
Keywords: electrocardiogram signal; nonlinear features; improved complete ensemble empirical
mode decomposition; inter-patient scheme; voting; classification; FPGA
1. Introduction
1.1. Aim of the Work
Nowadays, mortality rates are increasing due to noncommunicable diseases (NCDs) over
infectious diseases. Annually about 70% of deaths are because of the NCDs worldwide. As per
Sensors 2019, 19, 5079; doi:10.3390/s19235079 www.mdpi.com/journal/sensors
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the World Health Organization (WHO) report, cardiovascular diseases (CVDs) are the primary cause
of death among other NCDs [1]. The effect of CVDs is more in low and middle-income countries.
The report demonstrates that this impact will continue further. This alarming scenario influences not
only the health perspective, but also the socio-economic advancement of the country. Therefore, the
need for adequate diagnosis and treatment for NCDs, especially for CVDs, is highly essential. This
situation demands advancements in healthcare technology.
Cardiac arrhythmias are one of the significant sources of CVDs. All arrhythmias may not be fatal,
but some need immediate treatment for the patient to survive. Arrhythmias may occur owing to erratic
electrical impulse conduction or formation in the heart. Electrocardiograms (ECGs) are an essential
tool to study the electrical activity of the heart. ECG discloses any variations in the heartbeat pattern.
Clinicians have to explore the longer duration ECG records in the diagnosis process. However, this
manual examination is tiresome because of low amplitude and subtle variations in the ECG [2]. Hence,
computer-aided diagnosis (CAD) helps clinicians remarkably. CAD-based heartbeat classification is a
significant task before the arrhythmia recognition.
1.2. State-of-the-Art
If we look at the literature on heartbeat classification, it can be observed that the Massachusetts
Institute of Technology-Beth Israel hospital (MIT-BIH) arrhythmia database [3] is the majority choice.
The essential literature of heartbeat classification using this database can be categorized into two types
based on the assessment process, viz., class-oriented and subject-oriented. The majority among them
are class-oriented based works [4–22].
In the class-oriented approach, from the 16 types of beats including the normal ones in the MIT
database, a part or an entire collection of beats are preferred for classification. In [4], 17 types of
heartbeats including normal and pacemaker are classified using the features based on various power
spectrum density methods. Later, a novel genetic algorithm is used to identify the optimum features
to enhance the classification process. Finally, these selected features are fed to the various standard
machine learning algorithms. In [19], 13 types of heartbeats are classified using the combination of
higher-order statistics (HOS) of the ECG and Hermite basis representation features using a support
vector machine (SVM) classifier. In [18], six types of heartbeats are classified by using a local fractal
dimension based nearest neighbor classifier. In [21], seven types of heartbeats are classified using
gray relational analysis. In [20], Ye et al. designed a heartbeat classification algorithm using dynamic
and morphological ECG features. For the morphological feature extraction process, the combination
of wavelet transform and the dimensionality reduction technique, namely independent component
analysis (ICA), is implemented on the heartbeats. R–R intervals are used as dynamic features. These
features are then fed to SVM for classifying 16 types of heartbeats. In [8], a novel genetic ensemble
of classifiers machine learning method is proposed. A new genetic training coupled with genetic
optimization is used to classify 17 types of heartbeats. In [17], statistical and nonlinear features are
derived from the modes obtained from the empirical mode decomposition (EMD) algorithm. Later,
these features are provided to one-against-one SVM for classifying five types of heartbeats. In [22],
ventricular extra systole or ectopic beats are recognized with the help of morphology matching, R–R
intervals, and clustering algorithms. In [6], 17 types of EG beats are classified using hexadecimal local
patterns claculated from wavelet sub-bands. In [7], five primary types of heartbeats are classified using
ensemble empirical mode decomposition (EEMD) based features subjected to sequential minimal
optimization-SVM (SMO-SVM). Besides, Neural networks plays a crucial role in biological signal
analysis [23]. Recently, deep learning-based class-oriented schemes come into the picture. Deep
learning techniques are a part of machine learning techniques implemented based on more hidden
neural networks. In [9,10] these works, 17 types of heartbeats are classified using 1D-CNN and a novel
3-layer deep genetic ensemble of classifiers.
In the subject-oriented approach, the entire MIT-BIH database is subdivided into five groups
of heartbeats according to the American National Standards Institute/Advancement of Medical
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Instrumentation (ANSI/AAMI) EC57:1998 standard. The list of these groups is non-ectopic (N),
supraventricular ectopic (S), ventricular ectopic (V), fusion (F), and unknown (Q). Again, two
strategies are observed for classifying these distinct groups: intra-patient and inter-patient schemes.
The fundamental disagreement between these two strategies is the separation of training and testing
datasets. Intra-patient scheme based methods are widely explored in the literature [24–30]. However,
these approaches have less impact in real-time scenarios. Because, in real-time applications, an
unknown subject that usually undergoes the testing will be foreign to the constructed model. Thus, the
model has to be adequate to capture the inter-individual variations among the ECG. While designing
the intra-patient based model, there might be a chance of having common subject information in
both training and testing. To mitigate such an issue, De Chazal et al. [31] introduced an inter-patient
scheme based heartbeat classification. Here, the overall MIT-BIH database is separated into two groups.
One group is assigned to training, and the other one is for testing by ensuring that there is no similar
subject data in both groups.
The advantage of the aforementioned computer-aided expert systems can be exploited only after
developing real-time systems. In literature, in recent years, some of the field-programmable gate
array (FPGA) based ECG signal analysis systems are implemented. In [32], an FPGA based heartbeat
classification system is developed using the least-squares linear-phase finite impulse response filter
and feed-forward neural network. In [33], three types of common arrhythmia beats, namely, premature
ventricular contraction, ventricular fibrillation, and heart block beat along with normal beats, are
classified using a real-time FPGA implementation. In [34], an intra-patient scheme based on arrhythmia
classification is implemented in the FPGA system. However, most of the successful FPGA implemented
systems are followed by an intra-patient scheme. Very few methods are developed in real-time systems
based on inter-patient schemes [35]. However, still, these systems failed in detecting rare abnormal
beats accurately. Hence, there is a need for developing a new expert system that can succeed in
identifying rare heartbeats.
1.3. Contribution
In this paper, we presented an efficient inter-patient heartbeat classification algorithm. For any
pattern recognition process, identifying an appropriate set of features and classifier is highly significant.
From [36], it is noticeable that ECG is a non-stationary, non-Gaussian signal derived from nonlinear
systems. Hence, we employed a decomposition method, namely improved complete ensemble
empirical mode decomposition (ICEEMD) to obtain features from the ECG beats. This technique is
capable of disclosing the implicit information lying in the ECG. Later, different nonlinear measures like
entropies and HOS are determined from the modes obtained after ICEEMD. These measures will serve
as features for proper discrimination of the heartbeat groups. The fundamental difficulty in processing
these groups is the class imbalance. Here, a significant fraction of the heartbeats is non-ectopic. Hence,
the results may be biased toward the majority group, which is undesirable. Therefore, to alleviate
such an issue, we followed an algorithmic level approach. To achieve this, we employed a majority
voting scheme based classification. It is a type of ensemble classification. The advantage of ensemble
classification is that it can reduce both variance and bias. In this work, we used different combinations
of classifiers, namely, naïve Bayes, linear, and quadratic discriminant functions, J48, and consolidated
J48 classifiers for majority voting.
The rest of the paper is ordered as follows: the ECG data set, training, and testing data division of
AAMI labeling, experimental details and theoretical background of the methodology are presented
in Section 2. Section 3 presents the simulation results of the proposed method. The comparison with
existing works, limitations, and future directions are presented in Section 4. The conclusions of the
work are presented in Section 5.
Sensors 2019, 19, 5079 4 of 27
2. Methods
The block diagram of the proposed method is illustrated in Figure 1. The methodology consists
of three stages including pre-processing, feature extraction on training and testing data, and a
classification model for evaluation. In this section, the database used and the theoretical background





























Figure 1. Block diagram of the proposed methodology.
2.1. Database
The proposed method is examined using the MIT-BIH arrhythmia database. MIT-BIH is a standard
database widely explored for arrhythmia classification. It comprises of Holter monitoring records from
several male and female patients. Each record duration is 30 minutes, sampled at 360 Hz. The records
consist of both normal and abnormal beats of 15 types.
The annotation files available in the database are obtained from the chart recordings recognized
by the experts. This file describes the ‘R’ peak locations and the labeling of normal and abnormal
beats. Based on the recommendations of AAMI, class-labeling was assigned for discriminating various
heartbeat groups.
AAMI Class Labeling Recommendations
According to the ANSI/AAMI EC57:1998 standard, within the annotation files, beat labels are
divided into five groups, namely, N, S, V, F, and Q based on the physiological origin of the beats. Here,
the mainly N group consists of normal and bundle branch block beats. S and V groups consist of
ectopic beats, originated above and below Atrio Ventricular (A–V) junction of the heart, respectively.
The F group consists of the combination of ventricular and normal beats. Unclassifiable beats are
placed in the Q group. According to [31], the total number of available heartbeats are divided into
training for modeling and testing for evaluation. Details of the number of heartbeats utilized for this
work are presented in Table 1.
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Table 1. Details of the number of beats selected from each group of AAMI classes.
AAMI Classes MIT-BIH Heartbeats Total Data Training (DS1) Testing (DS2)
N Normal, left and right bundle branch block 83,761 41,746 42,015
atrial and nodal escape beats
S atrial premature contraction, Aberrated atrial, 2614 777 1837
supra ventricular and junctional premature beats
V premature ventricular contraction, ventricular flutter 6893 3787 3106
and escape beats
F fusion of ventricular and normal 526 266 260
beats
Q paced, unclassifiable, 12 6 6
fusion of paced and normal beats
Sensors 2019, 19, 5079 6 of 27
2.2. Pre-Processing
Pre-processing is an initial step in any data processing systems. Raw ECG signals will inherently
have some artifacts. These may occur due to instrumental noise (power line interference), a
physiological signal disturbance (muscular movements), or the environment where the experiment
takes place. These artifacts are undesirable and diminish significant features in the ECG. Therefore, to
attenuate the effect of this noise, we perform denoising as one of the pre-processing steps. For this,
we used a filtering routine proposed by [37] with minimal modification. This operation comprises
the following:
1. Mean separation from the noisy ECG,
2. Moving average filter of order five,
3. High-pass filter with cut-off frequency 1 Hz (for baseline wander suppression),
4. Low pass Butter worth filter with cut-off frequency 45 Hz (To suppress any left out
high-frequency noise).
We need individual heartbeats from the long-term ECG recording for heartbeat classification.
We perform a segmentation process after denoising. In the segmentation process, the annotation chart
records with ‘R’ peak locations are utilized. From the annotation file, it is observed that there are a lot
of variations among R-peak positions time-to-time. The difference between the R-peak positions is
dynamic. Hence, we applied a window of length 300 samples on ECG signal to obtain an ECG segment
that covers the QRS complex which is an important epoch in the ECG. Our segmentation process retains
other important epochs like P and T waves, unlike centered R-peak distribution segmentation methods.
2.3. Feature Extraction
Feature extraction has a critical role in heartbeat classification. A feature provides crucial
information about a signal and facilitates better discrimination of classes. From [36], it is evident that
ECG is a non-stationary signal stemming from a nonlinear system. Hence, exploration of ECG with
nonlinear methods can improve the performance of a model since they extract subtle information lying
in ECG. Therefore, in the feature extraction stage, initially, we perform ICEEMD on ECG segments to
get intrinsic mode functions (IMFs). Later, entropy and higher-order cumulants are extracted from
the selected modes. In this section, the techniques employed and their support in the methodology
development are briefly discussed.
2.3.1. ICEEMD
The EMD decomposes a given signal in a full data-dependent approach by exploiting the local
characteristics. However, EMD is limited by “mode-mixing” problem while analyzing the real data [38].
Therefore, some noise-assisted data analysis methods can provide a solution. Here, noise is added in a
controlled manner for developing new extrema. Thus, the local mean is limited to that of the original
version where extrema are generated. A few among these noise assisted methods are EEMD [39] and
CEEMD [40]. Among these methods, CEEMD provides a better solution to the mode-mixing problem.
However, CEEMD has some limitations:
(i) Some residual can be present in the modes.
(ii) During the initial decomposition stages, information may appear “late” with undesired modes,
when it is compared to EEMD.
To address these issues, Colominas et al. [41] introduced a new noise aided adaptive data analysis
method called ICEEMD. The mathematical details of the ICEEMD are given below [41].
Notation used in algorithm: El(.) = lth EMD mode, M(.) = local mean of the signal, < . >=
averaging operator, w(j) = realization of white Gaussian noise with zero mean and unit variance and
x = input signal.
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The algorithm steps:
1. Compute the local means of J realizations x(j) = x+ β0E1(w(j)), j = 1, 2, ..., J using EMD, to obtain
first residue r1 =< M(x(j)) >.
2. At the first stage (l = 1), compute the first IMF:
C1 = x− r1. (1)
3. For l = 2, ..., L, calculate rl as
rl =< M(rl−1 + βl−1El(w(j)) > . (2)
4. Calculate the lth mode as
Cl = rl−1 − rl . (3)
5. Go to step 3 for next l
Here, βl = ε0σ(rl) is used to obtain the desired SNR at each stage. We choose ε0 = 0.2.
The resultant IMFs provide significant underlying features of the ECG signal. The ICEEMD is a
beneficial tool used for analyzing non-stationary signals originating from nonlinear systems such as
bio-signals. The main advantage of ICEEMD is: avoiding the spurious modes and reducing the amount
of noise in the mode patterns. Thus, the decomposed IMFs capture the morphology of the signal. Later,
entropy and statistical measures are calculated from the first six modes of each ECG segment.
2.3.2. Entropy Measures
Entropy measures the uncertainty in a given data. It is often used in signal processing and pattern
recognition applications [42]. A high value of entropy maps to higher uncertainty (or) unpredictability.
Entropy yields useful information for analyzing non-stationary signals [43]. In this work, we calculated
Shannon [44], log energy, and norm entropies [45]. The entropy E must be an additive cost function




where s is the probability of the given signal and i represents one of the discrete states. Various







• log Energy Entropy:
Elog energy(s) = ∑
i
log(s2i ), (5)
with the convention log(0) = 0.
• norm Entropy: The lp norm entropy with 1 ≤ p is defined as
Enorm(s) = ∑
i




HOS provides a meaningful measure for analyzing non-stationary signals originating from
nonlinear systems [46,47]. HOS represents the deviation from Gaussianity and can provide useful
information from the non-Gaussian nature of ECG signals. In our work, we utilized second, third, and
fourth-order cumulants as HOS. The mathematical details of the HOS can be found in [48].
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We construct a feature vector of size 36× 1 for each heartbeat (6 features × 6 modes = 36). Later,
the training feature set is fed to a classifier for building a model, and that model is evaluated using a
testing set.
2.4. Voting Scheme
The final goal of machine learning is to get better-generalized performance. We come across
a question “which learning algorithm or classifier is preferred over the other ?”. According to a
“No free launch theorem” [49], there is no precise answer to this. One algorithm fits or performs
well for a set of training and testing data and may fail for another. The learning algorithm overall
performance depends on the prior information, distribution of data, amount of training data, and some
cost functions. The performance generalization depends on the bias and variance errors. Always, there
will be a trade-off between bias and variance. Ensemble classifiers form a better choice, to improve the
performance generalization by reducing bias and variance. Combining several classifiers for the final
decision is called an ensemble classification or mixture-of-experts model or modular classification.
The primary motivation behind the classifier ensemble is improving the classification performance
using the complementary information offered by various classifiers. Kittler et al. [50] developed
a scheme for combining classifiers using voting based on a set of rules: min-rule, max-rule,
product-rule, sum-rule, and median-rule. From our experiments, we preferred product rule which
outperforms others.
Mathematical Framework: Consider a pattern recognition model where a pattern y is to be
assigned with one of the m possible classes (ω1, ω2, ......, ωm). Say there are R number of classifiers used
for combining. Let us assume that each classifier possesses a different representation of measurement
vector xi, i = 1, 2, ..., R.
The density function for each class ωk in the measurement space is p(xi|ωk) and the prior
probability is P(ωk). We assume that the models are mutually exclusive.
From the Bayesian framework, y is assigned to the class ωj having a maximum posterior
probability out of ωk classes:
assign y→ ωj if P(ωj|x1, x2, ....., xR) = max
k
P(ωk|x1, x2, ....., xR). (7)
Rewriting the posterior probability P(ωk|x1, x2, ....., xR) using the Bayes theorem:
P(ωk/x1, x2, ....., xR) =
p(x1, x2, ....., xR|ωk)P(ωk)
P(x1, x2, ....., xR)
. (8)
Here, P(x1, x2, ....., xR) can be expressed in terms of conditional measurement distribution as




p(x1, x2, ....., xR|ωj)P(ωj). (9)
Product Rule: p(x1, x2, ....., xR|ωj) represents the joint probability distribution of the measurements
computed by the classifiers. Assuming that these representations are statistically independent, we can
rewrite the joint probability distribution as





Based on p(xi|ωk), the measurement process model for ith representation is developed.
Substituting Equation (10) and Equation (9) into Equation (8)
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and using Equation (11) in Equation (7), we obtain the decision rule













Rewriting in terms of the posterior probabilities obtained from the respective learning algorithms,
















Equation (13) represents the likelihood decision rule obtained after combining the posterior
probabilities generated by different classifiers using the product rule.
In this work, we used five different classifiers for ensembling using a voting scheme to enhance
the performance of the system: naïve Bayes [51], linear and quadratic discriminant functions [52],
J48 [53], and J48 consolidated classifiers [54]. A brief description of these classifiers is given below.
Naïve Bayes Classifier: It is a probability-based learning algorithm developed on the Bayesian
framework. According to Bayes theorem, an unknown y is categorized into the one among the R
classes, with high posteriori probability:
y→ ωk if arg max
ωk∈ω
P(ω|y)P(y), (14)
where ω = {ω1, ω2, ...., ωR} is a vector of R classes.
Naïve Bayes is a modified version of Bayes classifier, based on the assumption that the features in
an unknown example vector are independent. Therefore, posteriori probability can be written as
P(ω|y) = P(y|ω)P(ω) = P(y1, y2, ..., ym|ω) = P(y1|ω)P(y2|ω)......P(ym|ω)P(ω). (15)





P(yi|ω = ωk). (16)
With this final rule, the naïve Bayes classifier operates. The parameters used for the Naïve Bayes
Classifier is given in Table 2.
Table 2. Naïve Bayes Classifier parameters used in this work.
Parameters Naïve Bayes
Use Kernel Estimator False
Use supervise Discretization True
In general, the naïve Bayes classifier assumes that the given features follow the normal distribution.
In Table 2, use the Kernel Estimator parameter set to false to follow this assumption. Supervised
discretization converts a specific range of attribute values to binary values. Here, the term supervised is
coined because the class information of the training instances is used for discretization. However, this
process is possible only when the class labels are nominal. The advantage of supervised discretization
in naïve Bayes classifier is present in [55].
Linear and Quadratic Discriminant Analysis Based Classifiers: The approach of discriminant
analysis is to derive a decision boundary or a discriminant function based on the linear combinations
of features that best separate the given classes. The assumption made is: examples from different
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categories follow Gaussian distribution. For instance, the discrimination function for two-class
problems based on Bayes theory can be written as
(y− µ1)TΣ−11 (y− µ1) + ln |Σ1| − (y− µ2)
TΣ−12 (y− µ2) > T, (17)
where µ1, µ2 are the mean vectors of class1 and class 2, Σ1, Σ2 are the covariance matrices of class 1
and class 2 and T is the threshold value.
The above function without further assumptions represents the quadratic discriminate function.
If the covariance matrices Σ1 = Σ2 = Σ, then the discriminant function simplifies to a dot product.
x.y > constant, (18)
where x = Σ−1(µ1 − µ2), constant = 12 (T − µT1 Σµ1 − µ2ΣµT2 ). This decision rule represents the
classification based on linear discriminant.
The parameters used for linear discriminant analysis (LDA) and quadrature discriminant analysis
(QDA) classifiers are given below in Table 3.
Table 3. LDA and QDA classifier parameters used in this work.
Parameters LDA QDA
Ridge 1.0× 10−6 1.0× 10−6
Ridge parameters in the discriminant analysis classifiers reduce the overfitting problem by
penalizing the large quantity coefficients. In our work, we use the default values as given in Table 3.
J48 Classifier: Recently, decision tree-based algorithms have become popular in machine learning
strategies. In practice, J48 is an execution of popular C 4.5 algorithms proposed by Quinlan [53].
According to this algorithm, the decision process involves the construction of a tree based on the
feature splitting. The superiority of matching y to a class label ωk ∈ ω depends on the choice of feature
splitting based on the value of information gain.
Information gain is measured with the help of difference entropy as the difference between the
entropy of the central node to the sum of entropies of the leaf nodes. It measures how well a given
feature splits the training data under its class label. A feature node having high information gain
is preferred.
J48 Consolidated (J48-C) Classifier: It is a consolidated version of C 4.5 classifier. “J48
consolidated” is an implementation of a consolidated tree’s construction algorithm, proposed by
Arbelaiz et al. [54] in WEKA. The basic idea is building a single tree using several subsamples. In each
iteration, we will find a better feature using information gain content similar to J48. After finding the
best feature split, all the subsamples are divided using the same features. More details can be found
in [54].The parameters used for J48 and J48-C classifiers are given in below Table 4.
Table 4. J48 and J48-C classifier parameters used in this work.
Parameters J48 J48-C
Minimum Objects 1000 1000
Use MDL correction True True
Number of folds 3 3
Sub-tree raising True True
Details of the parameters can be find in WEKA 3.9 version [56].
J48 and J48-C classifiers are decision tree classifiers in which tree splitting criteria play a significant
role. The above-mentioned parameters determine the growth and direction of the tree structures that
influence the final model accuracy. Sub-tree raising considers raising of a sub-tree when pruning is
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enabled. The minimum number of objects determines the number of instances per leaf. Minimum
description length (MDL) correction is a statistical measure like information gain to identify the best
split tree. The number of folds determines the data used for error reduce pruning; here, one fold is for
pruning and the other folds for building the tree.
All the parameters are fixed based on the final results. All the details of the parameters can be
found in WEKA 3.9 version [56].
3. Results
In this work, we are classifying the five classes: N, V, S, F, Q. The training set is constructed with
the array of records as DS1 = [101, 106, 108, 109, 112, 114, 115, 116, 118, 119, 122, 124,201, 203, 205, 207,
208, 209, 215, 220, 223, 230], and DS2 = [100, 103, 105, 111, 113, 117, 121, 123, 200, 202, 210, 212, 213,
214, 219, 221, 222, 228, 231, 232, 233, 234]. Here, the numerical values represent the patient record
number. Four records (102, 104, 107 and 217) having paced beats are exempted from both DS1 and DS2
data sets.
We start with scatter plots for justifying the choice of features in discriminating against the
heartbeats. Individual performance of five classifiers naïve Bayes, LDA, QDA, J48, and J48 consolidated
is presented, and analysis using a voting scheme with various combinations of these classifiers is
considered. The performance is illustrated for each combination. We used the WEKA 3.9 version
(University of Waikato, New Zealand) [56] for implementing the classification algorithms and scatter
plots. Data pre-processing and feature extraction is implemented using MATLAB 2018a (Mathworks,
MA, USA). All the experiments are carried out in Windows 8, 8 GB RAM, and 64-bit operating system.
The Performance Measures
An algorithm’s efficiency can be validated with appropriate performance measures. In this work,
Sensitivity (SEN), False Positive Rate (FPR), Positive Predictive Value (PPV), and Overall Accuracy (OA)
are used as performance measures to compare with the state-of-the-art methods, following the AAMI
recommendations. The confusion matrix required for calculating these measures is given in Table 5.
For V and S classes, the measures are calculated as per [31]. For remaining classes, we followed [57].
Table 5. Confusion matrix.
Predicted Labels
Actua Labels N V S F Q Sum
N Nn Nv Ns N f Nq RN
V Vn Vv Vs Vf Vq RV
S Sn Sv Ss S f Sq RS
F Fn Fv Fs Ff Fq RF
Q Qn Qv Qs Q f Qq RQ
Sum CN CV CS CF CQ R/C
Performance measure from Table 5 can be calculated as follows:
The sum measures of row-wise and column-wise calculations are:
RN = Nn + Nv + Ns + N f + Nq; CN = Nn + Vn + Sn + Fn + Qn;
RV = Vn + Vv + Vs + Vf + Vq; CV = Nv + Vv + Sv + Fv + Qv;
RS = Sn + Sv + Ss + S f + Sq; CS = Ns + Vs + Ss + Fs + Qs;
RF = Fn + Fv + Fs + Ff + Fq; CF = N f + Vf + S f + Ff + Q f ;
RQ = Qn + Qv + Qs + Q f + Qq; CQ = Nq + Vq + Sq + Fq + Qq;
R = RN + RV + RS + RF + RQ; C = CN + CV + CS + CF + CQ;
R = C.
(19)
Sensors 2019, 19, 5079 12 of 27
The false-positive and false negative values for each class are defined as below:
FNN = RN − Nn; FPN = CN − Nn;
FNV = RV −Vv; FPV = CV − (Vv + Fv + Qv);
FNS = RS − Ss; FPS = CS − (Ss + Qs);
FNF = RF − Ff ; FPF = CN − Ff ;
FNQ = RQ −Qq; FPQ = CN −Qq.
(20)
The other useful measures, true positives, and negatives can be calculated for Classes N,V,S,F,Q:
TPN = Nn; TNN = R− (RN + CN − Nn);
TPN = Vv; TNV = R− (RV + CV −Vv);
TPS = Ss; TNS = R− (RS + CS − Ss);
TPF = Ff ; TNF = R− (RF + CF − Ff );
TPQ = Qq; TNQ = R− (RQ + CQ −Qq).
(21)











TPN + TPV + TPS + TPF + TPQ
R
,
where TP = True Positive, TN = True Negative, FP = False Positive, andFN = False Negative.
We present the scatter plots with marginal histograms on the testing data set DS2, for features
in the two-dimensional feature space. These scatter plots reveal how different features spread in
feature space, thereby revealing the relationship between different heartbeat classes. Figure 2 shows
the two-dimensional scatter plot between cumulant 2 of IMF1 to norm entropy value of IMF2. In this
plot, we can observe that N and V beats are dominantly spread across space. In addition, the histogram
plots also reveal the good discrimination between N, V, and Q classes out of the five classes. The next
plot from Figure 3 gives the relation between the log energy entropy of IMF1 to cumulant 2 of IMF1.
In this figure, we can see the spreading of N, V, S, and F classes in the space. In particular, this space
provides good discrimination between N, V, and S classes. From Figures 4–6, we can observe that log
energy entropy values extracted from different IMFs provide a good perception of N, V, and S classes.
In the same way, Figures 7–8 give better discrimination of Q beats, which are very rare indeed.
In these figures, the characteristic feature is the norm entropy. In addition, different combinations
of features with norm entropy reveal different class spreads and discrimination capabilities. As a
whole, we can say that the combinations of selected features from different IMFs can predict the
required hypothesis.
After dividing the training and testing feature sets, we need to learn a model for classification.
In this work, we used an ensemble learner for classification. Ensemble classifiers use multiple learning
algorithms and combine all the decisions. It can be more accurate than the individual classifiers.
The main advantage of the ensemble classifiers is that we can achieve low bias error and low variance
error. Ensembles using multiple trained (high variance/ low bias) models can average out of the
variance, leaving just the bias. In addition, ensemble classifiers are preferred for imbalanced datasets.
Our DS1 and DS2 datasets are highly imbalanced with majority N group class and minor F and Q
classes. Therefore, in this work, we used a voting scheme based on product rule to ensemble the
classifiers. The individual classifier performance on DS2 (testing data) is presented in Tables 6 and 7.
Confusion matrices calculated for LDA, QDA, naïve Bayes, J48 and J48-C classifiers are shown in
Table 6. The performance measures for the corresponding matrices based on Table 5 are presented
in Table 7.
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Figure 2. Scatter plot with marginal histogram for CUM2 (IMF1) vs. norm entropy (IMF1).























Figure 3. Scatter plot with marginal histogram for log entropy (IMF1) vs. CUM2 (IMF1).
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Figure 4. Scatter plot with marginal histogram for log entropy (IMF1) vs. log entropy (IMF2).





















Figure 5. Scatter plot with marginal histogram for log entropy (IMF1) vs. log entropy (IMF3).
























Figure 6. Scatter plot with marginal histogram for log entropy (IMF1) vs. log entropy (IMF4).
Sensors 2019, 19, 5079 15 of 27
























Figure 7. Scatter plot with marginal histogram for norm entropy (IMF1) vs. CUM2 (IMF1).





















Figure 8. Scatter plot with marginal histogram for norm entropy (IMF1) vs. log entropy (IMF1).
From this table, we can see that each classifier yields different prediction. LDA and J48 give
better classification for the N and V classes. It is an understandable phenomenon because of the
dominating number of examples in N and V. LDA and J48-C provides better discrimination to Q
group. The other classifiers J48-C and naïve Bayes are providing better SEN results for F group. Finally,
S class is predicted accurately by J48-C and QDA classifiers. The other important point is, although
all classifiers yield better results for the specific group of categories, the OA is dominated by the N
class discrimination. Therefore, it is noticeable that OA is no longer a useful performance measure for
imbalanced data classification.
In Table 8, the confusion matrix after combining J48, LDA, and naïve Bayes classifiers using the
voting scheme is presented. The corresponding performance measures are demonstrated in Table 9.
From the results, it is evident that this combination yields better results for N, V, F, and Q classes and
average result for S class. The critical point is N, and S classes have more morphological similarities.
Therefore, individual classifiers are giving complementary results for N and S. However, this ensemble
selection enhances the prediction generalization for both classes.
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Table 6. Confusion matrices for LDA, QDA, naïve Bayes, J48, and J48-C classifiers.
LDA QDA
N V S F Q N V S F Q
N 40,842 33 47 1093 0 2777 266 36,394 2578 0
V 319 2787 0 0 0 5 3101 0 0 0
S 1831 1 2 3 0 95 56 1675 11 0
F 171 0 0 89 0 91 64 20 85 0
Q 0 0 0 0 6 0 6 0 0 0
naïve Bayes J48
N V S F Q N V S F Q
N 36,222 745 997 3289 762 41,801 214 0 0 0
V 930 1874 52 231 19 363 2743 0 0 0
S 1321 3 133 27 353 1819 18 0 0 0
F 8 0 2 245 5 259 1 0 0 0
Q 1 0 0 4 1 5 1 0 0 0
J48-C
N V S F Q
N 0 6941 28,966 5290 818
V 0 2205 894 6 1
S 0 24 1785 19 9
F 0 30 23 191 16
Q 0 0 0 0 6
Table 7. Performance measures for LDA, QDA, naïve Bayes, J48 and J48-C classifiers.
LDA QDA
OA = 92.60 SEN% FPR% PPV% OA = 16.20 SEN% FPR% PPV%
N 97.2 44.6 94.6 6.6 3.7 93.6
V 89.7 0.1 98.8 99.8 0.9 88.8
S 0.1 0.1 4.1 91.2 80.2 4.4
F 34.2 2.3 7.5 32.7 5.5 3.2
Q 100 0 100 0 0 0
naïve Bayes J48
OA = 81.47 SEN% FPR% PPV% OA = 94.32 SEN% FPR% PPV%
N 86.2 43.4 94.1 99.5 47 94.5
V 60.3 1.7 71.5 88.3 0.5 92.1
S 7.2 2.3 11.2 0 0 0
F 94.2 7.6 6.5 0 0 0
Q 16.7 2.4 0.1 0 0 0
J48-C
OA = 8.86 SEN% FPR% PPV%
N 0 0 0
V 71.0 15.9 24.0
S 97.2 65.8 5.6
F 73.5 11.3 3.5
Q 100 1.8 0.7
Table 8. Confusion matrix for combining J48, LDA, and naïve Bayes classifiers using a Voting scheme.
Voting (J48, LDA, naïve Bayes)
N V S F Q
N 39,542 53 489 1931 0
V 395 2708 3 0 0
S 1473 1 353 10 0
F 22 5 1 232 0
Q 0 0 0 0 6
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Table 9. Performance measures for combining J48, LDA, and naïve Bayes classifiers using a
Voting scheme.
Voting (J48, LDA, naïve Bayes)
OA = 90.71 SEN% FPR% PPV%
N 94.1 36.3 95.4
V 87.2 0.1 97.9
S 19.2 1.1 41.7
F 89.2 4.1 10.7
Q 100 0 100
Similarly, we performed ensemble voting for different combinations and the results are presented
in Tables 10–15. Each combination provides various enhanced results in some aspects.
Table 10. Confusion matrix for combining J48, naïve Bayes, and QDA classifiers using a voting scheme.
Voting ( J48, naïve Bayes, QDA)
N V S F Q
N 35,629 253 3836 2297 0
V 11 3095 0 0 0
S 1188 11 624 14 0
F 28 61 11 160 0
Q 0 6 0 0 0
Table 11. Performance measures for combining J48, naïve Bayes, and QDA classifiers using a
Voting scheme.
Voting ( J48, naïve Bayes, QDA)
OA = 83.6 SEN% FPR% PPV%
N 84.8 23.6 96.7
V 99.6 0.8 90.3
S 34 8.5 14
F 61.5 4.9 6.5
Q 0 0 0
Table 12. Confusion matrix for combining J48-C, naïve Bayes, and QDA classifiers using a
Voting scheme.
Voting (J48-C, naïve Bayes, QDA)
N V S F Q
N 29,730 255 9089 2491 0
V 8 3098 0 0 0
S 1031 8 779 19 0
F 21 61 12 166 0
Q 0 6 0 0 0
As mentioned earlier, the dataset is dominated by N, V, and S classes, respectively. The F and Q
classes are sporadic. Therefore, in some works, only N, V, and S classes are considered for classification.
We provide the results for such schemes in Tables 16–25. Here, first results are also presented for
individual classifiers; later, the ensemble voting scheme is performed on different combinations of
classifiers. Each one gives better classifications than individual classifiers.
Sensors 2019, 19, 5079 18 of 27
Table 13. Performance measures for combining J48-C, naïve Bayes, and QDA classifiers using a
Voting scheme.
Voting (J48-C,naïve Bayes, QDA)
OA = 71.51 SEN% FPR% PPV%
N 70.8 20.3 96.6
V 99.7 0.7 90.4
S 42.4 20.1 7.9
F 63.8 6.3 5.3
Q 0 0 0
Table 14. Confusion matrix for combining J48-C, naïve Bayes, and LDA classifiers using a
Voting scheme.
Voting (J48-C, naïve Bayes, LDA)
N V S F Q
N 38,329 66 942 2678 0
V 553 2532 20 1 0
S 1405 2 416 14 0
F 20 4 1 235 0
Q 0 0 0 0 6
Table 15. Performance measures for combining J48-C, naïve Bayes, and LDA classifiers using a
Voting scheme.
Voting (J48-C,naïve Bayes, LDA)
OA = 87.91 SEN% FPR% PPV%
N 91.2 38 95.1
V 81.5 0.2 97.2
S 22.6 2.1 30.2
F 90.4 5.7 8
Q 100 0 100
Table 16. Confusion matrices for various classifiers (N, V, and S classes).
LDA QDA
N V S N V S
N 41,875 27 113 4569 480 36,966
V 280 2826 0 5 3101 0
S 1835 0 2 105 56 1676
naïve Bayes J48
N V S N V S
N 37,385 2968 1662 41,998 17 0
V 922 2120 64 1095 2011 0
S 1336 18 483 1837 0 0
J48-C
N V S
N 34,999 7016 0
V 651 2455 0
S 1585 252 0
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Table 17. Performance measures for various classifiers (N,V, S classes).
LDA QDA
OA = 95.19 SEN% FPR% PPV% OA = 19.90 SEN% FPR% PPV%
N 99.7 42.8 95.2 10.9 2.2 97.6
V 91.0 0.1 99.1 99.8 1.2 85.3
S 0.1 0.3 1.7 91.2 81.9 4.3
naïve Bayes J48
OA = 85.15 SEN% FPR% PPV% OA = 93.71 SEN% FPR% PPV%
N 89 45.7 94.3 100 59.3 93.5
V 68.3 6.8 41.5 64.7 0 99.2
S 26.3 3.8 21.9 0 0 0
J48-C
OA = 79.76 SEN% FPR% PPV%
N 83.3 45.2 94
V 79 16.6 25.2
S 0 0 0
Table 18. Confusion matrix for combining J48, LDA, and naïve Bayes classifiers using a Voting scheme
(N,S,V).
Voting ( J48, LDA, naïve Bayes)
N V S
N 40,918 361 736
V 205 2897 4
S 1469 3 365
Table 19. Performance measures for combining J48, LDA, and naïve Bayes classifiers using Voting
scheme (N,S,V).
Voting ( J48, LDA, naïve Bayes)
OA = 94.08 SEN% FPR% PPV%
N 97.4 33.9 96.1
V 93.3 0.8 88.8
S 19.9 1.6 33
Table 20. Confusion matrix for combining J48, naïve Bayes, and QDA classifiers using Voting scheme
(N,S,V).
Voting ( J48, naïve Bayes, QDA)
N V S
N 37,421 574 4020
V 12 3094 0
S 1203 8 626
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Table 21. Performance measures for combining J48, naïve Bayes, and QDA classifiers using Voting
scheme (N,S,V).
Voting ( J48, naïve Bayes, QDA)
OA = 87.61 SEN% FPR% PPV%
N 89.1 24.6 96.9
V 99.6 1.3 84.2
S 34.1 8.9 13.5
Table 22. Confusion matrix for combining J48-C, naïve Bayes, and QDA classifiers using Voting scheme
(N,S,V).
Voting ( J48-C, naïve Bayes, QDA)
N V S
N 32011 598 9406
V 7 3099 0
S 1062 8 767
Table 23. Performance measures for combining J48-C, naïve Bayes, and QDA classifiers using Voting
scheme (N,S,V).
Voting ( J48-C, naïve Bayes, QDA)
OA = 76.40 SEN% FPR% PPV%
N 76.2 21.6 96.8
V 99.8 1.4 83.6
S 41.8 20.8 7.5
Table 24. Confusion matrix for combining J48-C, naïve Bayes, and LDA classifiers using Voting scheme
(N,S,V).
Voting ( J48-C, naïve Bayes, LDA)
N V S
N 40,248 688 1079
V 359 2735 12
S 1407 2 428
Table 25. Performance measures for combining J48-C, naïve Bayes, LDA classifiers using Voting scheme
(N,S,V).
Voting ( J48-C, naïve Bayes, LDA)
OA = 92.44 SEN% FPR% PPV%
N 95.8 35.7 95.8
V 88.1 1.6 79.9
S 23.3 2.4 28.2
4. Discussion
This section contains a discussion on simulating the proposed methodology illustrated in Figure 1.
In this work, we employ an adaptive non-stationary and nonlinear decomposition method, namely
ICEEMD, to analyze the ECG heartbeats. ICEEMD produces a local and entirely data-driven separation
of a signal in the form of fast and slow oscillations called IMFs. The main advantage of ICEEMD is
that it successfully avoids the spurious nodes and reduces the amount of noise in the modes.
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Later, six nonlinear morphological features: higher-order cumulants, log, Shannon energy, and
norm entropies are extracted from the first six IMFs of each heartbeat, to generate a 36× 1 feature
vector. Then, these feature vectors are divided based on training and testing sets DS1 and DS2 as
specified above. Statistics (median and interquartile range) of these features for each class are presented
in Table 26. Variation of attributes corresponding to different heartbeats can be observed from this
table.
In Table 6, we presented the individual performance of various classifiers on the given problem.
Here, all classifier models offer separate results for all the classes. Each model performs well for a
specific class or classes. However, it fails in providing the overall better performance. For example, the
S class contains 1837 beats, the J48, LDA, and naïve Bayes are predicting 51, 2, 1516 beats, respectively.
Whenever we combine these three models using the voting scheme as shown in Table 12, this combined
model identified 779 beats correctly. The voting scheme uses the product of probabilities rule. In this
scheme, it is assumed that each model representation for a given class is statistically independent. It is
because of the different representation capabilities of each model. From this, a final decision rule is
formed as described in Section 2.4. This decision rule quantifies the probability of class choice from
combined hypothesis models and the same type of results we can observe for other classes. In this work,
we implemented four voting schemes with different classifier combinations. Each combination again
provides different but better results than individual classifier models. The proposed combinations of
classifier details are given in Table 27.
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Table 26. Median ± interquartile range of features extracted on DS1.
Feature Number Features N S V F Q
1 CUM2(IMF1) 1.0 × 10−6 ± 4.0 × 10−6 8.0 × 10−6 ± 4.03 × 10−5 7.50 × 10−5 ± 0.00045775 0.000162 ± 0.000326 0.0001405 ± 0.009121
2 CUM3(IMF1) 0 ± 0 0 ± 0 0 ± 2.0 × 10−6 0 ± 5.0 × 10−6 0 ± 0.000313
3 CUM4(IMF1) 0 ± 0 0 ± 0 1.0 × 10−6 ± 2.58 × 10−5 2.50 × 10−6 ± 1.1 × 10−5 4.5 × 10−6 ± 0.006113
4 Shan(IMF1) 0.004769 ± 0.009686 0.017643 ± 0.06530625 0.112159 ± 0.4199265 0.216149 ± 0.330006 0.153638 ± 1.47632
5 log(IMF1) −4792.4962 ± 379.828 −4735.1172 ± 286.978 −4532.44 ± 467.507 −4358.371 ± 271.824 −4604.445 ± 1783.20
6 norm(IMF1) 0.1004 ± 0.0726 0.1538 ± 0.1719 0.0815 ± 0.05794 0.5541 ± 0.5434 18.1790 ± 20.55612
7 CUM2(IMF2) 0.001 ± 0.00347 0.00109 ± 0.0035 0.00028 ± 0.00137 0.00107 ± 0.00143 0.00411 ± 0.0134
8 CUM3(IMF2) 8.0 × 10−6 ± 5.20 × 10−5 4.0 × 10−6 ± 5.10 × 10−5 0 ± 6.0 × 10−6 5.0 × 10−6 ± 2.10 × 10−5 0 ± 0.000387
9 CUM4(IMF2) 1.50 × 10−5 ± 0.000185 2.10 × 10−5 ± 0.000128 2.0 × 10−6 ± 4.20 × 10−5 1.60 × 10−5 ± 5.20 × 10−5 0.00046 ± 0.002581
10 Shan(IMF2) 1.3074 ± 2.9180 1.3675 ± 3.4250 0.431 ± 1.429 1.4044 ± 1.44285 2.90440 ± 6.76104
11 log(IMF2) −4055.72 ± 403.632 −4045.57 ± 565.833 −4064.90 ± 479.11 −3788.21 ± 266.57 −4023.39 ± 1366.58
12 norm(IMF2) 2.41 ± 3.81 2.57 ± 4.95 2.744 ± 1.768 2.69 ± 2.04 18.17 ± 20.556
13 CUM2(IMF3) 0.0069 ± 0.0097 0.00534 ± 0.009013 0.00443 ± 0.00936 0.011997 ± 0.00909 0.004148 ± 0.008015
14 CUM3(IMF3) −7.80 × 10−5 ± 0.000322 −8.60 × 10−5 ± 0.0003605 −3.10 × 10−5 ± 0.000246 −0.00019 ± 0.00062 8.95 × 10−5 ± 0.000266
15 CUM4(IMF3) 0.000235 ± 0.000863 0.000104 ± 0.0006515 0.000117 ± 0.000747 0.0005255 ± 0.000767 0.0001945 ± 0.000396
16 Shan(IMF3) 6.3075515 ± 6.075866 5.532014 ± 6.254886 4.570122 ± 5.93904725 10.002892 ± 5.49255 3.8205085 ± 6.888019
17 log(IMF3) −3114.4106 ± 443.70730 −3071.71175 ± 705.504 −3178.659 ± 531.3571 −2731.2660 ± 467.4692 −3341.5431 ± 891.0573
18 norm(IMF3) 9.3564 ± 7.6444 8.69133 ± 8.37546 7.585 ± 4.1465 14.85 ± 7.440 18.179 ± 20.55
19 CUM2(IMF4) 0.013817 ± 0.0210 0.01233 ± 0.01653 0.0215 ± 0.03611 0.0370 ± 0.0297 0.0069 ± 0.0102
20 CUM3(IMF4) −0.00012 ± 0.00081 −6.80 × 10−5 ± 0.000469 −0.00014 ± 0.001305 −0.001542 ± 0.00207 0 ± 0.00039
21 CUM4(IMF4) 0.000147 ± 0.000734 4.60 × 10−5 ± 0.0003225 0.000404 ± 0.00189 0.00027 ± 0.00124 0.000138 ± 0.00018
22 Shan(IMF4) 13.05585 ± 12.76457 12.2365 ± 11.295 16.104 ± 15.135 25.934 ± 15.110 7.113 ± 10.471
23 log(IMF4) −2150.494 ± 533.542 −2143.567 ± 611.308 −2206.943 ± 794.75 −1614.17 ± 480.99 −2593.22 ± 1271.81
24 norm(IMF4) 19.367 ± 15.509 18.686 ± 14.240 16.26 ± 9.166 35.59 ± 20.941 18.179 ± 20.556
25 CUM2(IMF5) 0.0084 ± 0.018 0.0066 ± 0.0156 0.033 ± 0.0648 0.056 ± 0.058 0.0075 ± 0.0149
26 CUM3(IMF5) 1.0 × 10−6 ± 0.00017 0 ± 0.000103 −1.0 × 10−6 ± 0.00146 1.40 × 10−5 ± 0.0022 0 ± 0.000405
27 CUM4(IMF5) −7.00 × 10−6 ± 0.00012 −6.0 × 10−6 ± 0.000127 −3.0 × 10−5 ± 0.00193 −0.00236 ± 0.00621 −5.50 × 10−6 ± 0.000287
28 Shan(IMF5) 10.358 ± 15.6374 8.68112 ± 14.823 25.882 ± 29.195 39.2240 ± 25.737 8.992 ± 16.965
29 log(IMF5) −1917.009 ± 593.83 −1992.177 ± 872.920 −1567.422 ± 918.993 −1216.140± 489.3834 −2179.500 ± 1495.143
30 norm(IMF5) 17.118 ± 19.0735 14.983 ± 19.2726 19.495 ± 14.659 52.96 ± 32.190 18.179 ± 20.556
31 CUM2(IMF6) 0.0040 ± 0.0092 0.0028 ± 0.00723 0.0184 ± 0.04606 0.0571 ± 0.0827 0.0073 ± 0.01072
32 CUM3(IMF6) 1.0 × 10−6 ± 0.00010 0 ± 6.80 × 10−5 2.0 × 10−6 ± 0.0011117 8.0 × 10−6 ± 0.00527 0 ± 0.0002
33 CUM4(IMF6) −1.50 × 10−5 ± 0.00011 -8.0 × 10−5 6± 6.25 × 10−5 −0.00024 ± 0.00205 −0.00389± 0.01428 −4.40 × 10−5 ± 0.00017
34 Shan(IMF6) 6.50405 ± 11.11697 5.26119 ± 9.9055 20.0112 ± 31.26347 44.49 ± 39.5131 10.284 ± 13.481
35 log(IMF6) −1903.169 ± 637.510 −1983.32 ± 713.457 −1470.196 ± 744.176 −1062.5 ± 546.13 −1682.363 ± 1296.591
36 norm(IMF6) 13.0914 ± 15.1495 11.4410 ± 14.268 10.566 ± 12.262 57.357 ± 46.317 18.179 ± 20.556
Note: CUM2-second order cumulnat, CUM3-third order cumulant, CUM4-Fourth order cumulant, Shan-Shannon entropy, log-Log entropy, norm- norm entropy.
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4.1. Comparative Analysis
To assess the performance of our proposed methodology, we compared our results with the
existing methods in the literature. Comparisons are presented in Tables 28 and 29. The features and
classification schemes employed by various researchers listed in Tables 28 and 29 are given in Table 27.
In Table 28, we compare our four sets of voting schemes with the works which followed AAMI
recommendations based on [31] division scheme. In addition, Table 29 shows the performance measure
comparison with the literature on only N, V, and S classification. In Table 28, our proposed methods
yield almost similar performance compared to the state-of-the-art for N, S, and V classes; however, in
case of F and Q classes, our proposed work one and four outperforms the other compared methods.
From Table 29, it is evident that our proposed methods one and three are efficiently distinguished the
classes N, S, and V. The best results of our method are highlighted in bold. Overall, the measures of
our work are appreciable compared with other approaches.
Table 27. Methodology description of recent state-of-the-art compared in our work.
Literature Feature Extraction Classification
[58]
method-1 R–R intervals Optimum Path Forest (OPF)
method-2 Wavelet based features OPF
method-3 Mean, standard deviation and average power of wavelet sub-band OPF
method-4 Auto correlation and energy ratio of wavelet bands OPF
method-5 Fast-ICA OPF
method-6 (Wavelet+ICA+RR interval) OPF
[59] (ECG+VCG) complex network based features SVM
[42] Wavelet packet decomposition based entropy features Random Forest
[60]
method-1 Wavelet based features Hierarchical Classification (tree approach)
method-2 Mean, standard deviation and average power of wavelet sub-band Hierarchical Classification (tree approach)
method-3 Auto correlation and energy ratio of wavelet bands Hierarchical Classification (tree approach)
method-4 Fast-ICA Hierarchical Classification (tree approach)
method-5 (Wavelet+ICA+RR interval) Hierarchical Classification (tree approach)
[61] Temporal Vectrcardiogram(TCG) based features SVM
[62] A combination of projected features
(features derived from the projected matrix and DCT) and RR intervals SVM
[63] TCG feature selection by PSO SVM
proposed work
method-1 Entropy and statistical features calculated on ICEEMD modes Voting ( J48, LDA, naïve Bayes)
method-2 Entropy and statistical features calculated on ICEEMD modes Voting ( J48, QDA, naïve Bayes)
method-3 Entropy and statistical features calculated on ICEEMD modes Voting ( J48-C, QDA, naïve Bayes)
method-4 Entropy and statistical features calculated on ICEEMD modes Voting ( J48-C, LDA, naïve Bayes)
Table 28. Performance comparison with recent literature (N, S, V, F, and Q classes).
Literature N S V F QSEN/FPR/PPV SEN/FPR/PPV SEN/FPR/PPV SEN/FPR/PPV SEN/FPR/PPV
[58]
method-1 84.5/-/- 1.0/-/- 77.7/-/- 38.4/-/- 0/-/-
method-2 86.4/-/- 2.3/-/- 40.8/-/- 0.5/-/- 0/-/-
method-3 84.8/-/- 18.3/-/- 77.8/-/- 7.5/-/- 0/-/-
method-4 92.5/-/- 3.0/-/- 61.8/-/- 16.8/-/- 0/-/-
method-5 95.7/-/- 17.7/-/- 74.7/-/- 3.9/-/- 0/-/-
method-6 93.2/-/- 12.1/-/- 85.5/-/- 18.3/-/- 0/-/-
[59] 89.3/25.2/96.6 38.6/6.7/18 81.2/4.9/53.6 0/0/0 0/0/0
[42] 94.67/3.92/99.73 20/3.69/0.16 94.20/0.71/89.78 50/0.78/0.52 0/0/0
[60]
method-1 92.3/22.2/97.1 28.5/2.6/29.6 83.5/5.51/51.2 19.1/1.07/12.3 0/0/-
method-2 93.6/57.1/93.0 0.49/0.47/3.81 67.9/3.99/54.2 0/1.63/0 0/0/0
method-3 98.2/41.2/95.1 4.72/0.71/20.3 81.7/1.25/82.0 2.58/0.40/4.88 0/0/0
method-4 98.6/39.8/95.3 9.15/0.56/38.6 83.2/1.21/82.7 0.26/0.38/0.53 0/0/-
method-5 94.7/31.2/96.1 37.4/6.19/18.8 43.9/1.48/67.4 0.52/0.72/0.56 0/0/-
proposed work
method-1 94.1/36.3/95.4 19.2/1.1/41.7 87.2/0.1/97.9 89.2/4.1/10.7 100/0/100
method-2 84.8/23.6/96.7 34/8.5/14 99.6/0.8/90.3 61.5/4.9/6.5 0/0/0
method-3 70.8/20.3/96.6 42.4/20.1/7.9 99.7/0.7/90.4 63.8/6.3/5.3 0/0/0
method-4 91.2/38/95.1 22.6/2.1/30.2 81.5/0.2/97.2 90.4/5.7/8 100/0/100
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Table 29. Performance comparison with recent literature (N, S, and V classes).
Literature N S VSEN/FPR/PPV SEN/FPR/PPV SEN/FPR/PPV
[61] 95/27.9/96.5 29.6/3.1/26.4 85.1/3.01/66.3
[62] 98.4/-/95.4 29.5/-/38.4 70.8/-/85.1
[63]
method on VCG 79.1/27.0/96.3 31.2/8.4/13.0 89.5/7.2/46.1
proposed work
method-1 97.4/33.9/96.1 19.9/1.6/33 93.3/0.8/88.8
method-2 89.1/24.6/96.9 34.1/8.9/13.5 99.6/1.3/84.2
method-3 76.2/21.6/96.8 41.8/20.8/7.5 99.8/1.4/83.6
method-4 95.8/35.7/95.8 23.3/2.4/28.2 88.1/1.6/79.9
4.2. Limitation and Future Scope
Despite the proposed method giving significant results, the performance of the S class is still
limited when compared to other classes. Similar behavior is observed in other state-of-the-art methods.
Hence, there is a need to explore a new set of attributes and learning algorithms to improve this. In
addition, incorporating other physiological signals such as blood pressure, plethysmographic signals
along with ECG may improve the description of “heart functioning.”
5. Conclusions
In this work, we implemented a computer-aided inter-patient heartbeat classification algorithm.
We employed a nonlinear decomposition method called ICEEMED, to extract some important
information lying in ECG. Later, HOS and entropy measures are calculated on the modes obtained after
ICEEMD and used as features. Class imbalance is one of the critical challenges in medical diagnosis.
We addressed this issue by utilizing the voting scheme as the learning model. The extracted features
are then fed to this model for classification. To design this model, naïve Bayes, linear and quadratic
discriminating functions, J48 and J48 consolidated classifiers are explored. The proposed method
showed promising results compared to state-of-the-art techniques. Our method opens new frontiers to
the successful identification of rare heartbeat groups enabling a real-time heart monitoring system.
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Abstract—Einthoven unipolar leads include the potential of 
the right arm, left arm, and left leg which, by definition, are used 
to form the Wilson central terminal (WCT) as the average of 
these three limbs leads. In a traditional 12-lead ECG system, it is 
not possible to measure WCT directly. It is assumed to both be 
steady during the cardiac cycle with the assumed value most 
commonly being -2/3 of the augmented vector foot (aVF) lead. 
Using our novel ECG device that records Einthoven unipolar 
leads in addition to traditional 12-lead ECG signals, we 
investigate whether the WCT and aVF are proportional and the 
WCT can accurately be replaced by -2/3 of the aVF lead. We use 
the Einthoven unipolar leads features to evaluate both of the 
assumptions in regards to the WCT amplitude and value.  
Keywords—Electrocardiography, Wilson Central Terminal, 
Einthoven Unipolar Leads, Augmented leads.  
I. INTRODUCTION  
Electrocardiography (ECG) is probably one of the most 
common non-invasive diagnostic tool for cardiac diseases [1]. 
It shows the electrical activity of the heart as voltage variation 
over time using a total of ten electrodes, six are placed on the 
chest and three placed on the right arm (RA), left arm (LA), 
and left leg (LL), as well as one reference electrode placed on 
the right leg (RL) [1]. The six signals obtained from the chest 
electrodes have been named precordial leads (V1 to V6 or C1 
to C6) and are measured as the potential difference between a 
human body virtual reference potential and the chest electrodes 
[1]. The reference potential is named Wilson Central Terminal 
(WCT) after Wilson who discovered it and defined it as 
average potential of the three limbs mentioned above [1], [2]. 
Three limb leads (I, II, and III) measure the potential between 
the different pairs of limb electrodes, additional limb leads are 
the three augmented limb leads (aVR, aVL, and aVF), which 
measure each of the limb electrodes against a combination of 
the other two. The full set of twelve leads constitute the so 
called 12-lead ECG [1].  
Although the WCT had been initially assumed to have null 
amplitude, many researchers dispute this assumption [3]–[6] 
and have found that the WCT amplitude could be as large as 
0.4 of lead II. Consequently, the WCT amplitude could be 
medically relevant [4]–[6] since the precordial leads of the 
traditional ECG may miss some information. However, this 
systematic error has been widely accepted in clinical practice 
as the WCT measurement historically required a complicated 
apparatus [5], [7]. Although there have been some attempts to 
minimize the WCT amplitude [5], [8], [9], these attempts have 
been either unsuccessful [5] or the medical impact of its 
minimization remained unknown [8], [9]. 
On the contrary, our ECG device could record the potential 
of limb electrodes simultaneously with the 12-lead ECG 
signals [10], [11]. In this ECG device, we used the already 
used right leg (ground return) as the global reference point to 
measure the potential of the limbs hence of the WCT [10], 
[11]. We recorded data from 92 participants recruited from the 
Campbelltown hospital (NSW) patients’ cohort. Our dataset 
(WCTECGdb) is publicly available from the Physionet 
website1 [12]–[15]. Our records show that the WCT is highly 
variant with a large amplitude, which is also align with the 
findings in the literature. We measured the peak to peak 
amplitudes of the WCT potential in relation to lead II and 
found out that the WCT/II amplitude is in range of 0.11 to 2.7 
with an average of 0.78 among all patients in the dataset. 
Furthermore, the WCT clearly shows all the ECG 
                                                           
1 https://physionet.org/content/wctecgdb/ 
 
characteristics such as QRS complex and p-wave for most of 
the patients. 
In this paper, we aim to present a clear perspective of the 
Einthoven unipolar leads characteristics. We discuss the 
feasibility of the WCT signal replacing the current most 
common practice of using the aVF lead. 
II. PROBLEM FORMULATION 
Einthoven hypothesized the human body inscribed into an 
equilateral triangle in which the vertices are the electrodes 
placed on the left arm, right arm, and left leg. It could be easily 
shown that the sum of the Einthoven unipolar leads (RA, LA, 
and LL) is always equal to zero [16], which presents the 
potential of the heart (dipole). Later, Wilson suggested using 
the average of the Einthoven unipolar leads as the reference 
point (the WCT) for precordial lead recordings. 
   	
  
   (1) 
The voltage amplitude of each limb is highly dependent on 
its distance to the heart. Therefore, the right arm has a lower 
amplitude than the left arm as the heart is located on the left 
side of the chest, and left foot should have a very small 
amplitude as it is far from the heart. In this paper, we refer to 
this assumption as Einthoven unipolar leads hypothesis. 
Provided that the left leg amplitude is approximately zero, the 
WCT and aVF are claimed to be proportional.  
   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Although these hypotheses could easily solve the problem 
of measuring the WCT signal, they could not be verified as 
there was no practical approach to record the WCT signal or 
the Einthoven unipolar leads. We developed a 15 -Lead ECG 
device which is able to record the potential of Einthoven limb 
leads and the standard 12 lead ECG signals. Consequently, we 
are able to find the legitimacy of these hypotheses using the 
recorded WCT and aVF signals. 
III. METHOD 
 The new developed ECG device uses the right leg as the 
ground reference terminal for measuring all signals. It is 
designed with the use of a special chip: INA116 
instrumentation amplifier [17], commercially available from 
Texas Instruments (Burr-Brown series) [10], [11], [18], [19] 
which has a bias current of typically few fA and integrates a 
specialized guard ring amplifier which preserves the signal to 
noise ratio (SNR). This ECG system uses a specialized 
grounding circuitry incorporating the right leg signal and a 
modified version of voltage bootstrap circuitry to preserve the 
measured signals [10], [11], [20], [21].  
As the guard ring amplifier generates a replica of the input 
signal, it was used to measure the WCT components. Hence, 
the guard buffer of the limb electrodes was used for the direct 
measurement of the voltage of WCT components. To provide 
the required gain and bandpass filtering, three gain cells were 
employed for a total gain of 1000 V/V, the two last cells also 
perform active low-pass filtering. To obtain an ECG signal 
with a diagnostic quality, capacitors’ values that used to set the 
high-pass and low-pass frequencies of the gain cells are 
selected so that the required bandwidth is obtained even in the 
worst-case scenario (i.e. when the tolerance of the capacitor 
causes a -10% change in the initial value). Further software 
filtering (50th order IIR band pass filter into the range 0.05-149 
Hz and harmonics IIR notch filters at powerline frequency) are 
used to normalize the frequency content of all the signals. 
Using a combination of the right leg circuitry and a 
modified bootstrap circuitry, a specialized grounding circuitry 
was implemented to ensure providing sufficient SNR for the 
measured signals. The bootstrap circuitry directly offers the 
instrumentation amplifiers’ reference voltage using a damped 
version of the mean value of the potential of all electrodes [10], 
[19], [21]–[23]. The non-amplified average of the measurement 
electrodes is directly inputted to the driven right leg circuitry 
which is designed to contain current drive to 20 μA [24], [25]. 
A dual 9 V power supply (disposable batteries) was used to 
power the circuitry. Digital conversion and data logging is 
performed the BIOADC [20] sampling at 800 Hz over a  
resolution of ±5 V. The BIOADC has an anti-aliasing low-pass 
filter with cut-off frequency of Nyquist rate and it was directly 
connected to a battery-powered laptop via a galvanically 
insulated USB. The detailed description of the hardware can be 
found in [11]. 
IV. RESULTS AND DISCUSSION 
Our dataset (WCGECGdb) was recently published in the 
Physionet website and it contains 540 ten seconds segments 
recording from 92 patients [12].  
For most of the patients, the Einthoven unipolar leads have 
ECG features such as QRS complexes and P waves. As can be 
seen in Fig.1, the right arm has a smaller amplitude than the 
left arm, and the left leg has the smallest amplitude, consistent 
with the Einthoven unipolar leads hypothesis.  
 
Fig. 1. Comparison of the Einthoven unipolar leads. The RA is shifted 0.8 
mV and the left arm is shifted 1.0 mV from the original place for better 
visualization. Recorded from 68 years old female (Patient ID: 15). 
However, this is not seen in all patients. We calculated the 
average of three peak to peak amplitudes of the right arm, left 
arm, and left leg in relation to lead II for all patients (Table 1 




















peaks is because it is known that the width of the ECG peaks as 
well as its baseline wandering are influenced by the respiration. 
Taking into account multiple peaks minimizes this influence 
[1]. 
As it is shown in Fig.2, the left arm has a higher amplitude 
than the right arm for only 58 patients showing that Einthoven 
unipolar leads hypothesis is not valid for all patients. 
TABLE I.  THE MINIMUM, MAXIMUM AND AVERAGE 
AMPLITUDE OF THE EINTHOVEN UNIPOLAR LEADS IN RELATION 
WITH LEAD II AMONG ALL 92 PATIENTS 
 LA/II RA/II LL/II
Average 1.6 0.88 0.22
Maximum 6.41 2.79 1.78
Minimum 0.038 0.01 0.007
 
As it is referred from Table 1 and Fig.2, the left leg has the 
smallest amplitude among the Einthoven limbs’ potential. 
However, it has no negligible amplitude for all patients 
demonstrating that the aVF and the WCT are not proportional. 
Fig.3 and Fig.4 illustrate the relation between the WCT and the 
aVF lead when the left leg has small and large amplitude, 
respectively. 
 
Fig. 2. The amplitudes of the Einthoven unipolar leads in relation with 
lead II. The limb potential is not consistent with the initial assumption 
(LA>RA>LL) for all patients; the left leg does not have small amplitude 
for all patients; the RA has a larger amplitude than the LA for 29 patients. 
We measured the correlation and Sprague-Geer [26], [27] 
metric between -2/3aVF and the WCT for three consecutive 
beats. The Sprague-Geer metric shows the agreement between 
these two signals by measuring three errors: MS&G (magnitude 
error), PS&G (phase error), and CS&G (overall error). 
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Fig. 3. Comparison of the WCT and -2/3aVF lead. The LA, RA and LL 
amplitudes in relation with lead II are 0.9, 1.19 and 0.07 respectively. The 
aVF is shifted 0.4 mV from the original place for better visualization. 
Recorded from 59 years old male (Patient ID: 27). 
 
Fig. 4. Comparison of the WCT and -2/3aVF lead. The LA, RA and LL 
amplitudes in relation with lead II are 0.53, 0.21 and 0.22 respectively. 
Recorded from 87 years old male (Patient ID: 5). 
Table 2 shows the average and standard deviation of 
correlation and Sprague-Geer metric for all 92 patients. These 
results confirm that the WCT and -2/3aVF do not have an 
agreement for many patients as they are not highly correlated, 













































TABLE II.  THE CORRELATION AND SPRAGUE-GEER METRIC 
BETWEEN -2/3AVF AND THE WCT. AVERAGE AND STANDARD DEVIATION 
ARE MEASURED FOR THREE CONSECUTIVE BEATS AMONG 92 PATIENTS. 
 Correlation MS&G PS&G CS&G
Average 0.73 -0.19 0.21 0.35
Standard deviation 0.26 0.32 0.13 0.26
 
Nevertheless, it is too early to conclude that the WCT 
cannot be replaced by -2/3aVF. We only provided a statistical 
comparison of these two signals, and it still required to assess 
the medical impact of using -2/3aVF instead of the WCT on 
measuring the precordial leads. In other words, if the 
differences between these two signals are not medically 
significant, the WCT can be replaced by -2/3aVF, even though 
these two signals do not have a statistical agreement.  
V. CONCLUSION 
In this paper, we used our recent published dataset named 
WCTECGdb, which included the WCT components 
(Einthoven unipolar leads) to investigate whether the WCT and 
aVF are proportional. We used statistical metrics to develop a 
better understanding of Einthoven unipolar leads. Our results 
show that unlike the initial assumption, the left leg potential is 
not negligible for all patients, and it can influence the shape 
and amplitude of the WCT signal. Consequently, the WCT and 
aVF are not proportional. However, a larger clinical 
investigation is required to measure the medical impact of this 
finding. 
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Abstract: With this paper we communicated the existence of a surface electrocardiography (ECG)
recordings dataset, named WCTECGdb, that aside from the standard 12-lead signals includes the
raw electrode biopotential for each of the nine exploring electrodes refereed directly to the right
leg. This dataset, comprises of 540 ten second segments recorded from 92 patients at Campbelltown
Hospital, NSW Australia, and is now available for download from the Physionet platform. The data
included in the dataset confirm that the Wilson’s Central Terminal (WCT) has a relatively large
amplitude (up to 247% of lead II) with standard ECG characteristics such as a p-wave and a t-wave,
and is highly variable during the cardiac cycle. As further examples of application for our data, we
assess: (1) the presence of a conductive pathway between the legs and the heart concluding that in
some cases is electrically significant and (2) the initial assumption about the limbs potential stating
the dominance of the left arm concluding that this is not always the case and that might requires case
to case assessment.
Keywords: electrocardiography; Wilson’s Central Terminal; unipolar leads
1. Introduction
The surface electrocardiography (ECG) demonstrates the electrical activity of the heart as it spreads
towards the surface of the human body. Its most common incarnation is referred as 12-lead ECG, and
it is known as one of the most valuable non-invasive diagnostic tools for cardiac assessment [1,2].
The 12-lead ECG is composed of three limb leads; three augmented leads and six precordial leads.
The three limb leads (also known as bipolar leads) are referred as Lead I, Lead II, and Lead III, and
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III = LL− LA
(1)
Leads augmented Vector Left (aVL), augmented Vector Right (aVR) and augmented Vector Foot
(aVF) are referred to as augmented leads (also known as Goldberger leads) and are measured as the
potential difference between each limb electrodes and the average of the other two limb potentials [3]:
aVL = LA− 12 (RA + LL)
aVR = RA− 12 (LA + LL)
aVF = LL− 12 (RA + LA)
(2)
The six precordial leads (V1 to V6) are synthesized by calculating the difference potential between
each of the six chest electrodes potential (UV1:UV6) and the virtual reference point, known as Wilson
Central Terminal (WCT) [4]. This reference point is measured as the average potentials of the right
arm, left arm, and left leg electrodes’ potential [4]:
WCT =
(LA + RA + LL)
3
(3)
V1 : V6 = UV1 : UV6−WCT (4)
While current measurements are considered absolute, voltage measurements are relative to a
reference point. It is important to note that the original electrocardiography model was originally
conceived using current measurements (string galvanometer). The original cardiac conduction model
was rendered into a voltage model invoking the simplified homogeneous volume conductor hypothesis
and the Ohm’s law, when the solid-state electronic amplifier made its debut in this field. For this reason,
when considering the unipolar electrodes potentials in Equations (3) and (4) as they are supposedly
measured to a common voltage reference this seems to cancel out. Unfortunately, in the case of the
human body, where this reference point is directly or indirectly referred to the right leg, and the
conductive pathways between exploring electrodes and this connection are not homogenous the
cancellation of the reference point may not be perfect. This is particularly true for the WCT where
potentials of chest electrodes, already referenced to right leg, are furtherly referenced to an average of
electrodes (themselves referenced to the right leg) placed at a different distance from reference. As it is
beyond the purpose of this paper to digress into the details of the model and the hardware utilized, we
refer the reader to our previously published papers and in particular to [5] of which we adopted the
conduction model depicted in Figure 1. In this paper, to simplify the notation we use the term unipolar
lead to refer to the potential of Einthoven limbs’ electrodes (LA, RA, and LL) and the potential of the
six electrodes on the chest (UV1:UV6).
Despite the 12-lead ECG has been used clinically for decades, there is still no mutual understanding
of the WCT among researchers or cardiologists [6]. It is true that other more realistic cardiac conduction
models have been proposed during the years, i.e., the Frank model [7] but these have not gained
the traction required to enter clinical practice; exploring the reasons why these methods have not
received the same research attention of the 12-lead ECG systems is beyond the scope of this brief
communication. With this paper we would like to officially announce the availability of an ECG
dataset available for download via the Physionet platform, under the name of WCTECGdb [8–11].
Although many ECG datasets with different features have been published [12–14], the WCTECGdb is
a unique dataset as it contains the WCT signal and the unipolar leads. The dataset contains 540 ten
seconds segments recorded from 92 volunteer patients. Each record comprises of signals for three limb
leads, six precordials, three WCT components, six unipolar leads, and the WCT signal. In this paper,
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we demonstrate the characteristics of limb potentials, which lead to having a better understanding of
the WCT signal. We also show that unipolar leads can be used to synthesize the traditional ECG leads.
Together with the dataset we briefly discuss the potential clinical advantages of these new recordings
together with some exemplificative applications of the data like the investigation over the relative
amplitudes of unipolar limb leads to assess the presence of a conductive pathway between the legs
and the heart as well as a comparison between the WCT potential and other leads.
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2. Dataset Characterization
As mentioned, we have recorded ata from patients at the ospital (New South
Wales, Australia) over two years (2016–2018). All the patie ts l teere for this study and gave
written consent. This study was approved by the Ethics o ittee of the South est Sydney Health
District on 23 September 2015 with the protocol number HREC/15/LPOOL/302. The granted ethics
clearance has been extended (it is still current, although all the non-necessary clinical trials have been
suspended due to the COVID-19 outbreak) to increase the number of recordings.
We segmented each recording to ten second sections. Consequently, as the duration of the
recording is different, each patient has a different number of segments, ranging between one to
thirty-one. We recorded data from 92 patients (27 were female), and the total number of ten seconds
segments is 540 for all patients. The average age of the patient population is 65.23 years (with a
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standard deviation of 12.12 years); patients had a history of cardiac disease and had been admitted to
the hospital from the emergency department because of difficulties in breathing and/or chest pain.
This dataset comprises of raw and noise removed (cleaned) signals for the three limb leads, six
precordial leads, nine unipolar leads including three WCT components, and six unipolar precordial
leads. As the WCT is the average of the limb potential, we only added the cleaned WCT signal into
the dataset. To pre-process our signals, we used the same filters employed for our other published
studies. We employed a bandpass filter (0.05–149 Hz) and a powerline with harmonics up to the
Nyquist frequency notch filter bank. All filters were implemented in MATLAB as 50th order IIR and
applied with a zero-phase lag (bidirectional) [1].
In the uploaded dataset, we included supplementary information for each recorded segment
such as the patient’s ‘age’, ‘gender’, ‘patient diagnosis’, and the ‘reconstructed precordials’ (if there is
any). Each file in our dataset contained the signals and supplementary information listed in Table 1.
Cleaned and raw signals were included in the dataset. The raw signals are specified by ‘-raw’ in
the dataset (e.g., V2-raw) and refer to originally recorded signals prior to the noise filtering process.
The WCT signal is only presented in a clean format.
Table 1. The signal names and the detail of the recording presented for each segment.
Signals
I-raw I limb lead I
II-raw II limb lead II
III-raw III limb lead III
V1-raw:V6-raw V1:V6 precordial leads
LA-raw, RA-raw, LL-raw LA, RA, LL three WCT components
UV1-raw:UV6-raw UV1:UV6 unipolar chest leads






* Only included for 8 segments that needed to be synthesized for some of the precordial leads.
The patient diagnosis as supplied in the dataset is presented in Table 2; unfortunately, the hospital
could not provide us the diagnosis for ten patients. This is reflected in Table 2 under the patient
diagnosis column as “not reported”.
Table 2. Patient diagnosis list.
Patient Diagnosis Count Patient Diagnosis Count
Angina 1 Non-ST segment elevationmyocardial infarction (NSTEMI) 23
Atrial fibrillation 9 Pulmonary embolism-Atrialfibrillation 1
Atrial flutter 1 Pulmonary embolism 1
Atypical chest pain 5 Rapid atrial fibrillation with newcardiomyopathy 1
Cardiomyopathy 1 Rapid atrial fibrillation-pericarditis 1
Chest pain 1 Severe Mitral Stenosis 1
Complete Heart block 1 Sinus bradycardia 2
Congestive cardiac failure (CHF)
exacerbation 1 Slow atrial fibrillation 1
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Table 2. Cont.
Patient Diagnosis Count Patient Diagnosis Count
Congestive cardiac failure (CCF) 1 ST segment elevation myocardialinfarction (STEMI) 4
Coronary artery disease 3 Stable angina 7
Epigastric pain 1 Supraventricular tachycardia (SVT) 2
Fall secondary to alcohol
intoxication 1 Syncope 3
Gastritis (non-cardiac chest pain) 1 Unstable angina 1
Hypertrophic obstructive
cardiomyopathy 1 Urosepsis 1
Inferior ST segment elevation
myocardial infarction (STEMI) 1 Ventricular tachycardia (VT) 3
Myocardial infarction-Type 2 1 Not reported 10
We included synthesized precordial leads instead of directly measured signals for a total of
8 segments (from 5 patients), due to a poor signal to noise ratio and/or the final stage amplifier
saturation. The signal saturation usually is seen when large contact impedances and electrode
polarization generate large DC drifts at the unipolar potential that once amplified by the gain stages
result in saturation of the output amplifier. As we recorded the potential of chest electrodes (UV1:UV6)
and the WCT signal, we are able to reconstruct the missing precordial leads using Equation (4). It should
be noted that both cleaned and raw data are reconstructed for these signals. We flagged these signals
in the header file as “reconstructed precordials” and present the list of patients and signals in Table 3.
Table 3. List of patients with reconstructed precordial leads.






Seg1 V1, V2, V1-raw, V2-raw
Seg2 V1, V2, V1-raw, V2-raw
Patient10 Seg1 V2, V2-raw
Patient14 Seg1 V2, V2-raw
Patient31 Seg1 V2, V2-raw
3. Lead’s Reconstruction
Each file contains two sets of recordings: (1) standard ECG leads including three limb leads (I, II,
and III) and six precordial leads (V1:V6); (2) unipolar ECG leads comprising of three limb potential
(LA, RA, and LL), six unipolar chest leads (UV1:UV6), and the WCT signal. It could be possible
to reconstruct the standard ECG leads using unipolar leads by utilizing the Equations (1) and (4).
Figure 2 illustrates the recorded leads in comparison with reconstructed (represented by subscribed
‘R’) ECG signals. The reconstructed leads are shifted by 0.2 mV from the original place to better
presentation. Figure 2 shows that the synthesized and recorded leads are highly correlated and seem
exactly the same.
We used the Sprague and Geers’ metric [15,16] to show the agreement between recorded and
reconstructed signals. MS&G provides the magnitude error, PS&G gives the phase error, and CS&G
presents the overall error between recorded signals (m) and reconstructed signals (p) which both
have a length of N. There is a more than 99% correlation between the reconstructed and recorded
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leads, which clarifies that the recorded and reconstructed signals are identical. The small differences
(indistinguishable since that correlation for every lead exceeds 0.99) are due to components’ tolerances
and mismatches. Table 4 presents the summary of the Sprague and Geers’ error and correlation
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Table 4. The average Sprague and Geers’ error and correlation between recorded and reconstructed
leads for 92 patients.
Lead I Lead II Lead III V1 V2 V3 V4 V5 V6
MS&G 0.012 0.013 0.023 0.017 0.026 0.020 0.019 0.018 0.023
PS&G 0 0 0 0 0 0 0 0 0
CS&G 0.012 0.013 0.023 0.017 0.026 0.020 0.019 0.018 0.023
Correlation 0.998 0.997 0.995 0.992 0.995 0.998 0.998 0.997 0.996
4. Results and Discussion
We measured and reported the amplitude of the WCT as the percentage of lead II [5,17,18].
Our results support previous findings [19–21] to measure the WCT signal and showed that the WCT
amplitude could be as high as 247% of lead II. Figure 3 is an example of a large WCT amplitude
in relation to lead II. Furthermore, the WCT is highly individual, and it presents the standard ECG
characteristics such as the p-wave and the t-wave. The distribution of the WCT polarity mostly has
positive deflection, with some negative deflections and a handful of neutral polarities. We define
as ‘neutral polarities’ those signals whose QRS as a bipolar mode of approximately equal positive
and negative deflection [22]. Figure 4 demonstrates an example of positive, negatives, and neutral
deflection of the WCT.
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Figure 4. Top panel: the WCT with positive deflection (patient ID 44); middle panel: the WCT with
negative deflection (patient ID 50); and bottom panel: the WCT with neutral deflection (patient ID 67).
This dataset provides the opportunity to have a better understanding of the limb potentials, as it
contains the right arm, left arm, and left leg potential. The potential of limb electrodes depends on
their location in relation to the heart. Since the left arm electrode is closer to the heart, it is assumed to
have a larger amplitude while the left leg electrode has the largest distance from the heart and thus its
potential amplitude assumed to be small or even negligible. However, our recordings show that this
assumption was not correct for all patients. Figure 5 is an example of the patient with the right arm
potential higher than the left arm and the left leg potentials. In this patient, the peak to peak amplitude
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of the left leg and the left arm were very close to each other, and in comparison, with the right arm
potential, their amplitude was negligible.
 
Figure 5. Comparison of the left arm (LA), right arm (RA), and left leg (LL) potentials. The RA has the
peak to peak amplitude of 0.4 mV, while the LA has 0.07 mV, and the LL has 0.04 mV (patient ID 13).
We measured the peak to peak amplitudes of limbs’ potential for three beats and reported the
results in respect to lead II (Figures 6 and 7). Our recordings show that the RA had a higher potential
than the LA for 29 patients (Figure 6).
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 Figure 7. The amplitude of the WCT, LA, RA, and LL with respect to lead II for all 92 patients. Panel (a):
the WCT/lead II is in the range of [0.11, 2.47] with an average of 0.78; Panel (b): the RA/lead II is in the
range of [0.01, 2.7] with an average of 0.88; Panel (c): the LA/lead II is in the range of [0.038, 6.41] with
an average of 1.61; and Panel (d): the LL/lead II is in the range of [0.007, 1.78] with an average of 0.22.
5. Conclusions
In this paper, we presented a unique dataset, which contained the WCT signal, six unipolar
chest leads associated with three Einthoven limb leads, and six precordial leads. We recorded from
92 patients at Campbelltown Hospital (Campbelltown, Australia). We split each recording into ten
second sections. Consequently, there were 540 segments in this dataset. Our recordings demonstrated
that the WCT had ECG characteristics such as p-wave and t-wave. Additionally, our results confirmed
the previous finding that the WCT is not a steady voltage reference during the cardiac cycle, thus,
the WCT may be a new clinically relevant signal due to its high amplitude. We also presented the
Einthoven limbs potential features for the first time. Our data undermined the initial assumption that
the LL had a negligible amplitude and the LA had the highest potential among three Einthoven limbs.
Furthermore, we showed that the 12-lead ECG signals could be synthesized using our unipolar leads
(refereed directly to the right leg) with a high correlation (>0.99).
6. Appendix Further Notes on the WCT and Hardware
As mentioned in the paper the WCT has been the object of debate since its inception and to date
there is not a common understanding of what is WCT and where it is located.
What is the Wilson Central Terminal? The ideal reference point characterized by having (a) zero
amplitude and (b) constant and steady in all places/times [23]. Only the infinity has these features,
however, to find the feasible reference point respect to the volume conductor in the size of the human
body, Wilson suggested using the central terminal [4,23]. As the electrical activity of the heart was
assumed to be a single dipole in the centroid of the Einthoven triangle, he suggested averaging the
potential of the limbs electrodes in order to estimate the potential of the dipole. Wilson assumed
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by using three large resistors connected to the limb electrodes, only a negligible current could pass.
Therefore, each limb potential could be obtained. Nevertheless, Wilson’s theory initially absorbed
researchers’ attention to work on measuring the real amplitude of the WCT [19–21,24–28]. The initial
findings showed that the WCT amplitude could be as large as 40% of Einthoven’s ECG signals [19,21].
However, due to the difficulty of the WCT measurement, the method of measuring ECG using the
WCT has been widely accepted and received scant research attention since the 1960s.
Where is the Wilson Central Terminal? In theory, the WCT is formulated based on the simplified
assumption that the electrical activity of the heart can be reduced to a single electrical dipole
rotating around a fixed point in the chest [2,7] and located in the centre of the Einthoven’s triangle.
This hypothesis is built upon the assumption that the geometrical positions of the limbs’ electrode
construct the equilateral triangle, which is very unlikely in the routine ECG recording. In other words,
the Einthoven triangle is not really an equilateral triangle, and the average potential of the limbs’
electrode cannot represent the assumed zero potential of the dipole (Figure 8).
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What is the true unipolar chest leads? The precordial leads (V1:V6) have been referred to as
unipolar leads in the literature, as the WCT is assumed having a “null” amplitude in the cardiac cycle.
Contrary to the initial assumption, the WCT has a large amplitude and variability during the cardiac
cycle, and the precordial leads are actually bipolar and should not be considered as “true unipolar”.
Therefore, the WCT might remove important information from the potentials of chest electrodes.
Furthermore, changing the position of electrodes on the limb causes the WCT amplitude to change and
result in changing the precordial leads [29] (Figure 8).
In the past four years, we have developed and perfected (currently under trial) a new device,
which enables recording of unipolar ECGs without using the WCT [22]. Our device indeed is a voltage
recording device, as such it requires a reference point and a differential approach. Overall, our device
uses a combined supply voltage bootstrap technique (to minimize the common mode noise) and a body
reference placed to the right leg. According to the original inception of the surface electrocardiography
postulated by Einthoven, as there is not a direct circuit that would make a current to flow between the
legs that includes the heart directly in its pathway, we assumed that the right leg is the ideal reference
point as it has the largest distance from the dipole (heart). Once can note that although there is no
zero-potential in the human body, it is widely accepted that the right leg’s potential is near zero [30].
Therefore, we used this approximation to develop a new method to measure and store the WCT by
recording directly from limb electrodes [1]. Our ECG device is able to record (1) the traditional ECG
leads using the WCT as the reference point; and (2) the potential of electrodes on the limbs (RA, LA,
and LL) and chest (UV1:UV6) using the right leg (RL) as the reference point. Therefore, we can measure
the WCT amplitude, and the approximate unipolar leads, which are the raw biopotential measured
from the exploring electrodes directly referred to the right leg (RL). The full hardware is fully described
in [17].
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Glossary
• Electrocardiography: bioelectrical recording from the heart. Abbreviated ECG and EKG. It contains three
limb leads, three augmented leads, and six precordial leads.
• Reconstructed precordials: the difference between the potential of chest electrodes (UV1:UV6) and measured
WCT potential using our new ECG device VR1 : V
R
6 = UV1 : UV6−WCT. In this manuscript is referred to
the chest leads, which are synthesized due to having difficulty in recording.
• Unipolar lead: voltage or potential of an electrode referred to the zero-reference point.
• Wilson’s Central Terminal: the imaginary reference point of the human body used to measure the precordial
leads. Abbreviated as WCT. It is calculated by averaging the potential of right arm, left arm, and left leg, and
has been assumed to have a zero amplitude.
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